S-1 1 ammo_s1.htm REGISTRATION STATEMENT
As filed with the Securities and Exchange Commission on July 6, 2018
Registration Statement No. 333-_______

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AMMO, Inc.
(Exact name of registrant as specified in its charter)

Delaware |  | 2330 |  | 30-095972
(State or other jurisdiction of incorporation or organization) |  | (Primary Standard Industrial Code Number) |  | (I.R.S. Employer Identification Number)

6401 East Thomas Road, #106 Scottsdale, Arizona 85251 (480) 947-0001
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
Fred W. Wagenhals President and Chief Executive Officer 6401 East Thomas Road, #106 Scottsdale, Arizona 85251 (480) 947-0001
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)

Copy to:
Robert S. Kant, Esq. Greenberg Traurig, LLP 2375 East Camelback Road Suite 700 Phoenix, Arizona 85016 (602) 445-8000

Approximate date of commencement of proposed sale of the securities to the public: From time to time after the effective date of this registration statement.
If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

If this form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer | ☐ | Accelerated filer | ☐
Non-accelerated filer | ☐ (Do not check if a smaller reporting company) | Smaller reporting company | ☒

_____________________
CALCULATION OF REGISTRATION FEE

Title of Securities to be Registered | Amount to be Registered(1) | Proposed Maximum Offering Price per share | Proposed Maximum Aggregate Offering Price (1)(2) | Amount of Registration Fee
Common Stock, par value $0.001 per share | 13,242,186 | $6.04 | $79,982,803.00 | $9,957.86

(1) | Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), we are also registering an indeterminate number of shares that may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends, or similar transactions.

(2) | The proposed maximum offering price per share was computed in accordance with Rule 457(c) promulgated under the Securities Act, based upon the average of the high and low sales prices of our Common Stock as reported on June 30, 2018.

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

The information in this Prospectus is not complete and may be changed. The selling stockholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Prospectus is not an offer to sell these securities and it is not soliciting offers to buy these securities in any state where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED JULY 6, 2018
PROSPECTUS
AMMO, INC.
13,242,186 Shares
Common Stock
_______________
The selling stockholders may offer and sell, from time to time, in one or more offerings, up to 13,242,186 shares of our Common Stock, par value $0.001 per share. The Common Stock may be sold at fixed prices, prevailing market prices at the times of sale, prices related to the prevailing market prices, varying prices determined at the times of sale, or negotiated prices. The Common Stock offered by this Prospectus may be offered by the selling stockholders to or through underwriters, dealers, or other agents, directly to investors, or through any other manner permitted by law, on a continued or delayed basis. See “Plan of Distribution” beginning on page 54 of this Prospectus.
We are not selling any Common Stock under this Prospectus and will not receive any of the proceeds from the sale of the Common Stock sold by the selling stockholders. The registration of the securities covered by this Prospectus does not necessarily mean that any of these securities will be offered or sold by the selling stockholders. The timing and amount of any sale is within the respective selling stockholders’ sole discretion, subject to certain restrictions. To the extent that any selling stockholder resells any securities, the selling stockholder may be required to provide you with this Prospectus identifying and containing specific information about the selling stockholder and the terms of the securities being offered.
Our Common Stock is traded on the over-the-counter market under the symbol “POWW.” On June 30, 2018, the closing price of our Common Stock as reported by OTC Markets Group, Inc. was $6.04 per share.
_____________________
See “Risk Factors” in the section entitled “Risk Factors” on page 6 of this Prospectus for a discussion of certain risk factors that should be considered by prospective purchasers of the Common Stock offered under this Prospectus.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this Prospectus. Any representation to the contrary is a criminal offense.
_____________________
The date of this Prospectus is ________________, 2018

TABLE OF CONTENTS

PROSPECTUS SUMMARY | 3
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS | 5
RISK FACTORS | 6
USE OF PROCEEDS | 26
MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND PURCHASES OF EQUITY SECURITIES | 26
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 28
BUSINESS | 37
DIRECTORS AND EXECUTIVE OFFICERS | 43
CORPORATE GOVERNANCE | 45
EXECUTIVE COMPENSATION | 50
PRINCIPAL AND SELLING STOCKHOLDERS | 51
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE | 56
DESCRIPTION OF COMMON STOCK | 56
PLAN OF DISTRIBUTION | 57
SHARES ELIGIBLE FOR FUTURE SALE | 59
LEGAL MATTERS | 59
EXPERTS | 59
WHERE YOU CAN FIND MORE INFORMATION | 59
INDEX TO FINANCIAL STATEMENTS | 60

1

ABOUT THIS PROSPECTUS
This Prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a “shelf” registration process. Under this shelf registration process, the selling stockholders may, from time to time, offer and sell shares of Common Stock offered under this Prospectus.
We and the selling stockholders have not authorized anyone to provide any information or make any representations other than those contained in this Prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This Prospectus is an offer to sell only the shares of Common Stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information in this Prospectus is current only as of its date.
The selling stockholders are offering to sell, and seeking offers to buy, the Common Stock only in jurisdictions where offers and sales are permitted. The information contained in this Prospectus is accurate only as of the date of this Prospectus regardless of the time of delivery of this Prospectus or of any sale of the Common Stock. Neither the delivery of this Prospectus, nor any sale made hereunder, will under any circumstances create any implication that there has been no change in our affairs since the date hereof or that the information contained herein is correct as of any time subsequent to the date of such information.
______________
2

PROSPECTUS SUMMARY
The following summary does not contain all of the information that may be important to purchasers of our securities. Prospective purchasers of Common Stock should carefully review the detailed information and financial statements, including the notes thereto, appearing elsewhere in this Prospectus. Unless otherwise indicated, the terms “Ammo, Inc.,” “we,” “us,” “our,” and “our company” refer to Ammo, Inc.
Our Business
We are a designer, producer, and marketer of performance-driven, high-quality ammunition products for sale to a variety of consumers, including sport and recreational shooters, hunters, individuals seeking home or personal protection, and law enforcement and military agencies. To enhance the strength of our brands and drive product demand, we emphasize product innovation and technology to improve the performance, quality, and affordability of our products while providing support to our distribution channel and consumers. We seek to sell products that perform like high-end, custom, hand-loaded ammunition at competitive prices. We emphasize an American heritage by using predominantly American-made components in our products that are produced, inspected, and packaged at our facility in Payson, Arizona.
Our production processes focus on safety, consistency, precision, and cleanliness. Each round is developed for a specific purpose with a focus on a proper mix of consistency, velocity, accuracy, and recoil. Each round is chamber gauged and inspected with redundant seven-step quality control processes.
Our Growth Strategy
Our goal is to enhance our position as a leading designer, producer, and marketer of ammunition products. Key elements of our strategy to achieve this goal are as follows:
Design, Produce, and Market Innovative, Distinctive, Performance-Driven, High-Quality Ammunition
We are focused on designing, producing, and marketing innovative, distinctive, performance-driven, high-quality products that appeal to retailers and consumers that will enhance our users' shooting experiences. Our ongoing research and development activities; our safe, consistent, precision, and clean production processes; and our multi-faceted marketing programs are critical to our success.
Continue to Strengthen Relationships with Channel Partners and Retailers.
We continue to strive to strengthen our relationships with our current distributors, dealers, and mass market and specialty retailers and to attract additional distributors, dealers, and retailers. The success of our efforts depends on the innovation, distinctive features, quality, and performance of our products; the attractiveness of our packaging; the effectiveness of our marketing and merchandising programs; and the effectiveness of our customer support.
Emphasis on Customer Satisfaction and Loyalty
We plan to continue to emphasize customer satisfaction and loyalty by offering innovative, distinctive, high-quality products on a timely and cost-attractive basis and by offering effective customer service, training, and support. We regard the features, quality, and performance of our products as the most important components of our customer satisfaction and loyalty efforts, but we also rely on customer service and support, such as toll-free, customer support numbers, extensive service policies, and product warranties.
3

Continuously Improving Operations
We plan to continue focusing on improving all aspects of our business, including research and development, component sourcing, production processes, marketing programs, and customer support. We are continuing our efforts to enhance our production by increasing daily production quantities through equipment acquisitions, expanded shifts and process improvements, increased operational availability of our equipment, reduced equipment down times, and increased overall efficiency.
Enhance Market Share, Brand Recognition, and Customer Loyalty
We strive to enhance our market share, brand recognition, and customer loyalty. Industry sources estimate that 70 million to 80 million people in the United States own more than approximately 300 million firearms, creating a large installed base for our ammunition products. We are focusing on the premium segment of the market through the quality, distinctiveness, and performance of our products; the effectiveness of our marketing and merchandising efforts; and the attractiveness of our competitive pricing strategies.
Pursue Synergetic Strategic Acquisitions and Relationships
We intend to pursue strategic acquisitions and develop strategic relationships designed to enable us to expand our technology and knowhow, expand our product offerings, strengthen and expand our supply chain, enhance our production process, expand our marketing and distribution, and attract new customers.
Our Offices
We maintain our principal executive offices at 6401 East Thomas Road, #106, Scottsdale, Arizona. Our telephone number is (480) 947-0001. Our website is ammo-inc.com. The information contained on our website as that can be assessed through our website does not constitute part of this Prospectus.
The Offering

Common stock offered by the selling stockholders | 13,242,186 shares
Common stock outstanding before and after this offering | 31,475,684 shares
Use of Proceeds | We will not receive any of the proceeds from this offering.
Risk factors | This investment involves a high degree of risk. See the information contained in “Risk Factors” beginning on page 6 of this Prospectus.
Common stock symbol | Our Common Stock is listed in the over-the-counter market under the symbol POWW.

The number of shares of Common Stock outstanding before and after this offering is based on 31,475,684 shares outstanding on June 30, 2018 and excludes the following as of that date:

| · | outstanding warrants representing the right to purchase a total of 4,273,260 shares of Common Stock at a weighted exercise price of 2.48 per share

4

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
The statements contained in this Prospectus that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act. All statements other than statements of historical facts contained in this Prospectus, including statements regarding our future operating results, future financial position, business strategy, objectives, goals, plans, prospects, and markets, and plans and objectives for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “estimates,” “expects,” “intents,” “targets,” “contemplates,” “projects,” “predicts,” “may,” “might,” “plan,” “will,” “would,” “should,” “could,” “may,” “can,” “potential,” “continue,” “objective,” or the negative of those terms, or similar expressions intended to identify forward-looking statements. However, not all forward-looking statements contain these identifying words.
Specific forward-looking statements in this Prospectus include the effect of a variety of economic, social, and political factors on our business; legislative and regulatory matters; future products and product developments; the features and performance of our products; the success of particular product or marketing programs; competitive factors: any strategic partnerships or acquisitions we may enter into or make; our manufacturing costs, capabilities, and efficiencies; liquidity and anticipated needs and availability; the effect of interest rates or inflation; and the volitivity of our stock price.
All forward-looking statements included herein are based on information available to us as of the date hereof and speak only as of such date. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. The forward-looking statements contained in this Prospectus reflect our views as of the date of this Prospectus about future events and are subject to risks, uncertainties, assumptions, and changes in circumstances that may cause our actual results, performance, or achievements to differ significantly from those expressed or implied in any forward-looking statement.
Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future events, results, performance, or achievements. A number of factors could cause actual results to differ materially from those indicated by the forward-looking statements, including risks detailed from time to time in our reports to the SEC.
Readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on these forward-looking statements. All of the forward-looking statements we have included in this Prospectus are based on information available to us on the date of this Prospectus. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as otherwise required by law.
5

RISK FACTORS
Purchasing our Common Stock involves a high degree of risk. You should carefully consider the following risk factors, together with all of the information included in this Prospectus, before you decide to purchase shares of our Common Stock. We believe the risks and uncertainties described below are the most significant we face. Additional risks and uncertainties of which we are unaware, or that we currently deem immaterial, also may become important factors that affect us. If any of the following risks occur, our business, operating results, and financial condition could be materially and adversely affected. In that case, the trading price of our Common Stock could decline, and you may lose all or part of your investment.
We have a limited operating history on which you can evaluate our company.
We have a limited operating history on which you can evaluate our company. Although the corporate entity has existed since 1990, we have only operated as an ammunition manufacturer since March 2017. As result, our business will be subject to many of the problems, expenses, delays, and risks inherent in the establishment of a new business enterprise.
Our performance is influenced by a variety of economic, social, and political factors.
Our performance is influenced by a variety of economic, social, and political factors. General economic conditions and consumer spending patterns can negatively impact our operating results. Economic uncertainty, unfavorable employment levels, declines in consumer confidence, increases in consumer debt levels, increased commodity prices, and other economic factors may affect consumer spending on discretionary items and adversely affect the demand for our products. In times of economic uncertainty, consumers tend to defer expenditures for discretionary items, which affects demand for our products. Any substantial deterioration in general economic conditions that diminish consumer confidence or discretionary income could reduce our sales and adversely affect our operating results. Economic conditions also affect governmental political and budgetary policies. As a result, economic conditions also can have an effect on the sale of our products to law enforcement, government, and military customers.
Political and other factors also can affect our performance. Concerns about presidential, congressional, and state elections and legislature and policy shifts resulting from those elections can affect the demand for our products. In addition, speculation surrounding control of firearms, firearm products, and ammunition at the federal, state, and local level and heightened fears of terrorism and crime can affect consumer demand for our products. Often, such concerns result in an increase in near-term consumer demand and subsequent softening of demand when such concerns subside. Inventory levels in excess of customer demand may negatively impact operating results and cash flow.
Federal and state legislatures frequently consider legislation relating to the regulation of firearms, including amendment or repeal of existing legislation. Existing laws may also be affected by future judicial rulings and interpretations firearm products, and ammunition. If such restrictive changes to legislation develop, we could find it difficult, expensive, or even impossible to comply with them, impeding new product development and distribution of existing products.
Our success depends upon our ability to introduce new products that match customer preferences.
Our success depends upon our ability to introduce new products that match consumer preferences. Our efforts to introduce new products into the market may not be successful, and any new products that we introduce may not result in customer or market acceptance. We develop new products that we believe will match consumer preferences. The development of a new product is a lengthy and costly process and may not result in the development of a successful product. Failure to develop new products that are attractive to consumers could decrease our sales, operating margins, and market share and could adversely affect our business, operating results, and financial condition.
6

If we are unable to protect our intellectual property, we may lose a competitive advantage or incur substantial litigation costs to protect our rights.
Our future success depends upon our proprietary technology. Our protective measures, including patent and trade secret protection, may prove inadequate to protect our proprietary rights. The right to stop others from misusing our trademarks, service marks, and patents in commerce depends to some extent on our ability to show evidence of enforcement of our rights against such misuse in commerce. Our efforts to stop improper use, if insufficient, may lead to loss of trademark and service mark rights, brand loyalty, and notoriety among our customers and prospective customers. The scope of any patent that we have or may obtain may not prevent others from developing and selling competing products. The validity and breadth of claims covered in technology patents involve complex legal and factual questions, and the resolution of such claims may be highly uncertain, and expensive. In addition, our patents may be held invalid upon challenge, or others may claim rights in or ownership of our patents.
We may be subject to intellectual property infringement claims, which could cause us to incur litigation costs and divert management attention from our business.
Any intellectual property infringement claims against us, with or without merit, could be costly and time-consuming to defend and divert our management’s attention from our business. If our products were found to infringe a third party’s proprietary rights, we could be required to enter into costly royalty or licensing agreements to be able to sell our products. Royalty and licensing agreements, if required, may not be available on terms acceptable to us or at all.
Our efforts to avoid the patent, trademark, and copyright rights of others may not provide notice to us of potential infringements in time to avoid investing in product development and promotion that must later be abandoned if suitable license terms cannot be reached.
There is no guarantee that our use of conventional technology searching and brand clearance searching will identify all potential rights holders. Rights holders may demand payment for past infringements and/or force us to accept costly license terms or discontinue use of protected technology and/or works of authorship that may include for example photos, videos, and software.
We depend on the sale of our ammunition products.
We manufacture ammunition for sale to a wide variety of consumers, including gun enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement and security agencies and officers in the United States and throughout the world. The sale of ammunition is influenced by the sale and usage of firearms. As noted above, sales of firearms are influenced by a variety of economic, social, and political factors, which may result in volatile sales. Ammunition sales represented substantially all of our net sales for the three-month period ended March 31, 2018 and year ended December 31, 2017.
7

Our manufacturing facility is critical to our success.
Our Arizona manufacturing facility is critical to our success, as we currently produce all of our products at this facility. The facility also houses our principal research, development, engineering, and design functions.
Any event that causes a disruption of the operation of this facility for even a relatively short period of time would adversely affect our ability to produce and ship our products and to provide service to our customers. We make certain changes in our manufacturing operations from time to time to enhance the facility and associated equipment and systems and to introduce certain efficiencies in manufacturing and other processes to produce our products in a more efficient and cost-effective manner. We anticipate that we will continue to incur significant capital and other expenditures with respect to this facility, but we may not be successful in continuing to improve efficiencies.
To the extent demand for our products increase, our future success will depend upon our ability to enhance manufacturing production capacity.
We intend to continue marketing our ammunition products. To the extent demand for our products increase significantly in future periods, one of our key challenges will be to enhance production capacity to meet sales demand, while maintaining product quality. Our inability to meet any future increase in sales demand or access capital for inventory may hinder growth or increase dilution.
Shortages of components and materials may delay or reduce our sales and increase our costs, thereby harming our results of operations.
The inability to obtain sufficient quantities of raw materials and components, including casings, primers, gun powder, and projectiles, necessary for the production of our products could result in reduced or delayed sales or lost orders. Any delay in or loss of sales or orders could adversely impact our operating results. Many of the materials used in the production of our products are available only from a limited number of suppliers. We do not have long-term supply contracts with any suppliers. As a result, we could be subject to increased costs, supply interruptions, and difficulties in obtaining raw materials and components.
Our reliance on third-party suppliers for various raw materials and components for our products exposes us to volatility in the availability, quality, and price of these raw materials and components. Our orders with certain of our suppliers may represent a very small portion of their total orders. As a result, they may not give priority to our business, leading to potential delays in or cancellation of our orders. A disruption in deliveries from our third-party suppliers, capacity constraints, production disruptions, price increases, or decreased availability of raw materials or commodities could have an adverse effect on our ability to meet our commitments to customers or increase our operating costs. Quality issues experienced by third party suppliers can also adversely affect the quality and effectiveness of our products and result in liability and reputational harm.
We rely on third-party suppliers for most of our manufacturing equipment.
We also rely on third-party suppliers for most of the manufacturing equipment necessary to produce our products. The failure of suppliers to supply manufacturing equipment in a timely manner or on commercially reasonable terms could delay our plans to expand our business and otherwise disrupt our production schedules and increase our manufacturing costs. Our orders with certain of our suppliers may represent a very small portion of their total orders. As a result, they may not give priority to our business, leading to potential delays in or cancellation of our orders. If any single-source supplier were to fail to supply our needs on a timely basis or cease providing us manufacturing equipment or components, we would be required to locate and contract with substitute suppliers. We may have difficulty identifying a substitute supplier in a timely manner and on commercially reasonable terms. If this were to occur, our business would be harmed.
8

We do not have long-term purchase commitments from our customers, and their ability to cancel, reduce, or delay orders could reduce our revenue and increase our costs.
Our customers do not provide us with firm, long-term volume purchase commitments, but issue purchase orders for our products. As a result, customers can cancel purchase orders or reduce or delay orders at any time. The cancellation, delay, or reduction of customer purchase orders could result in reduced sales, excess inventory, unabsorbed overhead, and reduced income from operations.
We often schedule internal production levels and place orders for raw materials and components with third party suppliers before receiving firm orders from our customers. Therefore, if we fail to accurately forecast customer demand, we may experience excess inventory levels or a shortage of products to deliver to our customers. Factors that could affect our ability to accurately forecast demand for our products include the following:

| · | an increase or decrease in consumer demand for our products or for the products of our competitors;

| · | our failure to accurately forecast consumer acceptance of new products;

| · | new product introductions by us or our competitors;

| · | changes in our relationships within our distribution channels;

| · | changes in general market conditions or other factors, which may result in cancellations of orders or a reduction or increase in the rate of reorders placed by retailers;

| · | changes in laws and regulations governing the activities for which we sell products, such as hunting and shooting sports;

| · | weak economic conditions or consumer confidence, which could reduce demand for discretionary items, such as our products; and

| · | the domestic political environment, including debate over the regulation of firearms, ammunition, and related products.

Inventory levels in excess of consumer demand may result in inventory write-downs and the sale of excess inventory at discounted prices, which could have an adverse effect on our business, operating results, and financial condition. If we underestimate demand for our products, our manufacturing facility or third-party suppliers may not be able to react quickly enough to meet consumer demand, resulting in delays in the shipment of products and lost revenue, and damage to our reputation and customer and consumer relationships. We may not be able to manage inventory levels successfully to meet future order and reorder requirements.
Our revenue depends primarily on sales by various retailers and distributors, some of which account for a significant portion of our sales.
Our revenue depends on our sales through various leading national and regional retailers, local specialty firearms stores, and online merchants. The U.S. retail industry serving the outdoor recreation market has become relatively concentrated. Our sales could become increasingly dependent on purchases by several large retail customers. Consolidation in the retail industry could also adversely affect our business. If our sales were to become increasingly dependent on business with several large retailers, we could be adversely affected by the loss or a significant decline in sales to one or more of these customers. In addition, our dependence on a smaller group of retailers could result in their increased bargaining position and pressures on the prices we charge.
9

The loss of any one or more of our retail customers or significant or numerous cancellations, reductions, delays in purchases or changes in business practices by our retail customers could have an adverse effect on our business, operating results, and financial condition.
These sales channels involve a number of special risks, including the following:

| · | we may be unable to secure and maintain favorable relationships with retailers and distributors;

| · | we may be unable to control the timing of delivery of our products to end-user consumers;

| · | our retailers and distributors are not subject to minimum sales requirements or any obligation to market our products to their customers;

| · | our retailers and distributors may terminate their relationships with us at any time; and

| · | our retailers and distributors market and distribute competing products.

We have three customers that accounted for approximately 59% of our net sales for the three-month period ended March 31, 2018. At December 31, 2017, 58% of our net sales resulted from one customer. Although we intent to expand our customer base, our revenue would likely decline if we lost any major customers or if one of these sizable customers were to significantly reduce its orders for any reason. Because our sales are made by means of standard purchase orders rather than long-term contracts, we cannot assure you that our customers will continue to purchase our products at current levels, or at all.
In addition, periods of sluggish economies and consumer uncertainty regarding future economic prospects in our key markets can have an adverse effect on the financial health of our customers, which may in turn have a material adverse effect on our business, operating results, and financial condition.
We extend credit to our customers for periods of varying duration based on an assessment of the customer's financial condition, generally without requiring collateral, which increases our exposure to the risk of uncollectable receivables. In addition, we face increased risk of order reduction or cancellation when dealing with financially ailing retailers or retailers struggling with economic uncertainty. We may reduce our level of business with customers and distributors experiencing financial difficulties and may not be able to replace that business with other customers, which could have a material adverse effect on our business, operating results, and financial condition.
10

An inability to expand our E-commerce business could reduce our future growth.
Consumers are increasingly purchasing online. We operate direct-to-consumer e-commerce stores to maintain an online presence with our end users. The future success of our online operations depends on our ability to use our marketing resources to communicate with existing and potential customers. We face competitive pressure to offer promotional discounts, which could impact our gross margin and increase our marketing expenses. We are limited, however, in our ability to fully respond to competitor price discounting because we cannot market our products at prices that may produce adverse relationships with our customers that operate brick and mortar locations as they may perceive themselves to be at a disadvantage based on lower e-commerce pricing to end consumers. There is no assurance that we will be able to successfully expand our e-commerce business to respond to shifting consumer traffic patterns and direct-to-consumer buying trends.
In addition, e-commerce and direct-to-consumer operations are subject to numerous risks, including implementing and maintaining appropriate technology to support business strategies; reliance on third-party computer hardware/software and service providers; data breaches; violations of state, federal or international laws, including those relating to online privacy; credit card fraud; telecommunication failures; electronic break-ins and similar disruptions; and disruption of Internet service. Our inability to adequately respond to these risks and uncertainties or to successfully maintain and expand our direct-to-consumer business may have an adverse impact on our business and operating results.
Our gross margins depend upon our sales mix.
We have targeted a range for gross margin of between 25% to 35% of sales based upon a projected mix of proportionately larger sales for our higher-margin proprietary product lines versus a lower contribution from mid-market ammunition we also currently manufacture. If our actual sales mix results in a lower overall percentage from our proprietary lines, our gross margins will be significantly reduced, affecting our results of operations.
We may have difficulty collecting amounts owed to us.
Certain of our customers may experience business challenges and credit-related issues. We perform ongoing credit evaluations of customers, but these evaluations may not be completely effective. We grant payment terms to most customers ranging from 30 to 120 days and do not generally require collateral. Should more customers than we anticipate experience liquidity issues, or if payments are not received on a timely basis, we may have difficulty collecting amounts owed to us by such customers and our business, operating results, and financial condition could be adversely impacted. Retail consolidation could result in more concentrated credit-related risks.
We face intense competition that could result in our losing or failing to gain market share and suffering reduced sales.
We operate in intensely competitive markets that are characterized by price erosion and competition from major domestic and international companies. Competition in the markets in which we operate is based on a number of factors, including price, quality, product innovation, performance, reliability, styling, product features, and warranties, and sales and marketing programs. This intense competition could result in pricing pressures, lower sales, reduced margins, and lower market share.
Our competitors include Federal Premium Ammunition, Remington Arms, the Winchester Ammunition Division of Olin Corporation, and various smaller manufacturers and importers, including Black Hills Ammunition, CBC Group, Fiocchi Ammunition, Hornady, PMC, Rio Ammunition, and Wolf. Most of our competitors have greater market recognition, larger customer bases, long-term government contracts, and substantially greater financial, technical, marketing, distribution, and other resources than we possess and that afford them competitive advantages. As a result, they may be able to devote greater resources to the promotion and sale of products, to invest more funds in intellectual property and product development, to negotiate lower prices for raw materials and components, to deliver competitive products at lower prices, and to introduce new products and respond to consumer requirements more quickly than we can.
Our competitors could introduce products with superior features at lower prices than our products and could also bundle existing or new products with other more established products to compete with us. Certain of our competitors may be willing to reduce prices and accept lower profit margins to compete with us. Our competitors could also gain market share by acquiring or forming strategic alliances with other competitors.
Finally, we may face additional sources of competition in the future because new distribution methods offered by the Internet and electronic commerce have removed many of the barriers to entry historically faced by start-up companies. Retailers also demand that suppliers reduce their prices on products, which could lead to lower margins. Any of the foregoing effects could cause our sales to decline, which would harm our financial position and results of operations.
11

Our ability to compete successfully depends on a number of factors, both within and outside our control. These factors include the following:

| · | our success in developing, producing, marketing, and successfully selling new products;

| · | our ability to address the needs of our consumer customers;

| · | the pricing, quality, performance, and reliability of our products;

| · | the quality of our customer service;

| · | the efficiency of our production; and

| · | product or technology introductions by our competitors.

Because we believe technological and functional distinctions among competing products in our markets are perceived by many end-user consumers to be relatively modest, effectiveness in marketing and manufacturing are particularly important competitive factors in our business.
Seasonality and weather conditions may cause our operating results to vary from quarter to quarter.
Because many of our products are used for seasonal outdoor sporting activities, our operating results may be significantly impacted by unseasonable weather conditions. Accordingly, our operating results could suffer when weather patterns do not conform to seasonal norms.
Shipments of ammunition for hunting are highest during the months of June through September to meet consumer demand for the fall hunting season and holidays. The seasonality of our sales may change in the future. Seasonal variations in our operating results may reduce our cash on hand, increase our inventory levels, and extend our accounts receivable collection periods. This in turn may cause us to increase our debt levels and interest expense to fund our working capital requirements.
We manufacture and sell products that create exposure to potential product liability, warranty liability, or personal injury claims and litigation.
Our products are used in activities and situations that involve risk of personal injury and death. Our products expose us to potential product liability, warranty liability, and personal injury claims and litigation relating to the use or misuse of our products, including allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product or activities associated with the product, negligence, and strict liability. If successful, any such claims could have a material adverse effect on our business, operating results, and financial condition. Defects in our products may result in a loss of sales, recall expenses, delay in market acceptance, and damage to our reputation and increased warranty costs, which could have a material adverse effect on our business, operating results, and financial condition. Although we maintain product liability insurance in amounts that we believe are reasonable, we may not be able to maintain such insurance on acceptable terms, if at all, in the future and product liability claims may exceed the amount of insurance coverage. In addition, our reputation may be adversely affected by such claims, whether or not successful, including potential negative publicity about our products.
12

The failure to manage our growth could adversely affect our operations.
The failure to manage our growth could adversely affect our operations. To continue to expand our business and enhance our competitive position, we must make significant investments in equipment, facilities, systems, and personnel. In addition, we must commit significant funds to enhance our sales, marketing, information technology, and research and development efforts. As a result of the increase in fixed costs and operating expenses, our failure to increase our sales sufficiently to offset these increased costs could adversely affect our business, operating results, and financial condition.
Managing our planned growth effectively will require us to take a number of steps, including the following:

| · | enhance our operational, financial, and management systems;

| · | enhance our facilities and purchase additional equipment; and

| · | successfully hire, train, and retain additional employees, including additional personnel for our technological, sales, and marketing efforts.

The expansion of our products and customer base may result in increases in our overhead and selling expenses. We may be required to increase staffing and other expenses and our expenditures on capital equipment and leasehold improvements to meet the demand for our products. Any increase in expenditures in anticipation of future sales that do not materialize would adversely affect our profitability.
Our business is highly dependent upon our brand recognition and reputation, and the failure to maintain or enhance our brand recognition or reputation would likely have a material adverse effect on our business.
Our brand recognition and reputation are critical aspects of our business. We believe that maintaining and further enhancing our brands, particularly our Streak Visual Ammunition brands, and our reputation are critical to retaining existing customers and attracting new customers. We also believe that the importance of our brand recognition and reputation will continue to increase as competition in our markets continues to develop.
We anticipate that our advertising, marketing, and promotional efforts will increase in the foreseeable future as we continue to seek to enhance our brands and consumer demand for our products. Historically, we have relied on print and electronic media advertising to increase consumer awareness of our brands to increase purchasing intent and conversation. We anticipate that we will increasingly rely on other forms of media advertising, including social media and e-marketing. Our future growth and profitability will depend in large part upon the effectiveness and efficiency of our advertising, promotion, public relations, and marketing programs. These brand promotion activities may not yield increased revenue and the efficacy of these activities will depend on a number of factors, including our ability to do the following:

| · | determine the appropriate creative message and media mix for advertising, marketing, and promotional expenditures;

| · | select the right markets, media, and specific media vehicles in which to advertise;

| · | identify the most effective and efficient level of spending in each market, media, and specific media vehicle; and

| · | effectively manage marketing costs, including creative and media expenses, to maintain acceptable customer acquisition costs.

13

In addition, certain of our current or future products may benefit from endorsements and support from particular sportsmen, athletes, or other celebrities, and those products and brands may become personally associated with those individuals. As a result, sales of the endorsed products could be materially and adversely affected if any of those individuals' images, reputations, or popularity were to be negatively impacted.
Increases in the pricing of one or more of our marketing and advertising channels could increase our marketing and advertising expenses or cause us to choose less expensive but possibly less effective marketing and advertising channels. If we implement new marketing and advertising strategies, we may incur significantly higher costs than our current channels, which in turn could adversely affect our operating results. Implementing new marketing and advertising strategies also could increase the risk of devoting significant capital and other resources to endeavors that do not prove to be cost effective. We also may incur marketing and advertising expenses significantly in advance of the time we anticipate recognizing revenue associated with such expenses and our marketing and advertising expenditures may not generate sufficient levels of brand awareness and conversation or result in increased revenue. Even if our marketing and advertising expenses result in increased sales, the increase might not offset our related expenditures. If we are unable to maintain our marketing and advertising channels on cost-effective terms or replace or supplement existing marketing and advertising channels with similarly or more effective channels, our marketing and advertising expenses could increase substantially, our customer base could be adversely affected, and our business, operating results, financial condition, and reputation could suffer.
Our operating results may experience significant fluctuations.
Many factors contribute to significant periodic and seasonal quarterly fluctuations in our results of operations. These factors include the following:

| · | the cyclicality of the markets we serve;

| · | the timing and size of new orders;

| · | the cancellation of existing orders;

| · | the volume of orders relative to our capacity;

| · | product introductions and market acceptance of new products or new generations of products;

| · | timing of expenses in anticipation of future orders;

| · | changes in product mix;

| · | availability of production capacity;

| · | changes in cost and availability of labor and raw materials;

| · | timely delivery of products to customers;

| · | pricing and availability of competitive products;

| · | new product introduction costs;

| · | changes in the amount or timing of operating expenses;

| · | introduction of new technologies into the markets we serve;

| · | pressures on reducing selling prices;

| · | our success in serving new markets;

| · | adverse publicity regarding the safety, performance, and use of our products;

| · | the institution and outcome of any litigation;

| · | political, economic, or regulatory developments; and

| · | changes in economic conditions.

As a result of these and other factors, we believe that period-to-period comparisons of our results of operations may not be meaningful in the short term, and our performance in a particular period may not be indicative of our performance in any future period.
14

The failure to attract and retain key personnel could have an adverse effect on our operating results.
Our success depends substantially on the efforts and abilities of our senior management and key personnel. The competition for qualified management and key personnel is intense. Although we maintain noncompetition and nondisclosure covenants with many of our key personnel, we do not have employment agreements with most of them. The loss of services of one or more of our key employees or the inability to hire, train, and retain additional key personnel could delay the development and sale of our products, disrupt our business, and interfere with our ability to execute our business plan.
In addition, our ability to maintain our competitive position is dependent to a large degree on the efforts and skills of our senior management team, including Fred Wagenhals, our President and Chief Executive Officer. The loss of the services of one or more of our key personnel could materially and adversely affect our operations.
We may not be able to secure additional financing on favorable terms, or at all, to meet our future capital needs.
In the future, we may require additional capital to fund the planned expansion of our business and to respond to business opportunities, challenges, potential acquisitions, or unforeseen circumstances. We could encounter unforeseen difficulties that may deplete our capital resources rapidly, which could require us to seek additional financing in the near future. The timing and amount of any additional financing that is required to continue the expansion of our business and the marketing of our products will depend on our ability to improve our operating results and other factors. We may not be able to secure additional debt or equity financing in a timely basis or on favorable terms, or at all. Such financing could result in substantial dilution of the equity interests of existing stockholders. We have no commitments for any additional financing should the need arise. If we are unable to secure any necessary additional financing, we may need to delay expansion plans, conserve cash, and reduce operating expenses. There is no assurance that any additional financing will be sufficient, that the financing will be available on terms favorable to us or to existing stockholders and at such times as required, or that we will be able to obtain the additional financing required for the continued operation and growth of our business. Any debt financing obtained by us in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities. If we raise additional funds through further issuances of equity, convertible debt securities, or other securities convertible into equity, our existing stockholders could suffer significant dilution in their percentage ownership of our company, and any new equity securities we issue could have rights, preferences, and privileges senior to those of holders of our Common Stock. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to grow or support our business and to respond to business challenges could be significantly limited.
Potential strategic alliances may not achieve their objectives, which could impede our growth.
We anticipate that we will enter into strategic alliances in the future. We continue to explore strategic alliances designed to expand our product offerings, enter new markets, and improve our distribution channels. Strategic alliances may not achieve their intended objectives, and parties to our strategic alliances may not perform as contemplated. The failure of these alliances may impede our ability to introduce new products and enter new markets.
15

Any acquisitions that we undertake will involve significant risks, and any acquisitions that we undertake in the future could disrupt our business, dilute stockholder value, and harm our operating results.
We have a strategy to expand our operations through strategic acquisitions to enhance existing products and offer new products, enter new markets and businesses, strengthen and avoid interruption from our supply chain, and enhance our position in current markets and businesses. Acquisitions involve significant risks and uncertainties. We cannot accurately predict the timing, size, and success of any future acquisitions. We may be unable to identify suitable acquisition candidates or to complete the acquisitions of candidates that we identify. Increased competition for acquisition candidates or increased asking prices by acquisition candidates may increase purchase prices for acquisitions to levels beyond our financial capability or to levels that would not result in the returns required by our acquisition criteria. Unforeseen expenses, difficulties, and delays frequently encountered in connection with expansion through acquisitions could inhibit our growth and negatively impact our operating results.
Our ability to complete acquisitions that we desire to make will depend upon various factors, including the following:

| · | the availability of suitable acquisition candidates at attractive purchase prices;

| · | the ability to compete effectively for available acquisition opportunities;

| · | the availability of cash resources, borrowing capacity, or stock at favorable price levels to provide required purchase prices in acquisitions;

| · | the ability of management to devote sufficient attention to acquisition efforts; and

| · | the ability to obtain any requisite governmental or other approvals.

We may have little or no experience with certain acquired businesses, which could involve significantly different supply chains, production techniques, customers, and competitive factors than our current business. This lack of experience would require us to rely to a great extent on the management teams of these acquired businesses. These acquisitions also could require us to make significant investments in systems, equipment, facilities, and personnel in anticipation of growth. These costs could be essential to implement our growth strategy in supporting our expanded activities and resulting corporate structure changes. We may be unable to achieve some or all of the benefits that we expect to achieve as we expand into these new markets within the time frames we expect, if at all. If we fail to achieve some or all of the benefits that we expect to achieve as we expand into these new markets, or do not achieve them within the time frames we expect, our business, financial condition, and results of operations could be adversely affected.
As a part of any potential acquisition, we may engage in discussions with various acquisition candidates. In connection with these discussions, we and each potential acquisition candidate may exchange confidential operational and financial information, conduct due diligence inquiries, and consider the structure, terms, and conditions of the potential acquisition. In certain cases, the prospective acquisition candidate agrees not to discuss a potential acquisition with any other party for a specific period of time and agrees to take other actions designed to enhance the possibility of the acquisition, such as preparing audited financial information. Potential acquisition discussions frequently take place over a long period of time and involve difficult business integration and other issues. As a result of these and other factors, a number of potential acquisitions that from time-to-time appear likely to occur do not result in binding legal agreements and are not consummated, but may result in increased legal, consulting, and other costs.
16

Unforeseen expenses, difficulties, and delays frequently encountered in connection with future acquisitions could inhibit our growth and negatively impact our profitability. Any future acquisitions may not meet our strategic objectives or perform as anticipated. In addition, the size, timing, and success of any future acquisitions may cause substantial fluctuations in our operating results from quarter to quarter. These interim fluctuations could adversely affect the market price of our Common Stock.
If we finance any future acquisitions in whole or in part through the issuance of Common Stock or securities convertible into or exercisable for Common Stock, existing stockholders will experience dilution in the voting power of their Common Stock and earnings per share could be negatively impacted. The extent to which we will be able or willing to use our Common Stock for acquisitions will depend on the market price of our Common Stock from time-to-time and the willingness of potential acquisition candidates to accept our Common Stock as full or partial consideration for the sale of their businesses. Our inability to use our Common Stock as consideration, to generate cash from operations, or to obtain additional funding through debt or equity financings to pursue an acquisition could limit our growth.
Any acquisitions that we undertake could be difficult to integrate, disrupt our business, and harm our operations.
We may be unable to effectively complete an integration of the management, operations, facilities, and accounting and information systems of acquired businesses with our own; to implement effective controls to mitigate legal and business risks with which we have no prior experience; to manage efficiently the combined operations of the acquired businesses with our operations; to achieve our operating, growth, and performance goals for acquired businesses; to achieve additional sales as a result of our expanded operations; or to achieve operating efficiencies or otherwise realize cost savings as a result of anticipated acquisition synergies. The integration of acquired businesses involves numerous risks and uncertainties, including the following:

| · | the potential disruption of our core businesses;

| · | risks associated with entering markets and businesses in which we have little or no prior experience;

| · | diversion of management's attention from our core businesses;

| · | adverse effects on existing business relationships with suppliers and customers;

| · | risks associated with increased regulatory or compliance matters;

| · | failure to retain key customers, suppliers, or personnel of acquired businesses;

| · | the potential strain on our financial and managerial controls and reporting systems and procedures;

| · | greater than anticipated costs and expenses related to the integration of the acquired business with our business;

| · | potential unknown liabilities associated with the acquired company;

| · | risks associated with weak internal controls over information technology systems and associated cyber security risks;

| · | meeting the challenges inherent in effectively managing an increased number of employees in diverse locations;

| · | failure of acquired businesses to achieve expected results;

| · | the risk of impairment charges related to potential write-downs of acquired assets in future acquisitions; and

| · | the challenge of creating uniform standards, controls, procedures, policies, and information systems.

17

Breaches of our information systems could adversely affect our reputation, disrupt our operations, and result in increased costs and loss sales.
There have been an increasing number of cyber security incidents affecting companies around the world, which have caused operational failures or compromised sensitive corporate data. Although we do not believe our systems are at a greater risk of cyber security incidents than other similar organizations, such cyber security incidents may result in the loss or compromise of customer, financial, or operational data; disruption of billing, collections, or normal operating activities; disruption of electronic monitoring and control of operational systems; and delays in financial reporting and other management functions. Possible impacts associated with a cyber security incident may include among others, remediation costs related to lost, stolen, or compromised data; repairs to data processing systems; increased cyber security protection costs; reputational damage; and adverse effects on our compliance with applicable privacy and other laws and regulations.
A failure of our information technology systems, or an interruption in their operation due to internal or external factors including cyber-attacks, could have a material adverse effect on our business, financial condition or results of operations
Our operations depend on our ability to protect our information systems, computer equipment, and information databases from systems failures. We rely on our information technology systems generally to manage the day-to-day operations of our business, operate elements of our manufacturing facility, manage relationships with our customers, fulfill customer orders, and maintain our financial and accounting records. Failure of our information technology systems could be caused by internal or external events, such as incursions by intruders or hackers, computer viruses, cyber-attacks, failures in hardware or software, or power or telecommunication fluctuations or failures. The failure of our information technology systems to perform as anticipated for any reason or any significant breach of security could disrupt our business and result in numerous adverse consequences, including reduced effectiveness and efficiency of operations, increased costs, or loss of important information, any of which could have a material adverse effect on our business, operating results, and financial condition. Any technology and information security processes and disaster recovery plans we use to mitigate our risk to these vulnerabilities may not be adequate to ensure that our operations will not be disrupted should such an event occur.
We are subject to extensive regulation and could incur fines, penalties and other costs and liabilities under such requirements
Like many other manufacturers and distributors of consumer products, we are required to comply with a wide variety of laws, rules, and regulations, including those relating to labor, employment, the environment, the export and import of our products, and taxation. These laws, rules, and regulations currently impose significant compliance requirements on our business, and more restrictive laws, rules and regulations may be adopted in the future.
Our operations are subject to a variety of laws and regulations relating to environmental protection, including those governing the discharge, treatment, storage, transportation, remediation, and disposal of certain materials and wastes, and restoration of damages to the environment, and health and safety matters. We could incur substantial costs, including remediation costs, resource restoration costs, fines, penalties, and third-party property damage or personal injury claims as a result of liabilities under or violations of such laws and regulations or the permits required thereunder. While environmental laws and regulations have not had a material adverse effect on our business, operating results, financial condition, the ultimate cost of environmental liabilities is difficult to accurately predict and we could incur material additional costs as a result of requirements or obligations imposed or liabilities identified in the future.
18

As a manufacturer and distributor of consumer products, we are subject to the Consumer Products Safety Act, which empowers the Consumer Products Safety Commission to exclude from the market products that are found to be unsafe or hazardous. Under certain circumstances, the Consumer Products Safety Commission could require us to repurchase or recall one or more of our products. In addition, laws regulating certain consumer products exist in some cities and states, and in other countries in which we sell our products, and more restrictive laws and regulations may be adopted in the future. Any repurchase or recall of our products could be costly to us and could damage our reputation. If we were required to remove, or we voluntarily removed, our products from the market, our reputation could be tarnished and we could have large quantities of finished products that we are unable to sell. We are also subject to the rules and regulations of the Bureau of Alcohol, Tobacco, Firearms and Explosives, or the ATF. If we fail to comply with ATF rules and regulations, the ATF may limit our growth or business activities, levy fines against or revoke our license to do business. Our business, and the business of all producers and marketers of ammunition and firearms, is also subject to numerous federal, state, local, and foreign laws, regulations, and protocols. Applicable laws have the following effects:

| · | require the licensing of all persons manufacturing, exporting, importing, or selling firearms and ammunition as a business;

| · | require background checks for purchasers of firearms;

| · | impose waiting periods between the purchase of a firearm and the delivery of a firearm;

| · | prohibit the sale of firearms to certain persons, such as those below a certain age and persons with criminal records;

| · | regulate the use and storage of gun powder or other energetic materials;

| · | regulate our employment of personnel with criminal convictions; and

| · | restrict access to firearm manufacturing facilities for individuals from other countries or with criminal convictions.

Also, the export of our products is controlled by International Traffic in Arms Regulations, or ITAR, and Export Administration Regulations, or EAR. The ITAR implements the provisions of the Arms Export Control Act and is enforced by the U.S. Department of State. The EAR implements the provisions of the Export Administration Act and is enforced by the U.S. Department of Commerce. Among their many provisions, the ITAR and the EAR require a license application for the export of many of our products. In addition, the ITAR requires congressional approval for any firearms export application with a total value of $1 million or higher. Further, because our manufacturing process includes certain toxic, flammable and explosive chemicals, we are subject to the Chemical Facility Anti-Terrorism Standards, as administered by the U.S. Department of Homeland Security, which require that we take additional reporting and security measures related to our manufacturing process.
Several states currently have laws in effect that are similar to, and, in certain cases, more restrictive than, these federal laws. Compliance with all of these regulations is costly and time-consuming. Inadvertent violation of any of these regulations could cause us to incur fines and penalties and may also lead to restrictions on our ability to manufacture and sell our products and services and to import or export the products we sell.
19

Changes in government policies and firearms legislation could adversely affect our financial results
The sale, purchase, ownership, and use of firearms are subject to numerous and varied federal, state, and local governmental regulations. Federal laws governing firearms include the National Firearms Act, the Federal Firearms Act, the Arms Export Control Act, and the Gun Control Act of 1968. These laws generally govern the manufacture, import, export, sale, and possession of firearms and ammunition. We hold all necessary licenses to legally sell ammunition in the United States.
Currently, the federal legislature and several state legislatures are considering additional legislation relating to the regulation of firearms and ammunition. These proposed bills are extremely varied. If enacted, such legislation could effectively ban or severely limit the sale of affected firearms and ammunition. In addition, if such restrictions are enacted and are incongruent, we could find it difficult, expensive, or even practically impossible to comply with them, which could impede new product development and the distribution of existing products. We cannot assure you that the regulation of our business activities will not become more restrictive in the future and that any such restriction will not have a material adverse effect on our business.
Any change to the Second Amendment would dramatically impact our ability to conduct business.
Failure to comply with the U.S. Foreign Corrupt Practices Act or other applicable anti-corruption legislation, and export controls and trade sanctions, could result in fines or criminal penalties if we expand our business abroad
The expansion of our business internationally would expose us to trade sanctions and other restrictions imposed by the United States and other governments. The U.S. Departments of Justice, Commerce, Treasury and other agencies and authorities have a broad range of civil and criminal penalties they may seek to impose against companies for violations of export controls, the Foreign Corrupt Practices Act, anti-boycott provisions and other federal statutes, sanctions and regulations and, increasingly, similar or more restrictive foreign laws, rules and regulations, which may also apply to us. By virtue of these laws and regulations, and under laws and regulations in other jurisdictions, we may be obliged to limit our business activities, we may incur costs for compliance programs and we may be subject to enforcement actions or penalties for noncompliance. In recent years, U.S. and foreign governments have increased their oversight and enforcement activities with respect to these laws and we expect the relevant agencies to continue to increase these activities. A violation of these laws, sanctions or regulations could result in restrictions on our exports, civil and criminal fines or penalties and could adversely impact our business, operating results, and financial condition.
Our directors and officers will have the ability to control our company
Our current directors and officers and people affiliated with them own a majority of the issued and outstanding shares of our Common Stock (assuming no exercise of any outstanding options or warrants). Accordingly, the current directors and officers will be able to exert substantial influence over our company and control matters requiring approval by our stockholders, including electing all our directors, approving any amendments to our certificate of incorporation, increasing our authorized capital stock, effecting a merger or sale of our assets, and determining the number of shares available for issuance under our equity-based plans. As a result, no change of control of our company can occur without their consent.
This voting control may discourage transactions involving a change of control of our company, including transactions in which stockholders might otherwise receive a premium for their shares over the then current market price. The directors and officers are not prohibited from selling a controlling interest in our company to a third party and may do so without stockholder approval and without providing for a purchase of the shares of Common Stock held by others. Accordingly, shares of Common Stock may be worth less than they would be absent such concentrated voting power.
20

Our charter documents and Delaware law could make it more difficult for a third party to acquire us and discourage a takeover
Our Certificate of Incorporation, Bylaws, and Delaware law contain certain provisions that may have the effect of deterring or discouraging, among other things, a non-negotiated tender or exchange offer for shares of Common Stock, a proxy contest for control of our company, the assumption of control of our company by a holder of a large block of Common Stock, and the removal of the management of our company. Such provisions also may have the effect of deterring or discouraging a transaction which might otherwise be beneficial to stockholders. Our certificate of incorporation also may authorize our board of directors, without stockholder approval, to issue one or more series of preferred stock, which could have voting and conversion rights that adversely affect or dilute the voting power of the holders of Common Stock. Delaware law also imposes conditions on certain business combination transactions with "interested stockholders." Our certificate of incorporation authorizes our Board of Directors to fill vacancies or newly created directorships. A majority of the directors then in office may elect a successor to fill any vacancies or newly created directorships. Such provisions cold limit the price that investors might be willing to pay in the future for shares of our Common Stock and impede the ability of the stockholders to replace management.
The elimination of monetary liability against our directors, officers, and employees under Delaware law and the existence of indemnification rights to our directors, officers, and employees may result in substantial expenditures by us and may discourage lawsuits against our directors, officers, and employees. We also may have entered into contractual indemnification obligations under employment agreements with our executive officers. The foregoing indemnification obligations could result in our incurring substantial expenditures to cover the cost of settlement or damage awards against directors and officers, which we may be unable to recoup. These provisions and resultant costs may also discourage us from bringing a lawsuit against our directors and officers for breaches of their fiduciary duties and may similarly discourage the filing of derivative litigation by our stockholders against our directors and officers even though such actions, if successful, might otherwise benefit our company and our stockholders.
Our results of operations could be impacted by unanticipated changes in tax provisions or exposure to additional income tax liabilities
Our business operates in many locations under government jurisdictions that impose income taxes. Changes in domestic or foreign income tax laws and regulations, or their interpretation, could result in higher or lower income tax rates assessed or changes in the taxability of certain revenues or the deductibility of certain expenses, and higher excise taxes thereby affecting our income tax expense and profitability. In addition, audits by income tax authorities could result in unanticipated increases in our income tax expense.
Limited or No Public Market for our securities
There has been a limited public market for our Common Stock and no public market for our outstanding stock options and warrants. Our Common Stock is currently quoted on the OTC Pink Open Market. The daily trading volume of our Common Stock has been limited.
We cannot predict the extent to which investor interest in our company will lead to the development of an active trading market or how liquid that market might become. The lack of an active market may reduce the value of shares of our Common Stock and impair the ability of our stockholders to sell their shares at the time or price at which they wish to sell them. An inactive market may also impair our ability to raise capital by selling our Common Stock and may impair our ability to acquire or invest in other companies, products, or technologies by using our Common Stock as consideration.
21

We may be unable to list our stock on a national exchange, such as NASDAQ
There has been a limited public market for our Common Stock. Although it is our intention to quality for the trading of our Common Stock on a national exchange, we may not meet or maintain certain qualifying requirements. If we are unable to meet these requirements, we may be limited to trading conducted on the OTC Pink Open Market.
The market price of our Common Stock may be volatile and could decline
The market price of our Common Stock has fluctuated substantially in the past and is likely to continue to be highly volatile and subject to wide fluctuations in the future. A number of factors could cause the market price of our Common Stock to decline, many of which we cannot control, including the following:

| · | our ability to execute our business plan;

| · | actual or anticipated changed in our operating results;

| · | variations in our quarterly results;

| · | changes in expectations relating to our products, plans, and strategic position or those of our competitors or customers;

| · | announcements or introduction of technological innovations or new products by us or our competitors;

| · | market conditions within our market;

| · | the sale of even small blocks of Common Stock by stockholders;

| · | price and volume fluctuations in the overall stock market from time to time;

| · | significant volatility in the market price and trading volume of public companies in general and small emerging companies in particular;

| · | changes in investor perceptions;

| · | the level and quality of any research analyst coverage of our Common Stock, changes in earnings estimates or investment recommendations by securities analysis, or our failure to meet such estimates;

| · | any financial guidance we may provide to the public, any changes in such guidance, or our failure to meet such guidance;

| · | various market factors or perceived market factors, including rumors, whether or not correct, involving us, our customers, or our competitors;

| · | future sales of our Common Stock;

| · | Introductions of new products or new pricing policies by us or by our competitors;

22

| · | regulatory or environmental laws that restrict the sale of ammunition containing lead;

| · | acquisitions or strategic alliances by us or by our competitors;

| · | litigation involving us, our competitors, or our industry;

| · | regulatory, legislative, political, and other developments that may affect us, our customers, and the purchasers of our products;

| · | the gain or loss of significant customers;

| · | the volume and timing of customers' orders;

| · | recruitment or departure of key personnel;

| · | developments with respect to intellectual property rights;

| · | our international acceptance;

| · | market conditions in our industry, the business success of our customers, and economy as a whole; and

| · | general global economic and political instability.

In addition, the market prices of small emerging companies have experienced significant price and volume fluctuations that often have been unrelated or disproportionate to their operating performance. In the past, companies that have experienced volatility in the market price of their securities have been the subject of securities class action litigation. If we were the object of a securities class action litigation, it could result in substantial losses and divert management's attention and resources form other matters.
Sales of large numbers of shares could adversely affect the price of our Common Stock
Most of our Common Stock currently outstanding are restricted securities as that term is defined in Rule 144 under the Securities Act of 1933, as amended, or the Securities Act. All outstanding shares of Common Stock are or will be eligible for resale in the public markets at various times within the next six months with respect to affiliates, subject to compliance with the volume and manner of sale requirements of Rule 144 under the Securities Act of 1933, as amended, and with respect to all restricted securities, subject to compliance with the provisions of Rule 144(i)(2) pertaining to the availability of Rule 144 by former shell companies.
In general, under Rule 144 as currently in effect, any person (or persons whose shares are aggregated for purposes of Rule 144) who beneficially owns restricted securities with respect to which at least six months has elapsed since the later of the date the shares were acquired from us, or from an affiliate of ours, is entitled to sell within any three-month period a number of shares that does not exceed the greater of 1% of the then outstanding shares of our Common Stock or the average weekly trading volume in our Common Stock during the four calendar weeks preceding such sale. Sales under Rule 144 also are subject to certain manner-of-sale provisions and notice requirements and to the availability of current public information about us. A person who is not an affiliate, who has not been an affiliate within three months prior to sale, and who beneficially owns restricted securities with respect to which at least six months has elapsed since the later of the date the shares were acquired from us, or from an affiliate of ours, is entitled to sell such shares under Rule 144 without regard to any of the volume limitations or other requirements described above. Sales of substantial amounts of Common Stock in the public market could adversely affect prevailing market prices.
In accordance with our recent offering of Units, consisting of Common Stock and warrants to purchase Common Stock, we are required to file a registration statement with the SEC registering 13,242,186 shares of Common Stock, including the shares that may be issued upon the exercise of the warrants contained in Units. Once the registration is effective, the holders of such Common Stock, including the Common Stock issuable upon the exercise of the warrants will be able to freely sell their shares, which could have a negative effect on the prevailing market prices.
23

Conversion of warrants, and issuance of incentive stock grants may have a dilutive effective on our stock, and negatively impact the price of our Common Stock.
As of June 30, 2018 we had 9,328,153 warrants outstanding. Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase an aggregate of 4,223,260 shares of Common Stock at an average price of $2.50 per share over the next three years; (2) warrants to purchase 966,494 shares of Common Stock at an exercise price of $1.65 per share until March 2025; (3) warrants to purchase 4,088,399 shares of our Common Stock at an exercise price of $2.00 per share until March 2025; and (4) 50,000 warrants to purchase shares of Common Stock at an exercise price of $0.50 until October 2019
In November 2017, the Board of Directors approved the 2017 Equity Incentive Plan, or the Plan. Under the Plan, 485,000 shares of the common stock were reserved and authorized to be issued. As of December 31, 2017, 200,000 shares of common stock were approved and issued under the Plan, and we recognized approximately $250,000 of related consulting expense. On January 10, 2018, 200,000 shares were awarded, and we recognized $330,000 of compensation expense. There are 85,000 shares remaining to be issued under the Plan.
We plan to adopt an Incentive Stock Plan designed to assist us in attracting, motivating, retaining, and rewarding high-quality executives, directors, officers, employees, and individual consultants by enabling such persons to acquire or increase a proprietary interest in our company to strengthen the mutuality of interests between such persons and our stockholders and providing such persons with performance incentives to expand their maximum efforts in the creation of stockholder value under the plan. We will be able to grant stock options, restricted stock, restricted stock units, stock appreciation rights, bonus stocks, and performance awards under the plan.
To the extent that any of the outstanding warrants and options described above are exercised, dilution, to the interests of our stockholders may occur. For the life of such warrants and options, the holders will have the opportunity to profit from a rise in the price of the Common Stock with a resulting dilution in the interest of the other holders of Common Stock. The existence of such warrants and options may adversely affect the market price of our Common Stock and the terms on which we can obtain additional financing, and the holders of such warrants and options can be expected to exercise them at a time when we would, in all likelihood, be able to obtain additional capital by an offering of our unissued capital stock on terms more favorable to us than those provided by such warrants and options.
Effect of Issuance of Preferred Stock
We plan to adopt provisions of our Certificate of Incorporation to allow us to issue Preferred Stock with voting, liquidation, and dividend rights senior to those of the Common Stock without the approval of our stockholders. The issuance of Preferred Stock could have the effect of making it more difficult for a third party to acquire a majority of the outstanding stock of our company and result in the dilution of the value of the then current stockholders' Common Stock. We have no current plans to issue shares of Preferred Stock.
Resale of Common Stock
All of our outstanding shares of Common Stock and shares of our Common Stock that may be issued upon the exercise of our outstanding options and warrants may only be resold if they are registered pursuant to an effective registration statement under the Securities Act of 1933 or are resold pursuant to an applicable exemption and are qualified or exempt under the securities laws of the applicable states. We have agreed to use our best efforts to file by July 6, 2018 a registration statement under the Securities Act covering the resale of shares of Common Stock issued or underlying warrants sold by a private placement that closed in April 2018. In the absence of this registration statement, such sale of such shares of our Common Stock could only be made under Rule 144. As a former shell company, Rule 144 will be available for resales of our Common Stock only if we meet certain conditions, including the filings of applicable reports with the SEC and having been current in our filings of our SEC reports for the 12-months before the proposed resale under Rule 144. There is no assurance that investors will be able to resale their securities at such time as they may want or need to do so.
24

We do not expect to pay any dividends for the foreseeable future
We do not anticipate paying any dividends to our stockholders for the foreseeable future. Accordingly, stockholders may have to sell some or all of their Common Stock to generate cash flow from their investment. Stockholders may not receive a gain on their investment when they sell our Common Stock and may lose some or all of the amount of their investment. Any determination to pay dividends in the future will be made at the discretion of our board of directors and will depend on our results of operations, financial conditions, contractual restrictions, restrictions imposed by applicable law, and other factors our board of directors deems relevant.
Failure to achieve and maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our ability to produce accurate financial statements and on our stock price
Under SEC regulations adopted pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, in the future, we will be required to furnish a report by our management on our internal control over financial reporting with our Form 10-K. We have not been subject to these requirements in the past. The internal control report must contain (1) a statement of management's responsibility for establishing and maintaining adequate internal control over financial reporting, (2) a statement identifying the framework used by management to conduct the required evaluation of the effectiveness of our internal control over financial reporting, (3) management's assessment of the effectiveness of our internal control over financial reporting as of the end of our most recent fiscal year, including a statement as to whether or not internal control over financial reporting is effective, and (4) a statement that our independent auditors have issued an attestation report on management's assessment of internal control over financial reporting.
To achieve compliance with the applicable SEC regulations within the prescribed future period, we would be required to engage in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. Despite our efforts, we can provide no assurance as to our or our independent auditors' conclusions with respect to the effectiveness of our internal control over financial reporting. There is a risk that neither we nor our independent auditors will be able to conclude that our internal controls over financial reporting are effective, as has been the case with a significant number of companies attempting to comply with these regulations for the first time. This could result in an adverse reaction in the financial markets resulting from a loss of confidence in the reliability of our financial statements.
If we fail to comply in a timely manner with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 regarding internal control over financial reporting or to remedy any material weaknesses in our internal controls that we may identify, such failure could result in material misstatements in our financial statements, cause investors to lose confidence in our reported financial information, limit our ability to raise needed capital, and have a negative effect on the trading price of our Common Stock.
Penny stock regulations are applicable to investments in share of our Common Stock, and they can reduce the level of trading activity in our Common Stock
Our Common Stock may be deemed to be a "penny stock" under the Securities Exchange Act of 1934. The Financial Industry Regulatory Authority, or FINRA has adopted rules that relate to the application of the SEC's penny stock rules. Broker-dealer practices in connection with transactions in "penny stocks" are regulated by certain penny stock rules adopted by the SEC. Penny stocks generally are equity securities with a price of less than $5.00 (other than securities registered on certain national securities exchanges, provided that current prices and volume information with respect to transactions in such securities are provided by the exchange or system) or that have tangible net worth of less than $5.0 million ($2.0 million if the company has been operating for three or more years). Penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly account statements showing the market value of each penny stock held in the customer's account. In addition, penny stock rules generally require that prior to a transaction in a penny stock, the broker-dealer make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written agreement to the transaction.
Under interpretations of these rules, FINRA believes that there is a high probability that speculative, low priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker/dealers to recommend that their customers buy our Common Stock, which may have the effect of reducing the level of trading activity and liquidity of our Common Stock. Further, many brokers charge higher transactional fees for penny stock transactions. As a result, fewer broker/dealers may be willing to make a market in our Common Stock, reducing a stockholder's ability to resell shares of our Common Stock.
25

USE OF PROCEEDS
We will not receive any of the proceeds from the offer and sale of the securities by the selling stockholders. The selling stockholders will receive all of the proceeds from this offering, if any.
MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND PURCHASES OF EQUITY SECURITIES
Market Information
Information about our Common Stock is reported by OTC Markets Group, Inc. at www.otcmarkets.com. OTC Markets Group, Inc. is a provider of trading systems, pricing, and financial information for over the counter, or OTC, markets. OTC Markets Group, Inc. provides broker-dealers, market data providers, issuers and investors with software and information services that improve the transparency and efficiency of the OTC markets. Currently, our Common Stock trades under the symbol POWW. The table below sets forth the high and low prices of our Common Stock as reflected by OTC Markets Group, Inc. for the period from January 1, 2016 to June 25, 2018. Quotations represent prices between dealers, do not include retail markups, markdowns or commissions, and do not necessarily represent prices at which actual transactions were affected.

Fiscal Year Ending |  | High |  |  | Low |
December 31, 2016 |  |  |  |  |  |
First Quarter |  | $ | 1.25 |  |  | $ | 1.25 |
Second Quarter |  | $ | 1.28 |  |  | $ | 1.28 |
Third Quarter |  | $ | 1.28 |  |  | $ | 1.28 |
Fourth Quarter |  | $ | 1.25 |  |  | $ | 1.25 |
December 31, 2017 |  |  |  |  |  |  |  |
First Quarter |  | $ | 3.60 |  |  | $ | 3.60 |
Second Quarter |  | $ | 3.00 |  |  | $ | 3.00 |
Third Quarter |  | $ | 2.30 |  |  | $ | 2.30 |
Fourth Quarter |  | $ | 3.20 |  |  | $ | 3.08 |
Transition Peroid |  |  |  |  |  |  |  |
First Quarter |  | $ | 4.75 |  |  | $ | 2.95 |
April 1, 2018 – June 30, 2018 |  | $ | 7.95 |  |  | $ | 4.75 |

On June 30, 2018, the "best bid" and "best ask" quotations by OTC Markets Group, Inc. were $6.00 and $6.07, respectively, and an average daily volume of 8,543 shares of Common Stock was reported for the past 30 days.
Holders
As of June 30, 2018, a total of 31,475,684 shares of our Common Stock were outstanding and there were approximately 429 holders of record.
26

Penny Stock Rules
Due to the price of our Common Stock, and the fact that we are not listed on Nasdaq or a national securities exchange, our stock is characterized as a "penny stock" under applicable securities regulations. Our stock will therefore be subject to rules adopted by the Securities and Exchange Commission, or SEC, regulating broker-dealer practices in connection with transactions in penny stocks. The broker or dealer proposing to effect a transaction in a penny stock must furnish his customer a document containing information prescribed by the SEC and obtain from the customer an executed acknowledgment of receipt of that document. The broker or dealer must also provide the customer with pricing information regarding the security prior to the transaction and with the written confirmation of the transaction. The broker or dealer must also disclose the aggregate amount of any compensation received or receivable by him in connection with such transaction prior to consummating the transaction and with the written confirmation of the trade. The broker or dealer must also send an account statement to each customer for which he has executed a transaction in a penny stock each month in which such security is held for the customer's account. The existence of these rules may have an effect on the price of our stock, and the willingness of certain brokers to effect transactions in our stock.
Transfer Agent
We have appointed Action Stock Transfer Corporation ("AST") as the transfer agent for our Common Stock. The principal office of AST is located at 2469 E. Fort Union Blvd, Suite 214, Salt Lake City, UT 84121, and its telephone number is (801) 274-1088.
Dividend Policy
We have never declared or paid dividends on our Common Stock. Payment of future dividends, if any, will be at the discretion of our Board of Directors after taking into account various factors, including the terms of any credit arrangements, our financial condition, operating results, current and anticipated cash needs and plans for expansion. At the present time, we intend to retain any earnings in our business, and therefore do not anticipate paying dividends in the foreseeable future.
Recent Sales of Unregistered Securities; Use of Proceeds from Unregistered Securities
From April 1, 2018 until June 30, 2018, we sold 1,967,886 shares of Common Stock for $1.65 per share and collected proceeds of $3,247,030. There was a cashless exercise of 14,719 warrants resulting in the issuance of 10,495 shares related to this offering. Additionally, there were 1,007,400 shares that were issued as a result of exercised warrants, 145,000 shares issued through employee stock awards, a return of 49,600 shares of stock unrelated to this offering.
On May 24, 2018, we provided a group of our warrant holders with a notice to call the warrants. Through June 30, 2018, the holders exercised 1,007,400 warrants to purchase 1,007,400 shares of common stock. The warrants are exercisable at a price of up to $2.50 and have raised approximately $2,354,125 throught June 30, 2018.
27

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and accompanying notes appearing elsewhere in this Prospectus. This discussion contains forward-looking statements, based upon our current expectations and related to future events and our future financial performance, that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors,” “Forward-Looking Statements,” and elsewhere in this Annual Report on Form 10-K.
Overview
Our vision is to modernize the ammunition industry by bringing new technologies to market. We intend to do that through acquisition and application of intellectual property that is unique to the industry and through investing in manufacturing equipment and processes that enable us to compete globally.
When we began our operations in early 2017, our focus was to sell the inventory of ammunition we acquired through an asset purchase of a private company located in northern Arizona. The inventory consisted primarily of standard pistol and rifle rounds and two proprietary lines that had not received much traction in the market. We sold the remaining inventory at a discount during 2017 to help fund the development of our manufacturing operations. This accounted for the majority of our sales through the end of the third quarter of the calendar year of 2017.
With the prior inventory successfully sold and new products being produced, our next objective in the calendar year of 2017 was to identify ammunition technologies unique to the industry that could be quickly implemented by our manufacturing team. We met with several organizations and projectile manufacturers looking for innovative products that could be used to establish us as a niche or high-end manufacturer for the recreational shooter, the American hunter, law enforcement, and military forces. Among the first of these technologies to meet our requirements was Streak, a one-way luminescent or OWL application, which we believe is the only non-incendiary tracer round in the ammunition market today. We secured the exclusive license to manufacture and sell the Streak line of ammunition in 2017. Upon completion of the transaction, we began implementing manufacturing processes to deliver the product to market.
We formally introduced the Streak portfolio of calibers, along with our rebranded One Precise Shot (OPS) and Stelth subsonic line of suppression ammunition, to the general public at the SHOT Show in Las Vegas held in January 2018. This product introduction resulted in the opening of major retail outlets across the United States and attracted the attention of distributors in the international community. We believe this was a critical milestone in establishing us as a significant player in technology-based ammunition.
To help promote our new products, we hired new sales and marketing personnel in late 2017, and early 2018. We also augmented our Board of Directors to include professionals who could provide guidance for our teams through their prior experience in the industries we have targeted: commercial retail – focused on the gun or hunting enthusiast; US Law Enforcement; the US Military; and international markets for both military and law enforcement. Together this team has worked to open sales channels and distribution networks and capitalize on industry relationships to introduce our products to the influencers required to grow our sales.
28

Our financial results for the last three months of 2017 and the first three months of 2018 more accurately reflect our newly positioned organization. We believe that we have hired a strong team of professionals, developed innovative products, and raised capital sufficient to establish our presence as a high-quality ammunition provider. This effort did not come without cost to our operations. Our gross margins and income from operations both declined during this six-month period as we hired staff ahead of recording product revenue, recognized the costs associated with the licensing of Streak, and expensed the costs of starting up our new equipment and product lines. We also incurred increased expenses as we transitioned to new brands and packaging to support our image in the market place. We believe these costs to be investments in our future and that a growth of our sales through our target markets would result in our gross margins improving to our target range of between 25% and 35% of sales dependent upon the sales mix for the period.
As we enter into 2018, we are focused on expanding our brand presence into the markets identified above, through grass roots marketing campaigns and social media outlets. We also intend to utilize the networks that our Board, and executive management have developed and to expand our operations through the additions of automated equipment for both manufacturing and inspection, enabling us to become more competitive on standard pistol ammunition used by law enforcement and military personnel as well as for target practice.
We will also focus on establishing strategic partnerships to pursue new sales opportunities including new market segments. Our addressable market includes the 2.6 million law enforcement officers around the world (800,000 domestically and 1.8 million internationally) who annually recertify with their firearms; 1.3 million enlisted personnel in the U.S. Armed Forces, and more than 30 million handgun owning households in the United States with later expansion to international markets for civilian purchasers which, based on industry statistics, represents addressable revenue of billions of dollars annually. Each of these markets has unique challenges or barriers to entry. We believe we are well positioned to grow our market share based on our commitment to innovation, and meeting the changing needs and demographics of ammunition buyers.
Our History
Our ammunition manufacturing business has been fully operational for just over one year. Although our corporate entity commenced in 1990 as a textile manufacturer and importer, then called Retrospettiva, our manufacturing operations formally began in 2017 when we acquired our ammunition business.
Results of Operations
The following table presents summarized financial information taken from our consolidated statements of operations for the three months ended March 31, 2018 compared with the three months ended March 31, 2017:

|  | For the Three-Months Ending |
|  | March 31, 2018 |  |  | March 31, 2017 (Unaudited) |
Net Sales |  | $ | 1,960,688 |  |  | $ | 653,784 |
Cost of Products Sold |  |  | 1,667,614 |  |  |  | 474,890 |
Gross Margin |  |  | 293,074 |  |  |  | 178,894 |
Sales, General & Administrative Expenses |  |  | 2,095,388 |  |  |  | 863,601 |
Loss from Operations |  |  | (1,802,314 | ) |  |  | (684,707 | )
Interest and other income (expense), net |  |  | 5,086 |  |  |  | (1,836,101 | )
Loss before provision for income taxes |  | $ | (1,797,228 | ) |  | $ | (2,520,808 | )
Provision for income taxes |  |  | - |  |  |  | - |
Net Loss |  | $ | (1,797,228 | ) |  | $ | (2,520,808 | )

29

The following table presents data from our consolidated statements of operations for the year ended December 31, 2017 compared with the period ended December 31, 2016:

|  | For the Twelve Months Ended |  |  | For the Period October 13, 2016 (Inception) to |
|  | December 31, 2017 |  |  | December 31, 2016 |
Net Sales |  | $ | 1,294,861 |  |  | $ | - |
Cost of Products Sold |  |  | 1,303,586 |  |  |  | - |
Gross Margin |  |  | (8,725 | ) |  |  | - |
Sales, General & Administrative Expenses |  |  | 3,967,503 |  |  |  | 136,274 |
Loss from Operations |  |  | (3,976,228 | ) |  |  | (136,274 | )
Interest and other income (expense), net |  |  | (1,812,673 | ) |  |  | (18,750 | )
Loss before provision for income taxes |  | $ | (5,788,901 | ) |  | $ | (155,024 | )
Provision for income taxes |  |  | - |  |  |  | - |
Net Loss |  | $ | (5,788,901 | ) |  | $ | (155,024 | )

Net Sales
Net sales during the three-month period ended March 31, 2018 increased by approximately $1.3 million compared with the three-month period ended March 31, 2017. The increase resulted from increased sales through our commercial retail channel and our online store, led by sales of our standard bulk ammunition, and the newly released Streak™ product lines. Our One Precise Shot and Stelth lines also increased during the same three-month period in 2018.
Net sales for the year ended December 31, 2017 were approximately $1.3 million. There were no sales recorded for the year ended December 31, 2016.
Approximately 77% of total sales were recognized in the six-month period ended June 30, 2017. The sales were at an unusually low gross profit rate due to the fact that we were attempting to liquidate the inventory acquired in a foreclosure transaction.
The following table details our gross sales by product line for the periods ended:

|  | Three Months Ended March 31, 2018 |  |  | Three Months Ended March 31, 2017 |  |  | Twelve Months Ended December 31, 2017 |
Prior Inventory1 |  | $ | 0 |  |  | $ | 581,117 |  |  | $ | 581,117 |
Streak Visual Ammunition |  |  | 543,285 |  |  |  | 0 |  |  |  | 0 |
One Precise Shot (OPS) Line |  |  | 94,936 |  |  |  | 47,081 |  |  |  | 285,715 |
Stelth |  |  | 31,493 |  |  |  | 18,179 |  |  |  | 32,123 |
Standard Ammunition2 |  |  | 1,290,974 |  |  |  | 7,407 |  |  |  | 395,906 |
Total Sales |  | $ | 1,960,688 |  |  | $ | 653,784 |  |  | $ | 1,294,861 |

| (1) | This total represents inventory purchased as part of the acquisition detailed in Note 3 of our Financial Statements.
| (2) | This total includes bulk ammunition sales of reprocessed brass casings, and other miscellaneous sales

30

Sales for the three months ended March 31, 2018 increased 51.4%, or $665,827, over the year ended December 31, 2017. This was a direct result of sales from our proprietary lines of ammunition detailed in the table above. Our goal is for our sales to continue to grow quarter-over-quarter as we continue to expand sales in commercial markets and initiate sales to U.S. law enforcement, military, and international markets.
It is important to note that, although U.S. law enforcement, military and international markets represent significant opportunities for our company, they also have a long sales cycle. Our Global Tactical Defense Division is currently working to establish distribution, both in the United States and abroad. To date, we have signed three U.S. distributors, covering 15 states, a sales representative to assist with U.S. Military sales, and are working to establish exclusive distribution in several countries approved by the U.S. State Department. Sales outside of the United States require licenses and approval from the U.S. State Department, which could take six months to a year for processing.
Cost of Goods Sold
Cost of goods sold increased by approximately $1.2 million for the first three months of 2018 compared with the three months ended March 31, 2017. This was the result of higher sales for the period and the expensing of increased labor, overhead, and raw materials used to produce finished product during the period. This increase is also the result of three full months of operations in 2018 compared with a partial period for the comparable period in 2017, following our acquisition of the Payson Arizona manufacturing facility. As a percentage of sales, cost of goods sold increased by 12.5% from 72.6% for the three-month period ended March 31, 2017 to 85.1% for the three-month period ended March 31, 2018.
Cost of goods sold increased by approximately $1.3 million for the year ended December 31, 2017 compared with the period ended December 31, 2016. As noted above, our operations did not begin until early 2017. As a result, no sales or associated cost of goods sold were recorded in 2016.
In comparing the cost of goods sold during the year ended December 31, 2017 to the recent three months ended March 31, 2018, our total costs as a percentage of sales have decreased by more than 15%. This was the result of increased sales, allowing us to cover a higher percentage of our fixed costs of manufacturing, which include our non-cash amortization and depreciation expense.
Gross Margin
Gross margin percentage declined during the first three months of 2018 compared with the comparable period in 2017. This resulted from a shift in sales mix, coupled with an increase in start up costs associated with manufacturing our new products.
The three months ended March 31, 2018 compared with the prior twelve months ended December 31, 2017 provided an increased gross margin of 15.6%. As noted above, this was a direct result of the increase in net sales, enabling us to more fully cover our fixed manufacturing costs.
Our goal is to increase gross margins to between 25% and 35% of net sales. This depends on our increased sales of our proprietary ammunition lines becoming more widely adopted, better leverage of our fixed overhead expenses through higher sales volume, efficiency improvements, and placing into service automation equipment currently being procured. We also expect our component costs to decrease as we increase volumes ordered through our supplier base.
31

Sales, General, and Administrative Expenses
During the three-month period ended March 31, 2018, our sales, general, and administrative expenses increased by approximately $1.2 million over the comparable three-month period in 2017. This increase was the result of increased payroll expense as we expanded our sales and support team, stock compensation expensed during the period, and trade show and marketing costs associated with introducing our Streak™ and rebranded OPS™ and Stelth product lines. We expect to see administrative expenditures decrease as a percentage of sales late in the 2018 calendar year, as we leverage our work force and expand our sales opportunities.
During the year ended December 31, 2017, our sales, general, and administrative increased by approximately $3.8 million, over 2016. This increase was the direct result of almost nine more months of operations, coupled with costs incurred to complete the acquisition of our business and re-establish our company as a fully operating entity as well as investments in hiring sales, marketing, and administrative staff to support the ongoing operations. General and administrative expenses included $564,000 in legal and accounting fees and $955,000 in consulting fees of which $665,433 was associated with non-cash stock awards for individuals preferring payment in the Company’s common stock over cash compensation.
As a percentage of total sales, sales, general, and administrative expenses decreased by more than 200% for the three months ended March 31, 2018 compared with the year ended December 31, 2017. In 2017, sales and administrative expenses included costs associated with the start-up of the new operations, marketing efforts to brand our company and our proprietary products, and compensation expense associated with issuance of our Common Stock in lieu of cash compensation for employees, newly appointed board members, and key consultants for the organization.
Interest and other Expenses
For the three-month period ended March 31, 2018, interest and other expenses decreased by $1,841,000 compared with the comparable three-month period in 2017. This decrease resulted from repayment of the outstanding notes payable for the 2017 three-month period. (Please refer to Note 6 – Convertible Note Payable) and the loss on notes receivable foreclosure.
For the first three months of 2018, we did not incur interest expense as all notes payable were paid in full in January 2018. The funds used to repay the outstanding debt at year-end were raised through the sale of Units, each consisting of one share of our Common Stock and a five-year warrant to purchase one-half share of Common Stock at an exercise price of $2.00 per share. Each unit was sold for $1.65. We sold 594,702 Units during the months of November and December of 2017, generating a total of $981,250 of cash for operations. We continued to sell Units through the first three months of 2018. (Please refer to Note 8 – Capital Stock). In total, we raised $10,244,674 from investors through March 31, 2018.
Interest and other expenses for the year ended December 31, 2017 increased by nearly $1.8 million over the year ended December 31, 2016. This increase was driven by a one-time write off of approximately $1.3 million remaining on a note receivable assumed with the acquisition of our business. We also expensed $431,000 of interest associated with the convertible note payable and notes to related parties in 2017. In 2016, interest expense was approximately $19,000.
32

Net Loss
As a result of higher production, selling, and payroll expenses, we ended the three-month period ended March 31, 2018 with a net loss of approximately $1.8 million compared with a net loss of $2.5 million for the three-month period ended March 31, 2017.
As a result of the higher costs of manufacturing from our first year of operations in 2017 and the expenses and write offs associated with the acquisition of our business, we ended 2017 with a net loss of approximately $5.8 million compared with a loss of $155,000 for 2016.
Our goal is to continue to improve our operating results as we focus on increasing sales and controlling our operating expenses. We also expect to see reductions in our direct labor expense as newly acquired automation equipment is brought on line, reducing handling and manual inspection operations.
Liquidity and Capital Resources
As of March 31, 2018, we had $4,381,643 of cash and cash equivalents, an increase of $3,594,820 from December 31, 2017.
Working Capital is summarized and compared as follows:

|  | March 31, 2018 |  |  | December 31, 2017 |  |  | December 31, 2016 |
Current assets |  | $ | 8,323,045 |  |  | $ | 3,019,061 |  |  | $ | 2,904,155 |
Current liabilities |  |  | 1,120,582 |  |  |  | 2,413,547 |  |  |  | 2,536,745 |
|  | $ | 7,202,463 |  |  | $ | 605,514 |  |  | $ | 367,410 |

Changes in cash flows are summarized as follows:
Operating Activities
For the three-month period ended March 31, 2018, net cash used in operations totaled $2,279,783. This was the result of a net loss of $1,797,228 and increases in our accounts receivable of $1,031,549, and inventory of $612,693.
The cash used in operations was partially offset by non-cash items and changes in operating assets and liabilities, which included stock issued for services of $125,000, stock issued for compensation of $482,624, stock grants of $106,563, a $289,007 increase in accounts payable and accrued liabilities, a $101,114 increase in our prepaid expenses, and depreciation and amortization of $72,258.
For the year ended December 31, 2017, net cash used in operations totaled $3,279,367. This was the result of a net loss of $5,788,901 for the year ended December 31, 2017, coupled with cash used to increase inventory of $928,762, an increase in our accounts receivable of $171,812, and $18,461 of cash paid to reduce our related party payable balances.
The cash used in operations was partially offset by non-cash items and changes in operating assets and liabilities, which included stock issued for legal and consulting of $567,813, stock issued for compensation of $160,000, discounts taken on notes payable or $356,250, $673,672 increase in accounts payable and accrued liabilities, $183,181 reduction in prepaid expenses, $186,486 reduction in vendor advances, depreciation and amortization of $148,860, a $26,046 allowance for doubtful accounts, $46,340 of imputed interest, and a one-time write off of $1,279,921 associated with the vendor note receivable from Advanced Tactical Armament Concepts, LLC.
33

Investing Activities
During the three-month period ended March 31, 2018, we used $607,181 in net cash for investing activities compared with $36,017 for the comparable period in 2017. Of this total, $100,000 was used to purchase an exclusive worldwide license to manufacture and sell our Stelth™ Visual ammunition technology. This patented technology, trade named "Streak", uses a non-flammable phosphor material that produces a glow by the use of light emitted during the round discharge. We believe this technology, applicable to all calibers of ammunition, will be a game changer for the industry moving forward. Additionally, we used $507,181 to purchase equipment to increase production at our Payson Arizona manufacturing facility.
For the year ended December 31, 2017, we used $404,188 in net cash for investing activities. Of the $404,188, $100,000 was used to acquire an exclusive worldwide license to manufacture and sell Streak Visual ammunition technology. Additionally, we used $304,188 to purchase equipment to increase production throughput at our Payson, Arizona manufacturing facility. There was no cash used in investing activities in 2016.
Financing Activities
We financed our operations primarily from the issuance of equity instruments. During the three-month period ended March 31, 2018, net cash provided by financing activities was $6,481,784. This was the net effect of $9,263,424 generated from the sale of Common Stock included in Units coupled with the collection of a prior year subscription receivable of $5,000, offset by the reduction of notes payable totaling $1,575,000, cash payments of $1,137,211 made to our investment banker in conjunction with the Unit offering, and the payment of $74,429 toward our insurance premium note payable.
We financed our operations primarily from the issuance of equity and debt instruments. For the year ended December 31, 2017, net cash provided by financing activities was $4,460,262. This was the net effect of $6,038,900 generated from the Unit offering. These sales of our securities, coupled with the collection of a prior year subscription receivable of $167,500, were offset by the repayment of notes payable totaling $1,260,000, the repayment of $207,033 for our insurance premium note payable, the issuance of shares of Common Stock to our founders totaling $99,355, and cash payments of $179,750 made to our investment banker in conjunction with the 2017 stock sales.
In comparison, for the year ended December 31, 2016, net cash provided by financial activities totaled $1,932,500, consisting of $1,500,000 cash generated from a convertible note and $732,500 generated through the sale of Common Stock, offset by a $75,000 repayment of a note payable, and $225,000 of cash from the sale of shares.
Liquidity and Capital Resources
Existing working capital, cash flow from operations, bank borrowings, and sales of equity and debt securities are expected to be adequate to fund our operations over the next 12 months. Generally, we have financed operations to date through the proceeds of stock sales, bank financings, and related-party notes.
We believe financing will be available, both through conventional financing relationships and through the continued sales of our Common Stock. However, there is no assurance that such funding will be available on terms acceptable to us or at all. We believe that our current cash on hand, coupled with alternative sources of funding will be sufficient to satisfy our currently anticipated cash requirements, including capital expenditures, working capital requirements, potential acquisitions and other liquidity requirements through at least the next 12 months.
34

Contractual Obligations
As part of the acquisition of our business, we assumed a triple-net operating lease for our 20,000 square foot manufacturing facility located in Payson, Arizona. The terms of the lease provide for a monthly payment of approximately $10,000, which includes an estimate for utilities, taxes, and repairs. This lease expires in November 2021.
We believe this facility will be adequate to meet our needs in the near future. However, we are making plans to expand the building footprint to accommodate additional automation equipment. We intend to pay for these improvements from working capital and will amortize the costs over the remaining lease period.
The following table outlines our future contractual financial obligations associated with this lease by period in which payment is expected, as of March 31, 2018:

| 2019 |  | 2020 |  | 2021 |  | 2022 |  | Total |
Payson Lease |  | $ | 120,000 |  |  | $ | 120,000 |  |  | $ | 120,000 |  |  | $ | 80,000 |  |  | $ | 440,000 |

Off-Balance Sheet Arrangements
As of March 31, 2018 and December 31, 2017, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, net sales, expenses, results of operations, liquidity capital expenditures, or capital resources.
Critical Accounting Policies
Our discussion and analysis of our financial condition and results of operation are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounted of assets, liabilities, revenues, and expenses. We have identified several accounting principles that we believe are key to the understanding of our financial statements. These important accounting policies require our most difficult subjective judgements.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Inventory
We state inventories at the lower of cost and net realizable value. We determine cost by using the weighted-average cost of raw materials method, which approximates the first-in, first-out method and includes allocations of manufacturing labor and overhead. We make provisions when necessary, to reduce excess, potential damaged or obsolete inventories. These provisions are based on our best estimates. At March 31, 2018, and December 31, 2017, we conducted a full analysis of inventory on hand and expensed all inventory not currently in use, or for which there was no future demand.
35

Research and Development
To date, we have expensed all costs associated with developing our product specifications, manufacturing procedures, and products through our cost of products sold, as this work was done by the same employees who produced the finished product. We anticipate that it may become necessary to reclassify research and development costs into our operating expenditures for reporting purposes as we begin to develop new technologies and lines of ammunition.
Revenue Recognition
We generate revenue from the production and sale of ammunition. We recognize revenue when it is realized or realizable and earned.
We consider revenue realized or realizable and earned when all of the following criteria are met:

| · | persuasive evidence of an arrangement exists
| · | the product has been shipped to the customer
| · | the sales price is fixed or determinable
| · | collectability is reasonably assured

We derived approximately 59% of total revenue from three customers during the three months ended March 31, 2018 and 68% of the accounts receivable were due from two customers at March 31, 2018. Additionally, we derived approximately 58% of total revenue from one customer for the year ended December 31, 2017 and 47% of the accounts receivable were due from two customers at December 31, 2017.
Excise Tax
As a result of regulations imposed by the Federal Government for sales of ammunition to non-government entities, we must charge and collect an 11% excise tax for all products sold into these channels. During the three-month period ended March 31, 2018, and the year ended December 31, 2017, we recognized $194,003 and $132,294, respectively, in excise taxes. For ease in selling to commercial markets, excise tax is included in our unit price for the products sold. We record this through net sales and expense the offsetting tax liability to cost of goods sold.
Fair Value of Financial Instruments
Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of March 31, 2018 and December 31, 2017. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair value. These financial instruments include cash, accounts payable, and amounts due to related parties. Fair values were assumed to approximate carrying values because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand.
Income Taxes
We follow ASC subtopic 740-10, "Accounting for Income Taxes") for recording the provision for income taxes. ASC 740-10 requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability each period. If available evidence suggest that is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change.
36

Stock-Based Compensation
We grant stock-based compensation to key employees and directors as a means of attracting and retaining highly qualified personnel. We also grant stock in lieu of cash compensation for key consultants and service providers. We recognize expense related to stock-based payment transactions in which we receive employee or non-employee services in exchange for equity. We measure stock compensation based on the closing fair market value of our Common Stock on the date of grant.
In addition to our base of employees, we also use the services of several contract personnel and other professionals on an "as needed basis". We plan to continue to use consultants, legal and patent attorneys, engineers and accountants as necessary. We may also expand our staff to support the market roll out of our products to both the commercial and government related organizations. A portion of any key employee compensation likely would include direct stock grants, which would dilute the ownership interest of holders of existing shares of our Common Stock.
Expected purchase or sale of plant and significant equipment
We anticipate investing significant resources in the purchase of plant and equipment in the coming months as we begin to scale production operations throughout calendar 2018. This equipment will be funded through working capital and bank financing. We believe these additions will significantly improve our plant capacity and reduce our cost per unit sold.
BUSINESS
Products
We design, produce, and sell ammunition in a variety types, sizes, and calibers for use in handgun and long guns. We ship our ammunition in the form of cartridges, or rounds. A cartridge consists of four components: a case made of brass, steel, or copper that holds together all the other components of the cartridge; the primer, which is an explosive chemical compound that ignites the gunpowder when struck by the firing pin; the gun powder, which is a chemical mixture that burns rapidly and creates an expanding gas when ignited and pushes the bullet out the barrel; and the bullet, or projectile, usually containing lead that is fired through the barrel to strike the target. Some of the bullets we produce for certain applications have a jacket, or outer shell, of brass or copper to improve performance and accuracy. We typically produce centerfire cartridges in which the primer is in the bottom, or center of the cartridge, rather than rim fire cartridges in which the primer is in the rim of the cartridge.
Streak Visual Ammunition
Streak Visual ammunition enables shooters to see the path of the bullets fired by them. Streak rounds utilize non-flammable phosphor material that produces a glow by the utilization of the light emitted during the round discharge to make streak glow. The luminescent material is applied only to the aft end of the projectile, making it visible only to the shooter and those within a 30-degree viewing window. As a result, the glow of streak ammunition is not visible to the target unlike conventional tracers, which we believe is important to the military and law enforcement. Unlike conventional tracer ammunition, streak rounds are not incendiary and do not utilize burning metals to generate light, thereby eliminating heat generation and making them safer for use in various environments and avoiding serious fire hazards. Streak ammunition comes in 380 auto, 9 mm, 40 S&W, 44 magnum, 45 long colt, and 38 special among other calibers.
We hold the exclusive worldwide sales and distribution rights for the patented technology used by our Streak visual ammunition and pay a royalty based on our product sales incorporating this technology.
37

OPS – One Precise Shot
OPS ammunition is designed to meet a wide variety of demanding engagement scenarios experienced by law enforcement personnel in the line of duty. The hollow point lead-free fragile bullet with hard outer casing and frangible copper core transfers 100% of its energy into the target. These bullets penetrate a variety of barriers, such as drywall, plywood, car doors, and auto glass. Upon entering soft tissue, the jacket and core separate with extensive force of impact, resulting in mass force trauma. The light weight projectile reduces recoil and enhances accuracy. OPS ammunition comes in 9 mm, 40 S&W, 45 auto calibers and a 223 rifle round.
Stelth Subsonic Ammunition
Stelth Subsonic ammunition is designed specifically for superior performance in suppressed firearms. Stelth ammunition finds applications in which silence is paramount, such as in tactical training, predator night hunts, and clandestine operations. The Stelth ammunition is produced to be a clean burning total metal jacket round to slow baffle corrosion and reduce lead emissions that collect in the suppressor body. Stelth pistol ammunition comes in 9mm, 40 S&W, and 45 AC3. It is also available in a 223 rifle round.
Jesse James Ammunition
Jesse James ammunition is jacketed hollow point projectiles designed for self-defense. The load specific development is designed to ensure accuracy, velocity, and consistency and a low recoil. Jesse James ammunition comes in 9mm, 40 S&W, 10mm, 357, 45 auto calibers.
Jeff Rann's American Hunter and Safari Services
Jeff Rann's ammunition is intended for a complete range of game hunting. This high-end hunting ammunition has been designed by Jeff Rann, a well-known professional hunter and sports channel host and the owner of the well-known 777 Ranch in Texas and three ranches in Africa.
Marketing
We market our products to consumers through distributors, dealers, mass market and specialty retailers, and direct to consumer through e-commerce. We maintain consumer-focused product marketing and promotional campaigns, which include print and digital advertising campaigns; social and electronic media; product demonstrations; point-of-sales materials; in-store training, and in-store retail merchandising. Our use of social media includes Instagram, Facebook, Twitter, and You Tube. We also utilize third-party endorsements, social influencers, and brand ambassadors, such as Jesse James, Jeff Rann, and Charissa Littlejohn.
Manufacturing
We conduct our research and development, manufacturing, assembly, inspection, and packaging operations in a 20,000 square foot facility located in Payson, Arizona. The facility currently produces 36 million rounds of ammunition annually with the capacity to scale to 200 million rounds. Our in-house testing operation at the facility is intended to enhance the performance and reliability of our products.
38

Research and Development
We conduct research and development activities to enhance existing products and develop new products at our facility in Payson, Arizona, utilizing our personnel and strategic relationships. We plan to expand our research and development activities in the future. We expense all costs associated with our research and development efforts through our cost of goods sold as they are performed by the same employees who produce our finished product.
Suppliers
We purchase certain of the raw materials and components for our ammunition products, including brass, steel, or copper casings; ammunition primers to ignite gun powder; gun powder; and projectiles. We believe we have reliable sources of supply for all our raw material and component needs, but from time to time raw materials and components are subject to shortages and price increases. Most of our suppliers are U.S.-based and provide us the materials and components at competitive rates. We plan to broaden our supplier base and secure multiple sources for all of the raw materials and components we require.
Customers
We sell our products to a wide variety of customers, including sport and recreational shooters, hunters, competitive shooters, individuals desiring home and personal protection, and law enforcement and military agencies, and selected international markets. We sell our products under the names of our four principle ammunition products. Three customers each accounted for approximately 59% of our net sales for the three-month period ended March 31, 2018 and the year ended December 31, 2017.
Competition
The ammunition industry is dominated by a small number of companies, a number of which are divisions of large public companies. We compete primarily on the quality, reliability, features, performance, brand awareness, and price of our products. Our primary competitors include Federal Premium Ammunition, Remington Arms, the Winchester Ammunition division of Olin Corporation, and various smaller manufacturers and suppliers, including Black-Hills Ammunition, CBC Group, Fiocchi Ammunition, Hornady Manufacturing Company, and PMC.
Employees
As of June 1, 2018, we had a total of 48 employees, including 10 part-time employees. Of these employees, 35 were engaged in manufacturing, four in sales and marketing, four in finance and accounting, and five in various executive and administrative functions. None of our employees are represented by a union in collective bargaining with us. We believe that our employee relations are good.
Seasonality
Our business has not exhibited a material degree of seasonality to date. Our net sales could be moderately higher in our third and fourth fiscal quarters because of the fall hunting and holiday seasons.
39

Intellectual Property
We believe our tradenames, trademarks, and service markets are important factors in distinguishing our products. In addition, we regard our trade secrets, technological resources, knowhow, licensing arrangements, and endorsements as important competitive factors.
Included in an acquisition for 600,000 shares of our Common Stock and $200,000 paid in cash to the former license holder, we acquired the exclusive license to produce ammunition using the patented "hybrid luminescence technology" owned by the University of Louisiana at Lafayette. We use that technology in connection with our Streak Visual ammunition.
We are a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company, or JJF. The licensing agreement grants us the exclusive worldwide rights through October 15, 2021 to Mr. James' image rights and all trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. In addition, Mr. James agreed to make himself available for certain promotional activities and to promote Jesse James Branded Products through his own social media outlets. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses. We also issued 100,000 shares of our Common Stock upon the execution of the license agreement with the potential issuance of up to 75,000 additional shares of Common stock upon achieving certain gross sales with $15 million in gross sales required to earn the entire 75,000 shares.
We are a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement grants for us through February 2022 the exclusive worldwide rights to Mr. Rann's image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. Mr. Rann agreed to make himself available for certain promotional activities and to promote the Branded Products through his own social media outlets. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses. We also issued 100,000 shares of our Common Stock upon the execution of the license agreement with the potential issuance of 75,000 additional shares of Common Stock upon achieving certain gross sales with $15 million in gross sales required to earn the entire 75,000 shares.
Backlog
We did not have a material amount of backlog of orders as of March 31, 2018 or December 31, 2017. Backlog consists of orders for which purchase orders have been received and which are generally scheduled for shipment within three months. We generally allow orders that have not yet been shipped to be cancelled. Our backlog may not be indicative of future sale.
Environmental Matters
Our operations are subject to a variety of federal, state, and local laws and regulations relating to environmental protection, including those governing the discharge, treatment, storage, transportation, remediation, and disposal of hazardous materials and wastes; the restoration of damages to the environment; and health and safety matters. We believe that our operations are in material compliance with these laws and regulations. We incur expenses in complying with environmental requirements and could incur higher costs in the future as a result of more stringent requirements that may be enacted in the future.
Some environmental laws, such as the U.S. federal Superfund law and similar state laws, can impose liability, without regard to fault, for the entire cost of the cleanup of contaminated sites on current or former site owners and operators or parties who sent wastes to such sites. Based on currently available information, we do not believe that environmental matters will have a material adverse effect on our business, operating results, or financial condition.
40

Regulatory Matters
The manufacture, sale, and purchase of ammunition are subject to extensive federal, state, local, and foreign governmental laws. We are also subject to the rules and regulations of the ATF and various state and international agencies that control the manufacture, export, import, distribution and sale of firearms, explosives, and ammunition. Such regulations may adversely affect demand for our products by imposing limitations that increase the costs or limit the availability of our products.
Our failure to comply with applicable rules and regulations may result in the limitation of our growth or business activities and could result in the revocation of licenses necessary for our business. Applicable laws and regulations provide for the following:

| · | require the licensing of all persons manufacturing, exporting, importing, or selling ammunition as a business;

| · | require serialization, labeling, and tracking of the acquisition and disposition of certain types of ammunition;

| · | regulate the interstate sale of certain ammunition;

| · | restrict or prohibit the ownership, use, or sale of specified categories of ammunition;

| · | require registries of so-called "ballistic images" of ammunition fired from new guns;

| · | govern the sale, export, and distribution of ammunition;

| · | regulate the use and storage of gun powder or other energetic materials;

| · | regulate the employment of personnel with certain criminal convictions;

| · | restrict access to ammunition manufacturing facilities for certain individuals from other countries or with criminal convictions; and

| · | require compliance with ITAR.

The handling of our technical data and the international sale of our products may also be regulated by the U.S. Department of State and Department of Commerce. These agencies can impose civil and criminal penalties, including denying us from exporting our products, for failure to comply with applicable laws and regulations.
In addition, bills have been introduced in Congress to establish, and to consider the feasibility of establishing a nationwide database recording so-called "ballistic images" of ammunition fired from new guns. Should such a mandatory database be established, the cost to us, our distributors, and our customers could be significant, depending on the type of firearms and ballistic information included in the database. Bills have been introduced in Congress in the past several years that would affect the manufacture and sale of ammunition, including bills to regulate the manufacture, importation, and sale.
We believe that existing federal, state, and local legislation relating to the regulation of firearms and ammunition have not had a material adverse effect on our sales of these products. However, the regulation of firearms and ammunition may become more restrictive in the future, and any such developments might have a material adverse effect on our business, operating results, financial condition, and cash flows. In addition, regulatory proposals, even if never enacted, may affect firearms or ammunition sales as a result of consumer perceptions.
41

Our History
We were formed under the name Retrospettiva, Inc. in November 1990 to manufacture and import textile products, including both finished garments and fabrics, but ceased operations in 2001. We were inactive from 2001 until following a series of events in December 2016 and March 2017. On December 15, 2016, our then principal stockholders sold their outstanding Common Stock to Fred W. Wagenhals, who is our Chairman of the Board, President, Chief Executive Officer, and largest stockholder. On the same date, Mr. Wagenhals became the sole officer and director of our company; we changed our name to AMMO, Inc.; we changed our trading symbol to POWW; we changed our state of incorporation from California to Nevada; we engaged in a 1-for-25 reverse stock split; and we increased our authorized capital to 100,000,000 shares of Common Stock.
Our principal stockholder, Fred Wagenhals, organized another company, on October 13, 2016, which immediately began to take steps to commence its ammunition business. We combined with that Company, which resulted in our acquisition of all the shares of its common stock for 604,371 shares of our Common Stock and our succession to its business.
We entered into licensing an endorsement agreement with Jesse James, a well-known motorcycle and gun designer, in October 2016, and a license and endorsement agreement with Jeff Rann, a well- known wild game hunter, guide, and spokesman for the firearm and ammunition industry, in February 2017; received a federal firearms license from the Bureau of Alcohol, Tobacco, and Explosives in February 2017; purchased an ammunition manufacturing facility in Payson, Arizona in March 2017; and built a management team and otherwise prepared ourself to participate in the ammunition industry.
42

DIRECTORS AND EXECUTIVE OFFICERS
The table below lists the current executive officers and directors of our company. All executive officers serve at the discretion of the Board of Directors. The term of office of each of our directors expire at our next annual meeting of stockholders or until their successors are duly elected and qualified.

Name |  | Age |  | Position
Fred W. Wagenhals 6401 E. Thomas Road, #106 Scottsdale, AZ 85251 |  |  | 75 |  | Chairman of the Board, Chief Executive Officer and President
Ron Shostack 6401 E. Thomas Road, #106 Scottsdale, AZ 85251 |  |  | 61 |  | Chief Financial Officer
Steve Hilko 6401 E. Thomas Road, #106 Scottsdale, AZ 85251 |  |  | 61 |  | Chief Operating Officer
Kathleen C. Hanrahan 6401 E. Thomas Road, #106 Scottsdale, AZ 85251 |  |  | 54 |  | President – Global Tactical Defense Division; Director
Christopher Besing 6401 E. Thomas Road, #106 Scottsdale, AZ 85251 |  |  | 57 |  | Director
Randy Luth 6401 E. Thomas Road, #106 Scottsdale, AZ 85251 |  |  | 63 |  | Director
Harry S. Markley 6401 E. Thomas Road, #106 Scottsdale, AZ 85251 |  |  | 55 |  | Director
Russell William Wallace, Jr. 6401 E. Thomas Road, #106 Scottsdale, AZ 85251 |  |  | 61 |  | Director

Fred Wagenhals has been the Chairman of the Board, President, and Chief Executive Officer of our company since December 2016. Mr. Wagenhals was a private investor from August 2005 until December 2016. Mr. Wagenhals served as Chairman, President, and Chief Executive Officer of Action Performance Companies, Inc., a Nasdaq-listed marketer and distributor of licensed motorsports merchandise, from November 1993; Chairman of the Board and Chief Executive Officer from May 1992 until September 1993; and President from July 1993 until September 1993. Action-Performance Companies, Inc. was sold in August 2005 to International Speedway Corp. and Speedway Motorsports. Mr. Wagenhals is a member of the Die-Cast hall of Fame; was named an Entrepreneur of the Year for the Retail/Wholesale category by the Center for Entrepreneurial leadership Inc.; and received the Anheuser-Bush Entrepreneur in Residence Award at the University of Arizona College of Business and Public Administration.
43

Ron Shostack has been the Chief Financial Officer of our company since March 2017. Mr. Shostack was the Chief Financial Officer of AQ Live, LLC, an e-commerce facilitator, from January 2016 through August 2016 and was a financial consultant to that company from February 2015 through December 2015.
Steve Hilko has been the Chief Operating Officer of our company since March 2017. Mr. Hilko was Vice President of Development and Logistics for Action International Marketing, a sports and entertainment license product company from May, 2014 until December, 2016; a principal of the Concept Consortium, an international consulting firm from May, 2008 until May 2014, and Vice President of Design and Production of Lionel, a consumer goods company, from May of 2006 until May, 2008; and Vice President of Research, Development and Operations of Action Performance Companies, Inc. from August 1998 until May of 2006.
Kathleen C. Hanrahan has been a director of our company since November 2017. In March, Ms. Hanrahan also became the President of our Global Tactical Defense Division whose responsibility it is to develop the law enforcement, US Military and international markets for our products. Prior to joining our company. Ms. Hanrahan was the CEO of New Horizons Management Consulting Inc., or NHMCI, which she founded in 2010. Under NHMCI, Ms. Hanrahan served a number of clients, both in both the public and private sectors. Among the higher profile clients served was LifeLock, Inc. where she served as interim CFO. Hanrahan also served as a board member and interim CFO for Guardian 8 Holdings, a public company that developed a hand held non-lethal device utilizing a layered defense approach to personal self-defense. Prior to starting her company (1996 to 2010), Ms. Hanrahan was employed by TASER International, Inc. (now Axon Enterprise, Inc.), a supplier of non-lethal weapons for use in the law enforcement, military, security and personal defense markets. At TASER, Hanrahan served in a number of key executive positions. These included, in order from her hire: Controller (1996 – 2000), Chief Financial Officer (2000 – 2004), taking the Company public on the NASDAQ stock exchange in 2001, Chief Operations Officer (2003 – 2006) and President and Chief Operating Officer (2006 – 2008). Her last position with the organization was as the Chief Executive Officer and Co-Chairperson for the TASER Foundation for Fallen Officers (2008 – 2010). The Foundation was an independent 501.c.3 created by TASER to support the families of officers killed in the line of duty.
Christopher S. Besing has been a director of our company since April 2018. Mr. Besing has been since January 2005 the principal owner and managing member of TLB Construction, LLC, a commercial landscape construction company. Mr. Besing was a partner in Fairway Productions, LLC, a business acceleration services firm, from October 2003 to January 2005; Chief Financial Officer of ITAX Group, Inc., a tax credit automation and software company, from September 2001 to October 2003; and a founder and Chief Executive Officer of IZOOM.com.Inc., an Internet portal serving the automotive community, from December 1999 to September 2001. Mr. Besing served as a Vice President and the Chief Financial Officer of Action Performance Companies, Inc. from January 1994 to December 1999, as Treasurer of that company from February 1996 to December 1999, and as a director of that company from May 1995 to December 1999. Prior to joining Action Performance Companies Inc., Mr. Besing held several financial and accounting positions with Orbital Sciences Corporation, or OSC, from September 1986 to December 1993, most recently as Director of Accounting and Controller of OSC’s Launch Systems Group in Chandler, Arizona. Prior to joining OSC, Mr. Besing was employed as an accountant with Arthur Andersen LLP from January 1985 to August 1986.
Randy Luth has been a director of our company since November 2017. Mr. Luth founded and has served as the president of Luth-AR-LLC, a producer of products for the AR-15 Market, since 2013. Mr. Luth was the Chief Executive Officer of DPMS Panther Arms, a producer of AR-15 firearms and firearm components, from 1986 until its sale in December 2007 to the Freedom Group.
44

Harry S. Markley has been a director of our company since March 2018. Mr. Markley served with the Phoenix Police Department for more than 30 years, most recently as Assistant Chief of the Patrol Division from 2013 through 2017 and Commander of the Family Investigations Bureau from 2002 to 2013. Mr. Markley currently serves as the Law Enforcement Senior Advisor for the United States of America Department of Commerce.
Russell William "Rusty" Wallace, Jr . has been a director of our company since June 2017. Mr. Wallace is the principal shareholder of the Rusty Wallace Automotive Group, a group of eight automotive dealerships located in Eastern Tennessee, and owns Rusty Wallace Racing, which has fielded entrees in the NASCAR Cup Series. Mr. Wallace, competed in NASCAR races for more than 16 years and had 55 victories prior to his retirement in 2005. Mr. Wallace serves as an analyst for ABC and ESPN. He is a member of the NASCAR Hall of Fame, the International Motorsports, Hall of Fame, the Motorsports Press Association Hall of Fame, and the Motorsports Hall of Fame of America.
Each director serves until the next annual meeting of the stockholders or their earlier resignation or removal. The Board of Directors elects officers whose terms of office are at the discretion of the Board of Directors. Each director serves until a successor is elected and qualified.
There are no family relationships between any of our directors or executive officers.
CORPORATE GOVERNANCE
Director Independence
Our Board of Directors has determined, after considering all the relevant facts and circumstances, that Christopher S. Besing, Randy Luth, Harry S. Markley, and Russell W. Wallace Jr. are independent directors, as “independence” is defined by the listing standards of the Nasdaq Stock Exchange, or Nasdaq, and by the Securities and Exchange Commission, or SEC, because they have no relationship with us that would interfere with their exercise of independent judgment in carrying out their responsibilities as a director. Fred Wagenhals and Kathleen C. Hanrahan, are not “independent” as defined by the listing standards, as they are employed by us and serve as employee directors.
Board Committees
Our bylaws authorize our Board of Directors to appoint from among its members one or more committees consisting of one or more directors. On April 24, 2018, our Board of Directors established an Audit Committee, a Compensation Committee, and a Nominations and Corporate Governance Committee, each consisting entirely of independent directors as “independence” is defined by the listing standards of Nasdaq and by the SEC.
45

Committee Charters, Corporate Governance Guidelines, and Codes of Conduct and Ethics
Our Board of Directors has adopted charters for the Audit, Compensation, and Nominations and Corporate Governance Committees describing the authority and responsibilities delegated to each committee by our Board of Directors. Our Board of Directors has also adopted Corporate Governance Guidelines, a Code of Conduct, and a Code of Ethics for the CEO and Senior Financial Officers. We post on our website, at www.ammo-inc.com, the charters of our Audit, Compensation, and Nominations and Corporate Governance Committees; our Corporate Governance Guidelines, Code of Conduct, and Code of Ethics for the CEO and Senior Financial Officers, and any amendments or waivers thereto; and any other corporate governance materials specified by SEC regulations. These documents are also available in print to any stockholder requesting a copy in writing from our Secretary at the address of our executive offices.
The Audit Committee
The purpose of the Audit Committee includes overseeing the accounting and financial reporting processes of our company and audits of the financial statements of our company and providing assistance to our Board of Directors with respect to its oversight of the integrity of our company’s financial statements, our company’s compliance with legal and regulatory requirements, the independent registered public accountant’s qualifications and independence, and the performance of our company’s independent registered public accountant. The primary responsibilities of the Audit Committee are set forth in its charter and include various matters with respect to the oversight of our company’s accounting and financial reporting process and audits of the financial statements of our company on behalf of our Board of Directors. The Audit Committee also selects the independent registered public accountant to conduct the annual audit of the financial statements of our company; reviews the proposed scope of such audit; approves the fees for services provided by the independent registered public accountant, reviews accounting and financial controls of our company with the independent registered public accountant and our financial accounting staff; and reviews and approves any transactions between us and our directors, officers, and their affiliates.
The Audit Committee currently consists of all non-employee directors. Christopher Besing, whose background is detailed in the director biographies on the prior page, qualifies as the “audit committee financial expert” in accordance with applicable rules and regulations of the SEC. Mr. Besing serves as Chair of the Audit Committee.
The Compensation Committee
The purpose of the Compensation Committee includes determining, or when appropriate, recommending to our Board of Directors for determination, the compensation of the Chief Executive Officer and other executive officers of our company and discharging the responsibilities of our Board of Directors relating to compensation programs of our company in light of the goals and objectives of our compensation program for that year. As part of its responsibilities, the Compensation Committee evaluates the performance of our Chief Executive Officer and, together with our Chief Executive Officer, assesses the performance of our other executive officers. The Compensation Committee is entitled to delegate its responsibilities to a subcommittee of the Compensation Committee, which complies with the applicable rules and regulations of the Nasdaq Stock Market, the SEC, and other regulatory bodies. From time to time, the Compensation Committee may retain the services of independent compensation consultants to review a wide variety of factors relevant to executive compensation, trends in executive compensation, and the identification of relevant peer companies. The Compensation Committee makes all determinations regarding the engagement, fees, and services of its compensation consultants, and its compensation consultants report directly to the Compensation Committee.
The Compensation Committee currently consists of all non-employee directors.
46

The Nominations and Corporate Governance Committee
The purpose of the Nominations and Corporate Governance Committee includes the selection or recommendation to our Board of Directors of nominees to stand for election as directors at each election of directors, the oversight of the selection and composition of committees of our Board of Directors, the oversight of the evaluations of our Board of Directors and management, and the development and recommendation to our Board of Directors of a set of corporate governance principles applicable to our company.
The Nominations and Corporate Governance Committee will consider persons recommended by stockholders for inclusion as nominees for election to our Board of Directors if the information required by our bylaws is submitted in writing in. timely manner addressed and delivered to our Secretary at the address of our executive offices. The Nominations and Corporate Governance Committee identifies and evaluates nominees for our Board of Directors, including nominees recommended by stockholders, based on numerous factors it considers appropriate, some of which may include strength of character, mature judgment, career specialization, relevant technical skills, diversity, and the extent to which the nominee would fill a present need on our Board of Directors.
The Nomination and Corporate Governance Committee currently consists of all non-employee directors.
Executive Sessions
We regularly schedule executive sessions in which independent directors meet without the presences or participation of management. The chairs of various committees of our Board of Directors serve as the presiding director of such executive sessions on a rotating basis.
Risk Assessment of Compensation Policies and Practices
We have assessed the compensation policies and practices with respect to our employees, including our executive officers, and have concluded that they do not create risks that are reasonably likely to have a material adverse effect on our company.
Board’s Role in Risk Oversight
Risk is inherent in every business. As is the case in virtually all businesses, we face a number of risks, including operational, economic, financial, legal, regulatory, and competitive risks. Our management is responsible for the day-to-day management of the risks we face. Our Board of Directors, as a whole and through its committees, has responsibility for the oversight of risk management.
In its oversight role, our Board of Directors’ involvement in our business strategy and strategic plans plays a key role in its oversight of risk management, its assessment of management’s risk appetite, and its determination of the appropriate level of enterprise risk. Our Board of Directors receives updates at least quarterly from senior management and periodically from outside advisors regarding the various risks we face, including operational, economic, financial, legal, regulatory, and competitive risks. Our Board of Directors also reviews the various risks we identify in our filings with the SEC and risks relating to various specific developments, such as acquisitions, debt and equity placements, and new service offerings.
47

Our board committees assist our Board of Directors in fulfilling its oversight role in certain areas of risk. Pursuant to its charter, the Audit Committee oversees the financial and reporting processes of our company and the audit of the financial statements of our company and provides assistance to our Board of Directors with respect to the oversight and integrity of the financial statements of our company, our company’s compliance with legal and regulatory requirements, the independent registered public accountant’s qualification and independence, and the performance of our independent registered public accountant. The Compensation Committee considers the risk of our compensation policies and practices and endeavors to assure that it is not reasonably likely that our compensation plans and policies would have a material adverse effect on our company. Our Nominations and Corporate Governance Committee oversees governance related risk, such as board independence, conflicts of interests, and management and succession planning.
Board Diversity
We seek diversity in experience, viewpoint, education, skill, and other individual qualities and attributes to be represented on our Board of Directors. We believe directors should have various qualifications, including individual character and integrity; business experience; leadership ability; strategic planning skills, ability, and experience; requisite knowledge of our industry and finance, accounting, and legal matters; communications and interpersonal skills; and the ability and willingness to devote time to our company. We also believe the skill sets, backgrounds, and qualifications of our directors, taken as a whole, should provide a significant mix of diversity in personal and professional experience, background, viewpoints, perspectives, knowledge, and abilities. Nominees are not to be discriminated against on the basis of race, religion, national origin, sex, sexual orientation, disability, or any other basis proscribed by law. The assessment of prospective directors is made in the context of the perceived needs of our Board of Directors from time to time.
All of our directors have held high-level positions in business or professional service firms and have experience in dealing with complex issues. We believe that all of our directors are individuals of high character and integrity, are able to work well with others, and have committed to devote sufficient time to the business and affairs of our company. In addition to these attributes, the description of each director’s background set forth above indicates the specific qualifications, skills, perspectives, and experience necessary to conclude that each individual should continue to serve as a director of our company.
Board Leadership Structure
We believe that effective board leadership structure can depend on the experience, skills, and personal interaction between persons in leadership roles and the needs of our company at any point in time. Our Corporate Governance Guidelines support flexibility in the structure the Board by not requiring the separation of the roles of Chairman of the Board and Chief Executive Officer.
Our Board of Directors currently believes that it is in the best interests of our company to have our Chief Executive Officer also serve as the Chairman of the Board. We believe that our Chairman and Chief Executive Officer provides strong, clear, and unified leadership that is critical in our relationships with our stockholders, employees, customers, suppliers, and other stakeholders. The extensive knowledge of the Chief Executive Officer regarding our operations and industries and the markets in which we compete uniquely positions him to identify strategies and prioritize matters for board review and deliberation. Additionally, we believe the combined role of Chairman and Chief Executive Officer facilitates centralized board leadership in one person, so there is no ambiguity about accountability. The Chief Executive Officer serves as a bridge between management and the Board, ensuring that both groups act with a common purpose. This structure also eliminates conflict between two leaders and minimizes the possibility of two spokespersons sending difference messages.
48

The Board does not believe that combining the position creates significant risks, including any risk that the Chairman and Chief Executive Officer will have excessive or undue influence over the agenda or deliberations of the Board. We believe we have effective and active oversight by experienced independent directors and independent committee chairs, and the independent directors meet together in executive session at virtually every Board meeting.
The Chairman of the Board provides guidance to the Board; facilitates an appropriate schedule for Board meetings; sets the agenda for Board meetings; presides over meetings of the Board; and facilitates the quality, quantity, and timeliness of the flow of information from management that is necessary for the board to effectively and responsibly perform its duties.
The Chief Executive Officer is responsible for the day-to-day leadership of our company and setting our company’s strategic direction.
Director and Officer Hedging and Pledging
We have a policy prohibiting directors and officers from purchasing financial instruments (including prepaid forward contracts, equity swaps, collars, and exchange funds) designed to hedge or offset decreases in the market value of compensatory awards of our equity securities directly or indirectly held by them. Additionally, we have a policy prohibiting directors and officers from pledging of shares.
Stock Ownership Guidelines
Our Board of Directors believes that the alignment of directors’ interests with those of our stockholders is strengthened when board members are also stockholders. Therefore, our Board of Directors is adopting minimum stock ownership guidelines under which non-employee directors are expected to acquire shares of our Common Stock with a value, at least equal to the annual retainer paid for serving on the Board. Non-employee directors will be expected to satisfy at least the minimum guidelines beginning on the later of five years following (i) the date the guidelines were adopted or (ii) the date the individual becomes a non-employee director. This program is designed to ensure that directors acquire a meaningful ownership interest in our company during their tenure on the Board.
Clawback Policy
We have adopted a clawback policy. In the event we are required to prepare an accounting restatement of our financial results as a result of a material noncompliance by us with any financial reporting requirement under the federal securities laws, we will have the right to use reasonable efforts to recover from any current or former executive officers who received incentive compensation (whether cash or equity) from us during the three-year period preceding the date on which we were required to prepare the accounting restatement, any excess incentive compensation awarded as a result of the misstatement. This policy is administered by the Compensation Committee of our Board of Directors. The policy is effective for financial statements for periods beginning on or after April 1, 2018. Once final rules are adopted by the SEC regarding the clawback requirements under the Dodd-Frank Wall Street Reform and Consumer Protection Act, we will review this policy and make any amendments necessary to comply with the new rules.
49

Board and Committee Meetings
Our Board of Directors held no formal Committee or regular Board of Directors meetings during the three months ended March 31, 2018. Our Board of Directors held one meeting during the year ended December 31, 2017.
Annual Meeting Attendance
We encourage each of our directors to attend annual meetings of stockholders. To that end, and to the extent reasonably practicable, we will schedule a meeting of our Board of Directors on the same day as our annual meeting of stockholders.
Communications with Directors
Stockholders and other interested parties may communicate with our Board of Directors or specific members of our Board of Directors, including our independent directors and the members of our various board committees, by submitting a letter addressed to the Board of Directors of our company in care of any specified individual director or directors at the address of our executive offices. Any such letters are sent to the indicated directors.
EXECUTIVE COMPENSATION
Summary Compensation Table
The following table sets forth, for the three months ended March 31, 2018 and the years ended December 31, 2017 and 2016, information with respect to compensation for services in all capacities to us and our subsidiaries earned by our principal executive officer, our principal financial officer, and our other executive officers who were serving as executive officers on March 31, 2018. We refer to these executive officers as our "named executive officers."

Name and Principal Position | Year (1) |  | Salary (2) |  |  | Bonus (1) |  |  | Option Awards (3) |  |  | All Other Compensation (4) |  |  | Total |
Fred W. Wagenhals | 2018 |  | $ | 30,000 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 30,000 |
President, Chief Executive Officer, | 2017 |  | $ | 140,000 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 140,000 |
and Director | 2016 |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  |  | 0 |
Steve Hilko (4) | 2018 |  | $ | 30,000 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 30,000 |
Chief Operating Officer | 2017 |  | $ | 108,350 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 108,350 |
Ron Shostack (5) | 2018 |  | $ | 19,500 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 19,500 |
Chief Financial Officer | 2017 |  | $ | 71,500 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 71,500 |

(1) The amounts in this column reflect the amounts earned during the fiscal year, whether or not actually paid during such year.
(2) The amounts in this column reflect the aggregate grant date fair value of options awards granted to our named executive officers during the transition period or fiscal year, as applicable, calculated in accordance with FASB ASC Topic 718. Stock Compensation. The valuation assumptions used in determining such amounts are described in the footnotes to our audited consolidated financial statements included in our Transition Report on Form 10-K for the transition period ended December 31, 2017. The amounts reported in this column reflect our accounting expense for these awards and do not correspond to the actual economic value that may be received by our named executive officers from their option awards.
(3) The named executive officers participate in certain group life, health, disability insurance, and medical reimbursement plans not disclosed in the Summary Compensation Table that are generally available to salaried employees and do not discriminate in scope, terms, and operation.
(4) Mr. Hilko assumed his position in March 2017.
(5) Mr. Shostack assumed his position in March 2017.
50

Director Compensation
We do not currently pay cash compensation for services of our directors. Instead we make an annual grant to each non-employee director of 40,000 shares of our Common Stock.
We reimburse all officers and directors for reasonable and necessary expenses incurred in their capacities as such.
Outstanding Equity Awards at Fiscal Year-end
As of March 31, 2018 and December 31, 2017, there were no outstanding stock options or restricted stock units. During the two years December 31, 2017 and the three months ended March 31, 2018, we did not grant any restricted stock units or stock options but granted restricted stock to directors, officers, and others who provided services to our company.
PRINCIPAL AND SELLING STOCKHOLDERS
The following table sets forth information regarding the beneficial ownership of our Common Stock as of June 1, 2018 by the following:

| · | each of our directors and executive officers;

| · | all of our directors and executive officers as a group;

| · | each person, or group of affiliated persons, who is known by us to beneficially own more than 5% of our Common Stock; and

| · | the Selling Stockholders.

Beneficial ownership is determined according to the rules of the SEC and generally means that a person has beneficial ownership of a security if he, she, or it possesses sole or shared voting or investment power of that security, including options and warrants that are currently exercisable or exercisable within 60 days of June 25, 2018. Shares issuable pursuant to stock options, warrants, and convertible securities are deemed outstanding for computing the percentage of the person holding such options, warrants, or convertible securities but are not deemed outstanding for computing the percentage of any other person. Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons named in the table below have sole voting and investment power with respect to all shares of Common Stock shown that they beneficially own, subject to community property laws where applicable. The information does not necessarily indicate beneficial ownership for any other purpose.
The Selling Stockholders, if they desire, may dispose of the shares covered by this Prospectus from time to time at such prices as it may choose. Before a stockholder not named below may use this Prospectus in connection with an offering of shares, this Prospectus must be amended or supplemented to include the name and number of shares beneficially owned by the Selling Stockholder and the number of shares to be offered. Any amended or supplemented Prospectus also will disclose whether any selling stockholder named in that amended or supplemented Prospectus has held any position, office or other material relationship with us or any of our predecessors or affiliates during the three years prior to the date of the amended or supplemented Prospectus. None of the Selling Stockholders has held any position or office, or has had any other material relationship with us or any of our affiliates within the past three years. As used in this Prospectus, “Selling Stockholders” includes the donees, pledgers, transferees, or other successors-in-interest who my later hold the Selling Stockholders’ interest.
51

Unless otherwise indicated, the address of each beneficial owner listed in the table below is c/o AMMO, Inc., 6401 East Thomas Road, #106, Scottsdale, Arizona 85251.

|  | Shares Beneficially Owned Prior to the Offering |  |  |  |  |  | Beneficially Owned Upon Completion of this Offering |
Name of Beneficial Owner |  | Number |  |  | Percent |  |  | Number of Shares Being Registered for Sale |  |  | Number |  |  | Percent |
Executive Officers and Directors: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fred W. Wagenhals (1) |  |  | 7,514,700 |  |  |  | 23.87 | % |  |  | 0 |  |  |  | 7,514,700 |  |  |  | 23.87 | %
Ron Shostack |  |  | 125,000 |  |  |  | 0.40 | % |  |  | 0 |  |  |  | 125,000 |  |  |  | 0.40 | %
Steve Hilko |  |  | 250,000 |  |  |  | 0.79 | % |  |  | 0 |  |  |  | 250,000 |  |  |  | 0.79 | %
Kathleen Hanrahan |  |  | 130,000 |  |  |  | 0.41 | % |  |  | 0 |  |  |  | 130,000 |  |  |  | 0.41 | %
Christopher S. Besing |  |  | 10,000 |  |  |  | 0.03 | % |  |  | 0 |  |  |  | 10,000 |  |  |  | 0.03 | %
Randy Luth |  |  | 305,000 |  |  |  | 0.97 | % |  |  | 0 |  |  |  | 305,000 |  |  |  | 0.97 | %
Harry S. Markley |  |  | 10,000 |  |  |  | 0.03 | % |  |  | 0 |  |  |  | 10,000 |  |  |  | 0.03 | %
Russell William Wallace, Jr. |  |  | 330,000 |  |  |  | 1.05 | % |  |  | 0 |  |  |  | 330,000 |  |  |  | 1.05 | %
All executive officers and directors as a group (eight people) |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  |  |
Beneficial Shareholders greater than 5% |  |  | 8,674,700 |  |  |  | 27.56 | % |  |  | 0 |  |  |  | 8,674,700 |  |  |  | 27.56 | %

Selling Stockholders |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Adolfo and Donna Carmona |  |  | 300,000 |  |  |  | 0.95 | % |  |  | 300,000 |  |  |  | - |  |  |  | 0.00 | %
Advanta IRA Services FBO David M Rhodes #8004842 |  |  | 45,456 |  |  |  | 0.14 | % |  |  | 45,456 |  |  |  | - |  |  |  | 0.00 | %
Albert Arciero |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Albert Landstrom |  |  | 8,181 |  |  |  | 0.03 | % |  |  | 8,181 |  |  |  | - |  |  |  | 0.00 | %
Allen Gabriel |  |  | 159,090 |  |  |  | 0.51 | % |  |  | 159,090 |  |  |  | - |  |  |  | 0.00 | %
Andrew Schink |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Angela Miller Trust |  |  | 181,818 |  |  |  | 0.58 | % |  |  | 181,818 |  |  |  | - |  |  |  | 0.00 | %
Anthony Adams |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Asian Gateway |  |  | 90,785 |  |  |  | 0.29 | % |  |  | 90,785 |  |  |  | - |  |  |  | 0.00 | %
Barrett Share Trust |  |  | 730,500 |  |  |  | 2.32 | % |  |  | 730,500 |  |  |  | - |  |  |  | 0.00 | %
Basil Christakos |  |  | 8,182 |  |  |  | 0.03 | % |  |  | 8,182 |  |  |  | - |  |  |  | 0.00 | %
Beacon Investments |  |  | 272,727 |  |  |  | 0.87 | % |  |  | 272,727 |  |  |  | - |  |  |  | 0.00 | %
Bennett Yanowitz Credit Shelter Trust |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Boston Light Advisors LLC |  |  | 72,750 |  |  |  | 0.23 | % |  |  | 72,750 |  |  |  | - |  |  |  | 0.00 | %
Bradford Paskewitz |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Bradley Karp and Linda Karp |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Bradly Mombert |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Brady Clark |  |  | 1,819 |  |  |  | 0.01 | % |  |  | 1,819 |  |  |  | - |  |  |  | 0.00 | %
Brenna Tanzosh |  |  | 22,734 |  |  |  | 0.07 | % |  |  | 22,734 |  |  |  | - |  |  |  | 0.00 | %
Brett Nesland |  |  | 75,000 |  |  |  | 0.24 | % |  |  | 75,000 |  |  |  | - |  |  |  | 0.00 | %
Bruce and Nancy Inglis |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Bruce McFadden |  |  | 13,634 |  |  |  | 0.04 | % |  |  | 13,634 |  |  |  | - |  |  |  | 0.00 | %

52

Caisson Breakwater Fund, LP |  |  | 272,730 |  |  |  | 0.87 | % |  |  | 272,730 |  |  |  | - |  |  |  | 0.00 | %
Caisson Breakwater Global Opportunity Fund LLP |  |  | 190,920 |  |  |  | 0.61 | % |  |  | 190,920 |  |  |  | - |  |  |  | 0.00 | %
Calcott Family Trust |  |  | 31,818 |  |  |  | 0.10 | % |  |  | 31,818 |  |  |  | - |  |  |  | 0.00 | %
Carolyn Roney |  |  | 9,090 |  |  |  | 0.03 | % |  |  | 9,090 |  |  |  | - |  |  |  | 0.00 | %
CD Walker LLC |  |  | 227,273 |  |  |  | 0.72 | % |  |  | 227,273 |  |  |  | - |  |  |  | 0.00 | %
Chad Krull |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Chris Merten |  |  | 68,183 |  |  |  | 0.22 | % |  |  | 68,183 |  |  |  | - |  |  |  | 0.00 | %
Christopher Clark |  |  | 146,669 |  |  |  | 0.47 | % |  |  | 146,669 |  |  |  | - |  |  |  | 0.00 | %
Christopher P Gutek |  |  | 68,183 |  |  |  | 0.22 | % |  |  | 68,183 |  |  |  | - |  |  |  | 0.00 | %
Clint Duty |  |  | 68,181 |  |  |  | 0.22 | % |  |  | 68,181 |  |  |  | - |  |  |  | 0.00 | %
Currie Family Trust |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Cynthia Lynne Stevens |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Dale Ragan |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Dan Cornwell |  |  | 75,000 |  |  |  | 0.24 | % |  |  | 75,000 |  |  |  | - |  |  |  | 0.00 | %
Darrell Roush |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
David and Elizabeth Kocyba |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
David Kinsel |  |  | 81,818 |  |  |  | 0.26 | % |  |  | 81,818 |  |  |  | - |  |  |  | 0.00 | %
Devon Browne |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Don Stangle |  |  | 22,500 |  |  |  | 0.07 | % |  |  | 22,500 |  |  |  | - |  |  |  | 0.00 | %
Douglas Harner LLC |  |  | 136,364 |  |  |  | 0.43 | % |  |  | 136,364 |  |  |  | - |  |  |  | 0.00 | %
Douglas Harner, LLC |  |  | 163,637 |  |  |  | 0.52 | % |  |  | 163,637 |  |  |  | - |  |  |  | 0.00 | %
Dyke Rogers |  |  | 265,455 |  |  |  | 0.84 | % |  |  | 265,455 |  |  |  | - |  |  |  | 0.00 | %
Edward O'Rourke |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Elizabeth V Sherertz |  |  | 45,750 |  |  |  | 0.15 | % |  |  | 45,750 |  |  |  | - |  |  |  | 0.00 | %
Emile Attar |  |  | 22,727 |  |  |  | 0.07 | % |  |  | 22,727 |  |  |  | - |  |  |  | 0.00 | %
Endeavour LP |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Eugene Webb |  |  | 258,591 |  |  |  | 0.82 | % |  |  | 258,591 |  |  |  | - |  |  |  | 0.00 | %
Eugenia Paulette Kraft Trust dated July 15, 1994 |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
FBO Gary W Zoellner |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Flying S Ranch Trust |  |  | 60,000 |  |  |  | 0.19 | % |  |  | 60,000 |  |  |  | - |  |  |  | 0.00 | %
G and D Conniff, LLC |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Gary Griesenauer |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Gary Saccaro |  |  | 10,908 |  |  |  | 0.03 | % |  |  | 10,908 |  |  |  | - |  |  |  | 0.00 | %
Gary W Levine |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
George Mokan |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
George W Holbrook, Jr. |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Gerald Clavette |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Gerald Yanowitz |  |  | 22,727 |  |  |  | 0.07 | % |  |  | 22,727 |  |  |  | - |  |  |  | 0.00 | %
Glenbrook Capital LP |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Glenn Parker |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Greg Buffington |  |  | 225,000 |  |  |  | 0.71 | % |  |  | 225,000 |  |  |  | - |  |  |  | 0.00 | %
Grover T Wickersham TTEE FBO GTW PC Employee Profit Sharing Plan |  |  | 54,545 |  |  |  | 0.17 | % |  |  | 54,545 |  |  |  | - |  |  |  | 0.00 | %
GTW and JW TTEE FBO 2000 Charitable Trust |  |  | 27,272 |  |  |  | 0.09 | % |  |  | 27,272 |  |  |  | - |  |  |  | 0.00 | %
Ian Ackerman |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
J Scott Ehlen |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
James Decosta |  |  | 22,727 |  |  |  | 0.07 | % |  |  | 22,727 |  |  |  | - |  |  |  | 0.00 | %
Jane Kantor 2011 Trust |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Jared Berg |  |  | 304 |  |  |  | 0.00 | % |  |  | 304 |  |  |  | - |  |  |  | 0.00 | %
Jeanne and Keith Fishback |  |  | 136,364 |  |  |  | 0.43 | % |  |  | 136,364 |  |  |  | - |  |  |  | 0.00 | %
Jeffrey and Diana Berg |  |  | 22,734 |  |  |  | 0.07 | % |  |  | 22,734 |  |  |  | - |  |  |  | 0.00 | %
Jill Wickersham |  |  | 27,000 |  |  |  | 0.09 | % |  |  | 27,000 |  |  |  | - |  |  |  | 0.00 | %
Jim Brown |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Jimmie Dixon, Jr. |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
John and Laura Maring |  |  | 75,000 |  |  |  | 0.24 | % |  |  | 75,000 |  |  |  | - |  |  |  | 0.00 | %
John and Linea Baldwin |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
John B Payne III |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
John V Wagner |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Jon Deonise |  |  | 22,727 |  |  |  | 0.07 | % |  |  | 22,727 |  |  |  | - |  |  |  | 0.00 | %
Jonathan Henrich |  |  | 607 |  |  |  | 0.00 | % |  |  | 607 |  |  |  | - |  |  |  | 0.00 | %
Joseph Michalczyk |  |  | 27,272 |  |  |  | 0.09 | % |  |  | 27,272 |  |  |  | - |  |  |  | 0.00 | %
Jud and Barbara Longaker |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Justin Brevoort |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
K Franklin and B Franklin |  |  | 22,727 |  |  |  | 0.07 | % |  |  | 22,727 |  |  |  | - |  |  |  | 0.00 | %
Kadi Family Trust |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Kathleen A Lannert Trust |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Keith Gelles |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Keith Wright |  |  | 188,637 |  |  |  | 0.60 | % |  |  | 188,637 |  |  |  | - |  |  |  | 0.00 | %
Kelli Krumenacker |  |  | 72,726 |  |  |  | 0.23 | % |  |  | 72,726 |  |  |  | - |  |  |  | 0.00 | %
Ken Shell |  |  | 75,000 |  |  |  | 0.24 | % |  |  | 75,000 |  |  |  | - |  |  |  | 0.00 | %
Kevin Gabrik |  |  | 22,730 |  |  |  | 0.07 | % |  |  | 22,730 |  |  |  | - |  |  |  | 0.00 | %
Kimberly J Sherertz |  |  | 45,750 |  |  |  | 0.15 | % |  |  | 45,750 |  |  |  | - |  |  |  | 0.00 | %
Kimberly J Sherertz - Kimberly J Sherertz for William C Sheretz UGMA |  |  | 45,750 |  |  |  | 0.15 | % |  |  | 45,750 |  |  |  | - |  |  |  | 0.00 | %
Ladd Hill Development |  |  | 77,271 |  |  |  | 0.25 | % |  |  | 77,271 |  |  |  | - |  |  |  | 0.00 | %
Les Schultz |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Lindsay Anne Wickersham 1999 Irrevocable Trust |  |  | 27,272 |  |  |  | 0.09 | % |  |  | 27,272 |  |  |  | - |  |  |  | 0.00 | %
Lloyd Pellham |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Lorraine Maxfield |  |  | 8,182 |  |  |  | 0.03 | % |  |  | 8,182 |  |  |  | - |  |  |  | 0.00 | %
Louis Schaufele |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Malcolm Alexander Winks |  |  | 16,364 |  |  |  | 0.05 | % |  |  | 16,364 |  |  |  | - |  |  |  | 0.00 | %
Mark Finckle |  |  | 10,495 |  |  |  | 0.03 | % |  |  | 10,495 |  |  |  | - |  |  |  | 0.00 | %
Marshall Brown |  |  | 304 |  |  |  | 0.00 | % |  |  | 304 |  |  |  | - |  |  |  | 0.00 | %
Matthew Bain |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Matthew Rea and Julie Bigler |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Melanie and Jon Stagnitti |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Michael Kram |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Michael and Leslie Heathington |  |  | 227,273 |  |  |  | 0.72 | % |  |  | 227,273 |  |  |  | - |  |  |  | 0.00 | %
Michael and Lisa Zupan |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Michael Lechter |  |  | 45,450 |  |  |  | 0.14 | % |  |  | 45,450 |  |  |  | - |  |  |  | 0.00 | %
Mike Donnelly |  |  | 22,500 |  |  |  | 0.07 | % |  |  | 22,500 |  |  |  | - |  |  |  | 0.00 | %

53

Nancy Cowgill Trust |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Neil Bowles |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Nick Panayotou |  |  | 120,455 |  |  |  | 0.38 | % |  |  | 120,455 |  |  |  | - |  |  |  | 0.00 | %
NJK Venture, LLC |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Patrick J Carney |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Paulson Investment Company, LLC |  |  | 147,267 |  |  |  | 0.47 | % |  |  | 147,267 |  |  |  | - |  |  |  | 0.00 | %
Pavel Vodkin |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
PAW Small Cap Partners, L.P. |  |  | 300,000 |  |  |  | 0.95 | % |  |  | 300,000 |  |  |  | - |  |  |  | 0.00 | %
Pensco Trust Company, LLC, Custodian FBO Robert L Dunn IRA |  |  | 136,364 |  |  |  | 0.43 | % |  |  | 136,364 |  |  |  | - |  |  |  | 0.00 | %
Peter Fogarty |  |  | 20,483 |  |  |  | 0.07 | % |  |  | 20,483 |  |  |  | - |  |  |  | 0.00 | %
Philip and Nancy Rosenblatt |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Phillip Parham |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Ralph E Hardt |  |  | 150,000 |  |  |  | 0.48 | % |  |  | 150,000 |  |  |  | - |  |  |  | 0.00 | %
RBC Capital Markets LLC Cust FBO Darin E Shelton Simple IRA |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
RBC Capital Markets LLC Cust FBO David S Perry Sep IRA |  |  | 181,818 |  |  |  | 0.58 | % |  |  | 181,818 |  |  |  | - |  |  |  | 0.00 | %
RBC Capital Markets LLC Cust FBO Phil Phillips IRA |  |  | 33,636 |  |  |  | 0.11 | % |  |  | 33,636 |  |  |  | - |  |  |  | 0.00 | %
RBC Capital Markets LLC Cust FBO Roger Langliers Segregated Rollover IRA |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
RBC Capital Markets LLC, Cust FBO Michael Zupan IRA |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
RBC Capital Markets LLC, Cust FBO Terry Michell IRA |  |  | 68,183 |  |  |  | 0.22 | % |  |  | 68,183 |  |  |  | - |  |  |  | 0.00 | %
RBC Capital Markets LLC, Cust FBO Thomas C Rolfstad Segregated Rollover IRA |  |  | 181,818 |  |  |  | 0.58 | % |  |  | 181,818 |  |  |  | - |  |  |  | 0.00 | %
Richard Carney |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Richard Travia |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Rick Christen |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Robert Fox |  |  | 272,727 |  |  |  | 0.87 | % |  |  | 272,727 |  |  |  | - |  |  |  | 0.00 | %
Robert Dodge |  |  | 136,364 |  |  |  | 0.43 | % |  |  | 136,364 |  |  |  | - |  |  |  | 0.00 | %
Robert J Monroe |  |  | 45,453 |  |  |  | 0.14 | % |  |  | 45,453 |  |  |  | - |  |  |  | 0.00 | %
Robert L Dunn and Theresa L Dunn as Trustees as the Dunn Family Community Property Trust Dtd February 28th, 20 |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Robert L Johnson |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Robert Lanphere, Jr. |  |  | 150,000 |  |  |  | 0.48 | % |  |  | 150,000 |  |  |  | - |  |  |  | 0.00 | %
Robert Rathbone |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Robert S Johnson |  |  | 22,727 |  |  |  | 0.07 | % |  |  | 22,727 |  |  |  | - |  |  |  | 0.00 | %
Robert Setteducati |  |  | 146,669 |  |  |  | 0.47 | % |  |  | 146,669 |  |  |  | - |  |  |  | 0.00 | %
Roger & Joyce Langeliers |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Roger and Joyce Langeliers |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Roger F Anderson |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Ron Holman |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Ronald Coby |  |  | 10,845 |  |  |  | 0.03 | % |  |  | 10,845 |  |  |  | - |  |  |  | 0.00 | %
Sally Russo |  |  | 9,090 |  |  |  | 0.03 | % |  |  | 9,090 |  |  |  | - |  |  |  | 0.00 | %
Scott Carmony |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Scott Mary |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Sharon Walker |  |  | 30,000 |  |  |  | 0.10 | % |  |  | 30,000 |  |  |  | - |  |  |  | 0.00 | %
Shawn Willard |  |  | 45,750 |  |  |  | 0.15 | % |  |  | 45,750 |  |  |  | - |  |  |  | 0.00 | %
Sheldon Miller |  |  | 68,183 |  |  |  | 0.22 | % |  |  | 68,183 |  |  |  | - |  |  |  | 0.00 | %
Stanton Rowe |  |  | 181,818 |  |  |  | 0.58 | % |  |  | 181,818 |  |  |  | - |  |  |  | 0.00 | %
Starla Goff |  |  | 19,722 |  |  |  | 0.06 | % |  |  | 19,722 |  |  |  | - |  |  |  | 0.00 | %
Stephen Ham |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Steve Bathgate |  |  | 22,727 |  |  |  | 0.07 | % |  |  | 22,727 |  |  |  | - |  |  |  | 0.00 | %
Tanya Urbach |  |  | 14,728 |  |  |  | 0.05 | % |  |  | 14,728 |  |  |  | - |  |  |  | 0.00 | %
Tanzosh Family Law LLC |  |  | 22,727 |  |  |  | 0.07 | % |  |  | 22,727 |  |  |  | - |  |  |  | 0.00 | %
The Calcott Family Trust |  |  | 30,000 |  |  |  | 0.10 | % |  |  | 30,000 |  |  |  | - |  |  |  | 0.00 | %
The GBS Living Trust, Dated November 20, 2003 and any amendments thereto |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
The Paxton Lee Shoen 1998 Education Trust |  |  | 27,272 |  |  |  | 0.09 | % |  |  | 27,272 |  |  |  | - |  |  |  | 0.00 | %
Thomas Hice |  |  | 31,818 |  |  |  | 0.10 | % |  |  | 31,818 |  |  |  | - |  |  |  | 0.00 | %
Thomas McChesney |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
Thomas Parigan |  |  | 146,669 |  |  |  | 0.47 | % |  |  | 146,669 |  |  |  | - |  |  |  | 0.00 | %
Troy O'Bryan |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Troy Stevens |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Troy Wells |  |  | 90,909 |  |  |  | 0.29 | % |  |  | 90,909 |  |  |  | - |  |  |  | 0.00 | %
Veronica Marano and Thomas M Volckening |  |  | 63,636 |  |  |  | 0.20 | % |  |  | 63,636 |  |  |  | - |  |  |  | 0.00 | %
Wayne Newkumet |  |  | 227,273 |  |  |  | 0.72 | % |  |  | 227,273 |  |  |  | - |  |  |  | 0.00 | %
William Bloomquist |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
William H Costigan |  |  | 31,820 |  |  |  | 0.10 | % |  |  | 31,820 |  |  |  | - |  |  |  | 0.00 | %
William Murphy |  |  | 68,190 |  |  |  | 0.22 | % |  |  | 68,190 |  |  |  | - |  |  |  | 0.00 | %
William O Williams |  |  | 22,728 |  |  |  | 0.07 | % |  |  | 22,728 |  |  |  | - |  |  |  | 0.00 | %
William Potts |  |  | 45,455 |  |  |  | 0.14 | % |  |  | 45,455 |  |  |  | - |  |  |  | 0.00 | %
Woodworth Contrarian Stock and Bond Fund LP |  |  | 67,500 |  |  |  | 0.21 | % |  |  | 67,500 |  |  |  | - |  |  |  | 0.00 | %
Total Selling Stockholders |  |  | 13,242,186 |  |  |  | 42.07 | % |  |  | 13,242,186 |  |  |  | 0 |  |  |  | 0 |

____________________
(1) Officer and director.
54

Changes in Control
Our principal stockholder owns 7,514,700 shares, or 23.87% of our outstanding Common Stock. The principal stockholder serves as an officer and director. They exercise significance influence over the control of our Company and may be able to cause or prevent a change in control.
Equity Incentive Plan
In November 2017, the Board of Directors approved the 2017 Equity Incentive Plan, or the Plan. Under the Plan, 485,000 shares of our company’s Common stock was reserved and authorized to be issued. At December 31, 2017, 200,000 shares of Common Stock were approved and issued under the Plan, and we recognized approximately $250,000 of related compensation expenses. On January 10, 2018, 200,000 shares were awarded, and we recognized $330,000 of compensation expense. There are 85,000 remaining to be issued.
55

CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS, AND DIRECTOR INDEPENDENCE
On December 16, 2016, we and Mansfield LLC, a company owned by our CEO, Fred Wagenhals, or Mansfield, as an affiliated party, entered into a note purchase and sale agreement to purchase a promissory note held by Mansfield, and payable by ATAC. We purchased the promissory note for $1,035,000. The Managing Member of Mansfield, Tod Wagenhals, is related to our CEO. The $1,035,000 was payable on or before the closing date of the note purchase and sale agreement. As of December 31, 2017, the note had been paid in full.
On March 17, we purchased for 17,285,800 shares of our Common Stock all of the outstanding shares of Common Stock of a private company, which was primarily owned by our Chairman of the Board, and Chief Executive Officer and which engaged in the ammunition business upon which our business is based.
Our executive offices are located in Scottsdale, Arizona where we lease approximately 5,000 square feet under a month-to-month triple net lease for $3,800 per month. This space houses our principal executive, administration, and marketing functions. We may require additional space in the near future but believe that suitable additional or alternative space will be available on commercially reasonable terms to accommodate our needs. Our Chief Executive Officer owns the building in which our executive offices are leased.
DESCRIPTION OF COMMON STOCK
This section describes the general terms of our Common Stock. Our Common Stock and the rights of the holders of our Common Stock are subject to the applicable provisions of the Delaware General Corporation Law, which we refer to as “Delaware Law,” our certificate of incorporation, our bylaws, the rights of the holders of our preferred stock, if any, as well as some of the terms of any outstanding indebtedness that we may incur.
As of June 30, 2018 under our certificate of incorporation, we had the authority to issue 100,000,000 shares of Common Stock, par value $0.001 per share, of which 31,475,684 shares of our Common Stock were outstanding as of that date.
The following description of our Common Stock may not be complete and is subject to, and qualified in its entirety by reference to Delaware law and the actual terms and provisions contained in our certificate of incorporation and our bylaws, each as amended from time to time.
Voting Rights
Each outstanding share of our Common Stock is entitled to one vote per share of record on all matters submitted to a vote of stockholders and to vote together as a single class for the election of directors and in respect of other corporate matters. At a meeting of stockholders at which a quorum is present, for all matters other than the election of directors, a majority of the votes cast decides all questions, unless the matter is one upon which a different vote is required by express provision of law or our amended and restated articles of incorporation or our bylaws. Directors will be elected by a plurality of the votes of the shares present at a meeting. Holders of shares of Common Stock do not have cumulative voting rights with respect to the election of directors or any other matter.
56

Dividends
Holders of our Common Stock are entitled to receive dividends or other distributions when, as, and if declared by our board of directors. The right of our board of directors to declare dividends, however, is subject to any rights of the holders of other classes of our capital stock, any indebtedness outstanding from time to time, and the availability of sufficient funds under Delaware law to pay dividends.
Preemptive Rights
The holders of our Common Stock generally do not have preemptive rights to purchase or subscribe for any of our capital stock or other Common Stock.
Redemption
The shares of our Common Stock are not subject to redemption by operation of a sinking fund or otherwise.
PLAN OF DISTRIBUTION
The Selling Stockholders may, from time to time, sell, transfer, or otherwise dispose of any or all of their shares of common stock on any stock exchange, market, or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. The Seller Stockholders may use any one or more of the following methods when disposing of shares:

| · | on any national securities exchange or quotation service on which the shares may be listed or quoted at the time of sale;

| · | in the over-the-counter market;

| · | in the transactions otherwise than on these exchanges or systems or in the over-the-counter market;

| · | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

| · | block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction;

| · | purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

| · | an exchange distribution in accordance with the rules of the applicable exchange;

| · | privately negotiated transactions;

| · | short sales;

| · | through the listing or settlement of options or other hedging transactions, whether such options are listed on an options exchange or otherwise;

| · | broker-dealers may agree with the Selling Stockholders to sell a specified number of such shares at a stipulated price per share;

| · | a combination of any such methods of sale; and

| · | any other method permitted pursuant to applicable law.

The Selling Stockholders may also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus.
57

If the Selling Stockholders effect such transactions by selling shares of Common Stock to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions, or commissions from the Seller Stockholders or commissions from purchasers of the shares of Common Stock for whom they may act as agent or to whom they may sell as principal (which discounts, concessions, or commissions as to particular underwriters, broker-dealers or agents may be in excess of those customary in the types of transactions involved). In connection with sales of the shares of Common Stock or otherwise, the Selling Stockholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares of Common Stock in the course of hedging in positions they assume. The Selling Stockholders may also sell shares of Common Stock short and deliver shares of Common Stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The Selling Stockholders may also loan or pledge shares of Common Stock to broker-dealers that in turn may sell such shares.
The Selling Stockholders may from time to time pledge or grant a security interest in some or all of the shares of Common Stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of Common Stock from time to time under this Prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act supplementing or amending the list of Selling Stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The Selling Stockholders also may transfer or donate the shares of Common Stock in other circumstances, in which case the transferees, donees, pledgees, or other successors in interest will be the selling beneficial owners for purposes of this prospectus.
Under the securities laws of some states, the shares of Common Stock may be sold in such states only through registered or licensed brokers or dealers. In addition, in some states the shares of Common Stock may not be sold unless such shares have been registered or qualified for sale in such state or an exemption from registration or qualification is available and is complied with.
There can be no assurance that any Selling Stockholder will sell any or all of the shares of Common Stock registered pursuant to the registration statement of which this prospectus forms a part.
The Selling Stockholders and any other person participating in such distribution will be subject to applicable provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, including, without limitation, the anti-manipulation rules of Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the Common Stock by the Selling Stockholders and any other participating person. Regulation M may also restrict the ability of any person engaged in the distribution of the shares of Common Stock to engage in market-making activities with respect to the shares of common stock.
In addition, to the extent applicable we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the Selling Stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The Seller Stockholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.
We are required to pay all expenses of the registration of the shares of Common Stock, including SEC filing fees and expenses of compliance with state securities or “blue sky” laws; provided, however, that the Selling Stockholders will pay all underwriting discounts and selling commissions, if any, and all fees and expenses of their respective legal counsel. We have agreed to indemnify the Selling Stockholders against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares offered by this prospectus. We may be indemnified by the Selling Stockholders against liabilities, including liabilities under the Securities Act, and state security laws, that may arise from any written information furnished to us by the Selling Stockholders specifically for use in this prospectus.
Once effective, our company has agreed to use its commercially reasonable efforts to keep such registration, and any qualifications, exemption or compliance under state securities laws which our company determines to obtain, continuously effective, and to keep the registration statement of which this prospectus forms a part free of any material misstatements or omissions, until the earlier of the following:(1) the date of which the Selling Stockholders cease to hold any shares of Common Stock registered hereunder, or (2) the date all shares of Common Stock held by the Selling Stockholders may be sold without restriction under Rule 144, including without limitation, any volume and manner of sale restrictions which may be applicable to affiliates under Rule 144.
Once sold under the registration statement of which this prospectus forms a part, the shares of common stock will be freely tradable in the hands of persons other than our affiliates.
58

SHARES ELIGIBLE FOR FUTURE SALE
As of June 30, 2018, we had outstanding 31,475,684 shares of Common Stock. Of those shares, the 13,242,186 shares (including 5,054,893 shares to be issued on the exercise of warrants are included in the units) covered by this Prospectus upon sale will be freely transferrable without restrictions unless purchased by persons deemed to be our affiliates as that term is defined in Rule 144 under the Securities Act. Any shares purchased by an affiliate may not be resold except pursuant to an effective registration statement or an applicable exemption from registration, including an exemption under Rule 144 under the Securities Act. Of our shares of Common Stock that are outstanding, 23,288,391 are "restricted," which means they were originally sold in offering, that were not registered under the Securities Act. Restricted shares may be sold through registration under the Securities Act or under an applicable exemption from registration, such as provided by Rule 144, which is summarized below.
Rule 144
In general, under Rule 144, a person who has beneficially owned restricted shares for at least six months would be entitled to sell those securities provided that (1) such person is not deemed to have been one of our affiliates at the time of, or at any time during the 90 days preceding, a sale and (2) we have been subject to the Exchange Act periodic reporting requirements for at least 90 days before the sale and are current in filing our periodic reports. Persons who have beneficially owned restricted shares of Common Stock for at least six months but who are our affiliates at the time of, or any time during the 90 days preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed 1% of the number of our Common Stock then outstanding, which will equal approximately 132,420 shares immediately after this offering and the concurrent private placement, based on the number of shares of Common Stock outstanding as of June 30, 2016. Such sales by affiliates must also comply with the manner of sale and notice provisions of Rule 144 and to the availability of current public information about us.
Rule 701
Rule 701 under the Securities Act, as in effect on the date of this Prospectus, permits resales of shares in reliance upon Rule 144 but without compliance with certain restrictions of Rule 144, including the holding period requirement. Most of our employees, executive offices or directors who purchased shares under a written compensatory plan or contract may be entitled to rely on the resale provisions of Rule 701, but all holders of Rule 701 shares are required to wait until 90 days after the date of this Prospectus before selling their shares. However, substantially all Rule 701 shares are subject to lock-up agreements as described below and will become eligible for sale upon the expiration of the restrictions set forth in those agreements.
LEGAL MATTERS
The validity of the securities offered hereby has been passed upon for us by Greenberg Traurig, LLP, Phoenix, Arizona.
EXPERTS
The consolidated balance sheet as of March 31, 2018 and December 31, 2017 and 2016 and the related consolidated statements of operations, stockholders’ equity, and cash flows for the three month period ended March 31, 2018, the years ended December 31, 2017, and for the periods from October 13, 2016 (inception) to December 31, 2016 are incorporated by reference in this Prospectus and in the registration statement have been so included in reliance on the reports of KWCO, PC, an independent registered public accounting firm, incorporated herein by reference, given on the authority of said firm as experts in accounting and auditing.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly, and current reports, proxy statements, and other information with the SEC. You may read and copy any document we file with the SEC at the SEC’s public reference room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Our SEC filings are also available to the public from the SEC’s website at www.sec.gov. The SEC’s website contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.
This Prospectus is part of a registration statement on Form S-1 that we filed with the SEC to register the securities offered hereby under the Securities Act. This Prospectus does not contain all of the information included in the registration statement, including certain exhibits and schedules. For further information with respect to our company and the securities offered by this Prospectus, as well as the exhibits and schedules to the registration statement, we refer you to the registration statement, those exhibits and schedules, and to the information incorporated by reference in this Prospectus. You may obtain the registration statement and exhibits to the registration statement from the SEC at the address listed above or from the SEC’s website.
59

INDEX TO FINANCIAL STATEMENTS

Report of KWCO, P.C. | 58
Consolidated Balance Sheet | 59
Consolidated Statements of Operations | 60
Consolidated Statements of Stockholders’ Equity | 61
Consolidated Statements of Cash Flow | 62
Notes to Consolidated Financial Statements | 64

60

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of Ammo, Inc. Scottsdale, Arizona 85251
Opinion on the consolidated financial statements
We have audited the accompanying consolidated balance sheets of Ammo, Inc. (the Company) as of March 31, 2018 and December 31, 2017 and 2016, and the related consolidated statements of operations, stockholders’ equity, and cash flows for the three month period ended March 31, 2018, the year ended December 31, 2017 and for the period from October 13, 2016 (Inception) to December 31, 2016, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of March 31, 2018 and December 31, 2017 and 2016, and the consolidated results of its operations and its cash flows for the three month period ended March 31, 2018, the year ended December 31, 2017 and for the period from October 13, 2016 (Inception) to December 31, 2016, in conformity with accounting principles generally accepted in the United States of America.
Basis for opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ KWCO, PC
KWCO, PC
We have served as the Company’s auditor since 2016.
Odessa, Texas
May 24, 2018
61

Ammo, Inc.
CONSOLIDATED BALANCE SHEETS

|  | March 31, 2018 |  |  | December 31, 2017 |  |  | December 31, 2016 |
ASSETS |  |  |  |  |  |  |  |  |
Current Assets: |  |  |  |  |  |  |  |  |
Cash |  | $ | 4,381,643 |  |  | $ | 786,823 |  |  | $ | 10,116 |
Accounts receivable, net of allowance for doubtful accounts of $23,046 |  |  |  |  |  |  |  |  |
at March 31, 2018 and $26,046 at December 31, 2017 |  |  | 1,201,117 |  |  |  | 166,731 |  |  |  | - |
Due from related parties |  |  | 14,204 |  |  |  | 18,461 |  |  |  | - |
Vendor notes receivable, net of allowance for doubtful |  |  |  |  |  |  |  |  |  |  |  |
collection of $360,993 |  |  | - |  |  |  | - |  |  |  | 2,585,000 |
Vendor advances receivable |  |  | - |  |  |  | - |  |  |  | 89,934 |
Inventories, at lower of cost or market, principally average cost method |  |  | 2,405,007 |  |  |  | 1,792,314 |  |  |  | 219,105 |
Prepaid expenses |  |  | 321,074 |  |  |  | 254,732 |  |  |  | - |
Total Current Assets |  |  | 8,323,045 |  |  |  | 3,019,061 |  |  |  | 2,904,155 |
Equipment, net of accumulated depreciation of $113,158 at March 31, |  |  |  |  |  |  |  |  |
2018 and $77,861 at December 31, 2017 |  |  | 1,241,326 |  |  |  | 769,442 |  |  |  | - |
Other Assets: |  |  |  |  |  |  |  |  |  |  |  |
Deposits |  |  | 16,300 |  |  |  | - |  |  |  | - |
Licensing agreements, net of accumulated amortization of $58,333 at |  |  |  |  |  |  |  |  |
March 31, 2018 and $45,833 at December 31, 2017 |  |  | 191,667 |  |  |  | 204,167 |  |  |  | 125,000 |
Patents, net of accumulated amortization of $49,627 at March 31, |  |  |  |  |  |  |  |  |
2018 and $25,166 at December 31, 2017 |  |  | 900,373 |  |  |  | 924,834 |  |  |  | - |
TOTAL ASSETS |  | $ | 10,672,711 |  |  | $ | 4,917,504 |  |  | $ | 3,029,155 |
LIABILITIES AND SHAREHOLDERS' EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Current Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | 479,465 |  |  | $ | 476,893 |  |  | $ | 57,995 |
Accrued liabilities |  |  | 541,210 |  |  |  | 254,774 |  |  |  | - |
Convertible note payable, net of debt discount of $356,250 |  |  |  |  |  |  |  |  |  |  |  |
at December 31, 2016 |  |  | - |  |  |  | 1,575,000 |  |  |  | 1,518,750 |
Note payable - related party |  |  | - |  |  |  | 100,000 |  |  |  | 960,000 |
Insurance premium note payable |  |  | 99,907 |  |  |  | 6,880 |  |  |  | - |
Total Current Liabilities |  |  | 1,120,582 |  |  |  | 2,413,547 |  |  |  | 2,536,745 |
Shareholders' Equity: |  |  |  |  |  |  |  |  |  |  |  |
Common stock, $0.001 par value, 100,000,000 shares authorized; |  |  |  |  |  |  |  |  |
28,394,503, 22,487,793 and 15,754,000 shares issued and outstanding at |  |  |  |  |  |  |  |  |
March 31, 2018, December 31, 2017 and 2016, respectively |  |  | 28,394 |  |  |  | 22,488 |  |  |  | 15,754 |
Additional paid-in capital |  |  | 17,264,888 |  |  |  | 8,430,394 |  |  |  | 799,180 |
Stock subscription receivable |  |  | - |  |  |  | (5,000 | ) |  |  | (167,500 | )
Accumulated (Deficit) |  |  | (7,741,153 | ) |  |  | (5,943,925 | ) |  |  | (155,024 | )
Total Shareholders' Equity |  |  | 9,552,129 |  |  |  | 2,503,957 |  |  |  | 492,410 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |  | $ | 10,672,711 |  |  | $ | 4,917,504 |  |  | $ | 3,029,155 |

The accompanying notes are an integral part of these consolidated financial statements.
62

Ammo, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS

|  | For the Three Months Ended March 31, |  |  | For the Year Ended December 31, |  |  | For the Period October 13, 2016 (Inception) to December 31, |
|  | 2018 |  |  | 2017 |  |  | 2016 |
Gross Sales, net of customer incentives, discounts, returns, and allowances |  |  | 1,960,688 |  |  | $ | 1,294,861 |  |  | $ | - |
Cost of Goods Sold, includes depreciation and amortization of $66,405 and |  |  |  |  |
$141,575 in 2018 and 2017, respectively, and federal excise taxes of |  |  |  |  |  |  |  |  |
$194,003 and $132,294 in 2018 and 2017, respectively |  |  | 1,667,614 |  |  |  | 1,303,586 |  |  |  | - |
Gross Margin |  |  | 293,074 |  |  |  | (8,725 | ) |  |  | - |
Operating Expenses |  |  |  |  |  |  |  |  |  |  |  |
Selling and marketing |  |  | 585,294 |  |  |  | 759,053 |  |  |  | - |
Corporate general and administrative |  |  | 589,983 |  |  |  | 2,154,498 |  |  |  | 136,274 |
Employee salaries and related expenses |  |  | 914,258 |  |  |  | 1,046,667 |  |  |  | - |
Depreciation expense |  |  | 5,853 |  |  |  | 7,285 |  |  |  | - |
Total operating expenses |  |  | 2,095,388 |  |  |  | 3,967,503 |  |  |  | 136,274 |
Loss from Operations |  |  | (1,802,314 | ) |  |  | (3,976,228 | ) |  |  | (136,274 | )
Other (Expenses) |  |  |  |  |  |  |  |  |  |  |  |
Loss on vendor notes receivable foreclosure |  |  | - |  |  |  | (1,279,921 | ) |  |  | - |
Interest expense |  |  | 5,086 |  |  |  | (532,752 | ) |  |  | (18,750 | )
(Loss) before Income Taxes |  |  | (1,797,228 | ) |  |  | (5,788,901 | ) |  |  | (155,024 | )
Provision for Income Taxes |  |  | - |  |  |  | - |  |  |  | - |
Net (Loss) |  | $ | (1,797,228 | ) |  | $ | (5,788,901 | ) |  | $ | (155,024 | )
(Loss) per share |  |  |  |  |  |  |  |  |  |  |  |
Basic and fully diluted: |  |  |  |  |  |  |  |  |  |  |  |
Weighted average number of shares outstanding |  |  | 26,045,890 |  |  |  | 19,279,601 |  |  |  | 15,754,000 |
(Loss) per share |  | $ | (0.07 | ) |  | $ | (0.30 | ) |  | $ | (0.01 | )

The accompanying notes are an integral part of these consolidated financial statements.
63

Ammo, Inc.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
For the Three Months Ended March 31, 2018, For the Year Ended December 31, 2017 and
For the Period October 13, 2016 (Inception) to December 31, 2016

|  | Common Shares |  |  | Additional Paid-In |  |  | Subscription |  |  | Accumulated |  |  |  |
|  | Number |  |  | Par Value |  |  | Capital |  |  | Receivable |  |  | (Deficit) |  |  | Total |
Balance as of October 13, 2016 |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Common stock issued for founder's shares |  |  | 14,934,000 |  |  |  | 14,934 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 14,934 |
Common stock issued for licensing agreement |  |  | 100,000 |  |  |  | 100 |  |  |  | 124,900 |  |  |  | - |  |  |  | - |  |  |  | 125,000 |
Common stock issued for cash |  |  | 720,000 |  |  |  | 720 |  |  |  | 899,280 |  |  |  | (167,500 | ) |  |  | - |  |  |  | 732,500 |
Organizational and fundraising cost |  |  | - |  |  |  | - |  |  |  | (225,000 | ) |  |  | - |  |  |  | - |  |  |  | (225,000 | )
Net loss for period ended December 31, 2016 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (155,024 | ) |  |  | (155,024 | )
Balance as of December 31, 2016 |  |  | 15,754,000 |  |  | $ | 15,754 |  |  | $ | 799,180 |  |  | $ | (167,500 | ) |  | $ | (155,024 | ) |  | $ | 492,410 |
Reverse merger and recapitalization |  |  | 604,371 |  |  |  | 604 |  |  |  | (604 | ) |  |  | - |  |  |  | - |  |  |  | - |
Subscriptions collected |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 167,500 |  |  |  | - |  |  |  | 167,500 |
Common stock issued to founders |  |  | 500,000 |  |  |  | 500 |  |  |  | 145 |  |  |  | - |  |  |  | - |  |  |  | 645 |
Founder shares repurchased |  |  | (400,000 | ) |  |  | (400 | ) |  |  | (99,600 | ) |  |  | - |  |  |  | - |  |  |  | (100,000 | )
Common stock issued for cash |  |  | 4,640,822 |  |  |  | 4,641 |  |  |  | 6,034,259 |  |  |  | - |  |  |  | - |  |  |  | 6,038,900 |
Common stock issued for payment of legal fees |  |  | 49,600 |  |  |  | 50 |  |  |  | 123,950 |  |  |  | - |  |  |  | - |  |  |  | 124,000 |
Subscription receivable |  |  | 4,000 |  |  |  | 4 |  |  |  | 4,996 |  |  |  | (5,000 | ) |  |  | - |  |  |  | - |
Organizational and fundraising cost |  |  | 20,000 |  |  |  | 20 |  |  |  | (179,770 | ) |  |  | - |  |  |  | - |  |  |  | (179,750 | )
Common stock issued for licensing agreement |  |  | 100,000 |  |  |  | 100 |  |  |  | 124,900 |  |  |  | - |  |  |  | - |  |  |  | 125,000 |
Legal, advisory and consulting fees |  |  | 495,000 |  |  |  | 495 |  |  |  | 554,130 |  |  |  | - |  |  |  | - |  |  |  | 554,625 |
Employee stock awards |  |  | 120,000 |  |  |  | 120 |  |  |  | 159,880 |  |  |  | - |  |  |  | - |  |  |  | 160,000 |
Shares issued for patents |  |  | 600,000 |  |  |  | 600 |  |  |  | 749,400 |  |  |  | - |  |  |  | - |  |  |  | 750,000 |
Imputed interest on related party note |  |  | - |  |  |  | - |  |  |  | 46,340 |  |  |  | - |  |  |  | - |  |  |  | 46,340 |
Issuance of warrants for interest |  |  | - |  |  |  | - |  |  |  | 46,188 |  |  |  | - |  |  |  | - |  |  |  | 46,188 |
Issuance of warrants for services |  |  | - |  |  |  | - |  |  |  | 67,000 |  |  |  | - |  |  |  | - |  |  |  | 67,000 |
Net loss for year ended December 31, 2017 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (5,788,901 | ) |  |  | (5,788,901 | )
Balance as of December 31, 2017 |  |  | 22,487,793 |  |  | $ | 22,488 |  |  | $ | 8,430,394 |  |  | $ | (5,000 | ) |  | $ | (5,943,925 | ) |  | $ | 2,503,957 |
Subscription collected |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 5,000 |  |  |  | - |  |  |  | 5,000 |
Common stock issued for cash |  |  | 5,614,210 |  |  |  | 5,614 |  |  |  | 9,257,810 |  |  |  | - |  |  |  | - |  |  |  | 9,263,424 |
Organizational and fundraising cost |  |  | - |  |  |  | - |  |  |  | (1,137,211 | ) |  |  | - |  |  |  | - |  |  |  | (1,137,211 | )
Employee stock awards |  |  | 292,500 |  |  |  | 292 |  |  |  | 482,332 |  |  |  | - |  |  |  | - |  |  |  | 482,624 |
Stock grant expense |  |  |  |  |  |  |  |  |  |  | 106,563 |  |  |  |  |  |  |  |  |  |  |  | 106,563 |
Issuance of warrants for services |  |  | - |  |  |  | - |  |  |  | 125,000 |  |  |  | - |  |  |  | - |  |  |  | 125,000 |
Net loss for period ended March 31, 2018 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (1,797,228 | ) |  |  | (1,797,228 | )
Balance as of March 31, 2018 |  |  | 28,394,503 |  |  | $ | 28,394 |  |  | $ | 17,264,888 |  |  | $ | - |  |  | $ | (7,741,153 | ) |  | $ | 9,552,129 |

The accompanying notes are an integral part of these consolidated financial statements.
64

Ammo, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOW

|  | For the Three Months Ended March 31, |  |  | For the Year Ended December 31, |  |  | For the Period October 13, 2016 (Inception) to December 31 |
|  | 2018 |  |  | 2017 |  |  | 2016 |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |
Net (Loss) |  | $ | (1,797,228 | ) |  | $ | (5,788,901 | ) |  | $ | (155,024 | )
Adjustments to reconcile Net (Loss) to Net Cash provided by operations: |
Debt discount amortization |  |  | - |  |  |  | 356,250 |  |  |  | 18,750 |
Depreciation and amortization |  |  | 72,258 |  |  |  | 148,860 |  |  |  | - |
Loss on vendor notes receivable foreclosure |  |  | - |  |  |  | 1,279,921 |  |  |  | - |
Founders shares issued as consulting fees |  |  | - |  |  |  | - |  |  |  | 14,934 |
Stock for services |  |  | - |  |  |  | 454,625 |  |  |  | - |
Warrants for services and interest |  |  | 125,000 |  |  |  | 113,188 |  |  |  | - |
Employee stock awards |  |  | 482,624 |  |  |  | 160,000 |  |  |  | - |
Stock Grants |  |  | 106,563 |  |  |  | - |  |  |  | - |
Imputed interest |  |  | - |  |  |  | 46,340 |  |  |  | - |
Changes in Current Assets and Liabilities |  |  |  |  |  |  |  |  |  |  |  |
Vendor notes receivable |  |  | - |  |  |  | - |  |  |  | (1,550,000 | )
Vendor advances receivable |  |  | - |  |  |  | 186,486 |  |  |  | (89,934 | )
Accounts receivable |  |  | (1,031,385 | ) |  |  | (171,812 | ) |  |  | - |
Allowance for doubtful accounts |  |  | (3,000 | ) |  |  | 26,046 |  |  |  | - |
Due from related parties |  |  | 4,257 |  |  |  | (18,461 | ) |  |  | - |
Inventories |  |  | (612,693 | ) |  |  | (928,762 | ) |  |  | (219,105 | )
Prepaid expenses |  |  | 101,114 |  |  |  | 183,181 |  |  |  | - |
Deposits |  |  | (16,300 | ) |  |  | - |  |  |  | - |
Accounts payable |  |  | 2,572 |  |  |  | 418,898 |  |  |  | 57,995 |
Accrued liabilities |  |  | 286,435 |  |  |  | 254,774 |  |  |  | - |
Net cash used in operating activities |  |  | (2,279,783 | ) |  |  | (3,279,367 | ) |  |  | (1,922,384 | )
Cash flows from investing activities |  |  |  |  |  |  |  |  |  |  |  |
Purchase of equipment |  |  | (507,181 | ) |  |  | (304,188 | ) |  |  | - |
Patent Note Payment |  |  | (100,000 | ) |  |  | (100,000 | ) |  |  | - |
Net cash used in investing activities |  |  | (607,181 | ) |  |  | (404,188 | ) |  |  | - |
Cash flow from financing activities |  |  |  |  |  |  |  |  |  |  |  |
Convertible note payable |  |  | (1,575,000 | ) |  |  | - |  |  |  | 1,500,000 |
Convertible note payment |  |  | - |  |  |  | (300,000 | ) |  |  | - |
Note payment - related party |  |  | - |  |  |  | (960,000 | ) |  |  | (75,000 | )
Insurance premium note payment |  |  | (74,429 | ) |  |  | (207,033 | ) |  |  | - |
Sale of common stock |  |  | 9,263,424 |  |  |  | 6,038,900 |  |  |  | 732,500 |
Collection of stock subscription |  |  | 5,000 |  |  |  | 167,500 |  |  |  | - |
Common stock activity - founder shares |  |  | - |  |  |  | (99,355 | ) |  |  | - |

65

(Continued)
Ammo, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOW

|  | For the Three Months Ended March 31, |  |  | For the Year Ended December 31, |  |  | For the Period October 13, 2016 (Inception) to December 31 |
|  | 2018 |  |  | 2017 |  |  | 2016 |
Organizational and fundraising costs |  |  | (1,137,211 | ) |  |  | (179,750 | ) |  |  | (225,000 | )
Net cash provided by financing activities |  |  | 6,481,784 |  |  |  | 4,460,262 |  |  |  | 1,932,500 |
Net increase in cash |  |  | 3,594,820 |  |  |  | 776,707 |  |  |  | 10,116 |
Cash, beginning of period |  |  | 786,823 |  |  |  | 10,116 |  |  |  | - |
Cash, end of period |  | $ | 4,381,643 |  |  | $ | 786,823 |  |  | $ | 10,116 |
Supplemental cash flow disclosures |  |  |  |  |  |  |  |  |  |  |  |
Cash paid during the period for - |  |  |  |  |  |  |  |  |  |  |  |
Interest |  | $ | - |  |  | $ | 9,105 |  |  | $ | - |
Income taxes |  | $ | - |  |  | $ | - |  |  | $ | - |
Non-cash investing and financing activities: |  |  |  |  |  |  |  |  |  |  |  |
Vendor note receivable foreclosure - |  |  |  |  |  |  |  |  |  |  |  |
Vendor notes receivable |  | $ | - |  |  | $ | 1,305,079 |  |  | $ | - |
Vendor advances receivable |  |  | - |  |  |  | (96,552 | ) |  |  | - |
Accounts receivable |  |  | - |  |  |  | (20,965 | ) |  |  | - |
Inventories |  |  | - |  |  |  | (644,447 | ) |  |  | - |
Equipment |  |  | - |  |  |  | (543,115 | ) |  |  | - |
Vendor notes receivable |  |  | - |  |  |  | - |  |  |  | (1,035,000 | )
Licensing Agreement |  |  | - |  |  |  | (125,000 | ) |  |  | (125,000 | )
Issuance of common stock |  |  | - |  |  |  | 125,000 |  |  |  | - |
Insurance premium note payable |  |  | 167,456 |  |  |  | 213,913 |  |  |  | - |
Prepaid expense |  |  | (167,456 | ) |  |  | (213,913 | ) |  |  | - |
Common Stock |  |  | - |  |  |  | 604 |  |  |  | - |
Additional paid-in-capital |  |  | - |  |  |  | (604 | ) |  |  | - |
Prepaid legal services |  |  | - |  |  |  | (224,000 | ) |  |  | - |
Issuance of common stock |  |  | - |  |  |  | 224,000 |  |  |  | 125,000 |
Notes payable - related parties |  |  |  |  |  |  | - |  |  |  | 1,035,000 |
Issuance of common stock |  |  | - |  |  |  | 750,000 |  |  |  | - |
Patent acquisition |  |  | - |  |  |  | (750,000 | ) |  |  | - |
Stock subscription receivable |  |  | - |  |  |  | (5,000 | ) |  |  | (167,500 | )
Additional paid-in-capital |  |  | - |  |  |  | 5,000 |  |  |  | 167,500 |
|  | $ | - |  |  | $ | - |  |  | $ | - |

The accompanying notes are an integral part of these consolidated financial statements.
66

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
NOTE 1 – ORGANIZATION AND BUSINESS ACTIVITY
We were formed under the name Retrospettiva, Inc. in November 1990 to manufacture and import textile products, including both finished garments and fabrics. We were inactive until following a series of events in December 2016 and March 2017. On December 15, 2016, our then principal stockholders sold their outstanding common stock to Fred W. Wagenhals, who is our Chairman of the Board, President, Chief Executive Officer, and largest stockholder. On the same date, Mr. Wagenhals became the sole officer and director of our company; we changed our name to AMMO, Inc., changed our trading symbol to POWW, changed our state of incorporation from California to Delaware, engaged in a 1-for-25 reverse stock split, and increased our authorized Common Stock to 100,000,000 shares of Common Stock.
Our principal stockholder organized another company ("AIP"), which immediately began to take steps to commence its ammunition business. On March 17, 2017, we entered into a Share Exchange Agreement with the stockholders of AIP that resulted in our acquisition of all the shares of common stock of AIP for 604,371 shares of our common stock and our succession to the ammunition business of AIP.
AIP entered into a licensing and endorsement agreement with Jesse James, a well-known motorcycle and gun designer in October 2016, and a license and endorsement agreement with Jeff Rann, a well-known wild game hunter, guide, and spokesman for the firearm and ammunition industry, in February 2017; received a Federal Firearms License from the Bureau of Alcohol, Tobacco, and Explosives in February 2017; purchased an ammunition manufacturing facility in Payson, Arizona in March 2017; built a management team; and otherwise prepared itself to participate in the ammunition industry.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Accounting Basis
We use the accrual basis of accounting and accounting principles generally accepted in the United States of America ("GAAP") and all amounts are expressed in U.S. dollars. We have adopted a March 31 year end.
The financial statements and related disclosures as of March 31, 2018, December 31, 2017, and December 31, 2016 are presented pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Unless the context otherwise requires, all references to "Ammo", "we", "us", "our," or the "Company" are to AMMO, Inc., a Delaware corporation.
Principles of Consolidation
The consolidated financial statements include the accounts of Ammo, Inc. and its wholly owned subsidiaries, SNI, LLC, and Ammo Technologies, Inc (inactive). All significant intercompany accounts and transactions are eliminated in consolidation
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
For purposes of the statement of cash flows, we consider highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.
67

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and for December 31, 2017 and 2016
Accounts Receivable and Allowance for Doubtful Accounts
Our accounts receivable represent amounts due from customers for products sold and include an allowance for uncollectible accounts which is estimated based on the aging of the accounts receivable and specific identification of uncollectible accounts. At March 31, 2018 and December 31, 2017, we reserved $23,046 and $26,046, respectively, of allowance for doubtful accounts.
License Agreements
We are a party to a license agreement with Jesse James, a well-known motorcycle designer, and Jesse James Firearms, LLC, a Texas limited liability company, or JJF. The license agreement grants us the exclusive worldwide rights through October 15, 2021 to Mr. James' image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of Jesse James Branded Products. In addition, Mr. James agreed to make himself available for certain promotional activities and to promote Jesse James Branded Products through his own social media outlets. We agreed to pay Mr. James royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses. We also issued 100,000 shares of our common stock upon the execution of the license agreement with the potential issuance of up to 75,000 additional shares of common stock upon achieving certain gross sales with $15 million in gross sales required to earn the entire 75,000 shares.
We are a party to a license agreement with Jeff Rann, a well-known wild game hunter and spokesman for the firearm and ammunition industries. The license agreement grants us through February 2022 the exclusive worldwide rights to Mr. Rann's image rights and trademarks associated with him in connection with the marketing, promotion, advertising, sale, and commercial exploitation of all Jeff Rann Branded Products. Mr. Rann agreed to make himself available for certain promotional activities and to promote the Branded Products through his own social media outlets. We agreed to pay Mr. Rann royalty fees on the sale of ammunition and non-ammunition Branded Products and to reimburse him for any out-of-pocket expenses and reasonable travel expenses. We also issued 100,000 shares of our common stock upon the execution of the license agreement with the potential issuance of 75,000 additional shares of common stock upon achieving certain gross sales with $15 million in gross sales required to earn the entire 75,000 shares.
Patent
On September 28, 2017, Ammo Technologies Inc. ("ATI"), an Arizona corporation, which is 100% owned by us, merged with Hallam, Inc, a Texas corporation, with ATI being the survivor. Under the terms of the Merger, we, the sole shareholder of Ammo Technologies Inc., issued to Hallam, Inc.'s two shareholders, 600,000 shares of our common stock, subject to restrictions, and payment of $200,000. The first payment of $100,000 to the Hallam, Inc. shareholders was paid on September 13, 2017, and the second payment of $100,000 was paid on February 6, 2018.
The shares were valued at $1.25 and the aggregate value of $950,000 was recorded as a patent asset. This asset will be amortized from September 2017, the first full month of the acquired rights, through October 29, 2028. Amortization of the patent for the years ended March 31, 2018 and December 31, 2017 were $24,461 and $25,166, respectively.
Under the terms of the Merger, ATI succeeded to all of the assets of Hallam, Inc. and assumed the liabilities of Hallam, Inc., which were none. The primary asset of Hallam, Inc. was an exclusive license to produce projectiles and ammunition using the Hybrid Luminescence Ammunition Technology under patent U.S. 8,402,896 B1 with a publication date of March 26, 2013 owned by University of Louisiana at Lafayette. The license was formally amended and assigned to Ammo Technologies Inc. pursuant to an Assignment and First Amendment to Exclusive License Agreement. Assumption Agreement dated to be effective as of August 22, 2017, the Merger closing date.
Impairment of Long-Lived Assets
We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. No impairment expense was recognized for the three-months ended March 31, 2018 or the year ended December 31, 2017 or for the period from October 13, 2016 (inception) to December 31, 2016.
68

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
Revenue Recognition
We generate revenue from the production and sale of ammunition. We recognize revenue when it is realized or realizable and earned.
We consider revenue realized or realizable and earned when all of the following criteria are met:

| · | persuasive evidence of an arrangement exists

| · | the product has been shipped to the customer

| · | the sales price is fixed or determinable

| · | collectability is reasonably assured

We derived approximately 59% of total revenue from three customers during the three months ended March 31, 2018 and 68% of the accounts receivable were due from two customers at March 31, 2018. Additionally, we derived approximately 58% of total revenue from one customer for the year ended December 31, 2017 and 47% of the accounts receivable were due from two customers at December 31, 2017.
Advertising Costs
We expense advertising costs as they are incurred. We incurred advertising and marketing costs of $245,472 and $220,154 for the three months ended March 31, 2018 and for the year ended December 31, 2017, respectively.
Fair Value of Financial Instruments
We measure options and warrants at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement ("ASC 820"). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable.
Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's own assumptions. These two types of inputs have created the following fair value hierarchy:

| Level 1 – Quoted prices for identical instruments in active markets;
| Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
| Level 3 – Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

This hierarchy requires us to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value.
We value all common stock issued for services on the date of the agreements, using the price at which shares were being sold to private investors or at the value of the services performed.
We valued warrants issued for services at the grant date of March 12, 2018 using valuation methods and assumptions that consider, among other factors, the fair value of the underlying stock, risk free interest rate, volatility, and expected life.
Assumptions included:

|  | March 31, 2018 |  |  | December 31, 2017 |
Risk free interest rate |  |  | 2.05 | % |  |  | 1.31 - 1.5 | %
Expected volatility |  |  | 195 | % |  |  | 250 | %
Expected term |  | 1 year |  |  | 1 - 1.5 years |
Expected dividend yield |  |  | 0 | % |  |  | 0 | %

69

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
In the year ended December 31, 2017, Equipment acquired in the foreclosure transaction and the patent were valued on their respective acquisition dates using fair values.

|  | Quoted Active Markets for Identified Assets |  |  | Significant Other Observable Inputs |  |  | Significant Unobservable Inputs |  |  | Total |
|  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  |  |
March 31, 2018 |  |  |  |  |  |  |  |  |  |  |  |
Employee stock awards |  |  | - |  |  | $ | 482,432 |  |  | $ | - |  |  | $ | 482,432 |
Executive Stock Grant Expense |  |  | - |  |  |  | 106,563 |  |  |  | - |  |  |  | - |
Warrants issued for services |  |  | - |  |  |  | - |  |  |  | 125,000 |  |  |  | 125,000 |
December 31, 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock issued for legal, advisory and consulting fees |  |  | - |  |  | $ | 454,625 |  |  | $ | - |  |  | $ | 454,625 |
Employee stock awards |  |  | - |  |  |  | 160,000 |  |  |  | - |  |  |  | 160,000 |
Common stock for licensing agreement |  |  | - |  |  |  | 125,000 |  |  |  | - |  |  |  | 125,000 |
Patent acquisition, noncash element |  |  | - |  |  |  | - |  |  |  | 750,000 |  |  |  | 750,000 |
Warrants issued for interest |  |  | - |  |  |  | - |  |  |  | 46,188 |  |  |  | 46,188 |
Warrants issued for services |  |  | - |  |  |  | - |  |  |  | 67,000 |  |  |  | 67,000 |
Assets acquired in foreclosure |  |  | - |  |  |  | - |  |  |  | 543,115 |  |  |  | 543,115 |
Common Stock issued for prepaid legal fees |  |  | - |  |  |  | 224,000 |  |  |  | - |  |  |  | 224,000 |

Inventories
We state inventories at the lower of cost or market. We determine cost using the average cost method. Our inventory consists of raw materials, work in progress, and finished goods. Cost of inventory includes cost of parts, labor, quality control, and all other costs incurred to bring our inventories to condition ready to be sold. We periodically evaluate inventories for obsolescence.
Property and Equipment
We state property and equipment at cost, less accumulated depreciation. We capitalize major renewals and improvements, while we charge minor replacements, maintenance, and repairs to current operations. We compute depreciation by applying the straight-line method over estimated useful lives, which are generally five to seven years.
Compensated Absences
We have not accrued a liability for compensated absences in accordance with Accounting Standards Codifications 710 – Compensation – General, as the amount of the liability cannot be reasonably estimated at March 31, 2018 and December 31, 2017 and 2016.
70

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
Stock-Based Compensation
We account for stock-based compensation at fair value in accordance with SFAS No. 123 and 123 (R) (ASC 718). 125,000 warrants were issued to Ron Shostack, Chief Financial Officer. Additionally, 292,500 shares of common stock were issued to employees for services.
On March 12, 2018, we entered into an employment agreement with Kathy Hanrahan, President of our Global Tactical Defense Division and a director, that included, among other provisions, an equity grant of 400,000 shares of common stock that vests at the rate of 100,000 shares annually for four years. The $660,000 compensation value is being recognized on a straight-line basis over the four-year period for each separately vesting portion of the award as if the award was, in substance, multiple awards.
Concentrations of Credit Risk
Accounts at banks are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000 at various times. As of March 31, 2018, our bank account balances exceeded federally insured limits.
Income Taxes
We file federal and state income tax returns in accordance with the applicable rules of each jurisdiction. We account for income taxes under the asset and liability method in accordance with Accounting Standards Codification 740 - Income Taxes ("ASC 740"). The provision for income taxes includes federal, state, and local income taxes currently payable, and deferred taxes. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable amounts in years in which those temporary differences are expected to be recovered or settled. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized. In accordance with ASC 740, we recognize the effect of income tax positions only if those positions are more likely than not of being sustained. We measure recognized income tax positions at the largest amount that is greater than 50% likely of being realized. We reflect changes in recognition or measurement in the period in which the change in judgment occurs. We currently have substantial net operating loss carryforwards. We have recorded a valuation allowance equal to the net deferred tax assets due to the uncertainty of the ultimate realization of the deferred tax assets.
Contingencies
Certain conditions may exist as of the date the consolidated financial statements are issued that may result in a loss to us but will only be resolved when one or more future events occur or fail to occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we evaluate the perceived merits of any legal proceedings or unasserted claims and the perceived merits of the amount of relief sought or expected to be sought therein.
If the assessment of a contingency indicates that it is possible that a material loss has been incurred and the amount of the liability can be estimated, the estimated liability would be accrued in our consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of range of possible loss if determinable and material, would be disclosed. There were no known contingencies at December 31, 2017 or March 31, 2018.
Recent Accounting Pronouncements
We have implemented all new accounting pronouncements that are in effect and that may impact our financial statements and do not believe there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.
Loss Per Common Share
We calculate basic loss per share using the weighted-average number of shares of common stock outstanding during each reporting period. Diluted loss per share includes potentially dilutive securities, such as outstanding options and warrants, using various methods, such as the treasury stock or modified treasury stock method, in the determination of dilutive shares outstanding during each reporting period. We have issued warrants to purchase 8,872,160 shares of common stock and stock options to purchase 400,000 shares of common stock that are potentially dilutive. All weighted average numbers were adjusted for the reverse stock split and merger transaction. Diluted earnings per share exclude all potentially dilutive shares because their effect is anti-dilutive.
71

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
NOTE 3 – VENDOR NOTES RECEIVABLE
Vendor note receivable consisted of the following at December 31, 2016:

Advanced Tactical Armament Concepts, L.L.C. Notes Payable Purchased by Ammo |  | Amount |
Western Alliance Bank |  | $ | 1,910,993 |
Less: Allowance for uncollectible amounts |  |  | (360,993 | )
|  |  | 1,550,000 |
Mansfield, LLC |  |  | 1,035,000 |
|  | $ | 2,585,000 |

On October 24, 2016, we entered into an agreement to purchase from Western Alliance Bank a note payable by Advanced Tactical Armament Concepts, L.L.C. ("ATAC"), which had an outstanding balance of $1,910,993 for $1,550,000, the amount that we determined to be the asset's fair value on the date of the purchase. The loan is secured by a master lease agreement (ATAC's manufacturing equipment), all assets of ATAC, and loan guarantees from the principal owners of ATAC. We determined that the value of the purchased note was the value paid to Western Alliance Bank. This promissory note held by us, between ATAC and Western Alliance Bank, was due in full on or before February 28, 2017.
In October and November 2016, Mansfield L.L.C. ("Mansfield"), a company owned by our CEO, Fred Wagenhals, loaned ATAC $900,000 and ATAC executed a promissory note payable for that amount. The note payable was secured by all of the assets of ATAC. On December 16, 2016, we and Mansfield entered into a note purchase and sale agreement. We purchased the promissory note for $1,035,000 and assumed Mansfield's collateral position. The Managing Member of Mansfield, Tod Wagenhals, is related to our CEO. The $1,035,000 was payable on or before the closing date of the note purchase and sale agreement.
On February 20, 2017, a sale was held for the disposition of collateral for Advanced Tactical Armament Concepts, LLC, a Nevada Limited Liability Company. We were a secured party and submitted a creditor bid. Our bid for the sale for the disposition of collateral was the highest and was accepted. We reflected this transaction in the following manner:

Vendor notes receivable |  | $ | $2,585,000 |
Vendor advances receivable |  |  | (96,552 | )
Accounts receivable |  |  | (20,965 | )
Inventories |  |  | (644,447 | )
Equipment |  |  | (543,115 | )
Loss on vendor notes receivable collectability |  |  | (1,279,921 | )
|  | $ | - |

NOTE 4 – INVENTORIES
At March 31, 2018, December 31, 2017 and 2016, the inventory balances consisted of the following:

|  | 2018 |  |  | 2017 |  |  | 2016 |
Finished product |  | $ | 809,680 |  |  | $ | 1,007,291 |  |  | $ | - |
Raw materials |  |  | 1,471,666 |  |  |  | 764,810 |  |  |  | 219,105 |
Work in process |  |  | 123,661 |  |  |  | 20,213 |  |  |  | - |
|  | $ | 2,405,007 |  |  | $ | 1,792,314 |  |  | $ | 219,105 |

72

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
NOTE 5 – PROPERTY AND EQUIPMENT
We state property and equipment at historical cost less accumulated depreciation. We compute depreciation using the straight-line method at rates intended to depreciate the cost of assets over their estimated useful lives, which are generally five to seven years. Upon retirement or sale of property and equipment, we remove the cost of the disposed assets and related accumulated depreciation from the accounts and any resulting gain or loss is credited or charged to selling, general, and administrative expenses. We charge expenditures for normal repairs and maintenance to expense as incurred.
We capitalize additions and expenditures for improving or rebuilding existing assets that extend the useful life. Leasehold improvements made either at the inception of the lease or during the lease term are amortized over the shorter of their economic lives or the lease term including any renewals that are reasonably assured.
Property and equipment consisted of the following at March 31, 2018 and December 31, 2017:

|  | 2018 |  |  | 2017 |
Leasehold Improvements |  | $ | 17,772 |  |  | $ | 15,475 |
Furniture and Fixtures |  |  | 8,102 |  |  |  | 33,751 |
Vehicles |  |  | 89,388 |  |  |  | 36,500 |
Tooling |  |  | 359,351 |  |  |  | 184,626 |
Equipment |  |  | 879,871 |  |  |  | 576,951 |
Total property and equipment |  | $ | 1,354,484 |  |  | $ | 847,303 |
Less accumulated depreciation |  |  | (113,158 | ) |  |  | (77,861 | )
Net property and equipment |  | $ | 1,241,326 |  |  | $ | 769,442 |

Depreciation expense for the three months ended March 31, 2018 and for the year ended December 31, 2017 totaled $35,297 and $77,861, respectively.
NOTE 6 – CONVERTIBLE NOTE PAYABLE
We entered into an agreement for a short-term convertible note payable to an unrelated party on December 22, 2016 with a 60-day maturity and a $1,875,000 principal balance. The note had a one-time fee of $375,000, which was amortized as interest ratably over the 60-day period. The note is convertible into shares of our common stock and one stock purchase warrant at a conversion price of $1.25 per unit and an exercise price of $2.50.
During the year ended December 31, 2016, we recognized $18,750 of interest as amortization of a portion of the one-time interest fee. As of December 31, 2016, the balance of the note payable was $1,518,750, net of $356,250 of debt discount.
During the year ended December 31, 2017, we recognized $356,250 of interest as amortization of a portion of the one-time interest fee and accrued an additional $74,896 in interest expense. As of December 31, 2017, the balance of the note payable was $1,575,000.
During the three months ended March 31, 2018, we recorded no additional interest expense and the note was paid in full.
73

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
NOTE 7 – NOTES PAYABLE – RELATED PARTY
On December 16, 2016, we and Mansfield, an entity controlled by our Chief Executive Officer, entered into a note purchase and sale agreement to purchase a promissory note held by Mansfield and payable by ATAC. We purchased the promissory note for $1,035,000. The note was repaid on December 31, 2017. Interest on the note was imputed in the amount of $46,340.
In connection with the acquisition of the patent on August 22, 2017, we were obligated to pay $200,000 to Hallam, Inc.'s shareholders. The first $100,000 was paid on August 22, 2017, and a note was executed in the amount of $100,000 which was paid in full on February 2, 2018.
On August 29, 2017, we borrowed $100,000 from a paid legal consultant to whom we issued warrants to purchase 40,000 shares of common stock with an exercise price of $0.50 per share, expiring two years from date of issuance. The warrants were valued at $46,188 and recognized as interest expense in 2017. The note was paid in full on October 31, 2017.
NOTE 8 – CAPITAL STOCK
Our authorized capital consists of 100,000,000 shares of common stock with a par value of $0.001 per share.
During the period from October 13, 2016 (Inception) to December 31, 2016, we sold 720,000 shares of our common stock for $1.25 per share, issued 14,934,000 shares of common stock to our company's founders for $14,934, and issued 100,000 shares of common stock valued at $125,000 for a license agreement
During the 12-month period ended December 31, 2017, we issued 6,733,793 shares of common stock as follows:

● | 604,371 were issued in connection with the acquisition of our business assets
● | 100,000 net shares were issued to founding shareholders
● | 4,640,822 shares were sold to investors for $6,038,900
● | 544,600 shares valued at $678,625 were issued for legal, advisory, and consulting fees
● | 600,000 shares valued at $750,000 were issued to acquire the use of a patent
● | 120,000 shares valued at $160,000 were issued to employees as compensation
● | 100,000 shares were issued to Jeff Rann for a licensing agreement
● | 24,000 shares were issued for other purposes

During the three-month period ended March 31, 2018, we issued 5,906,710 shares of common stock as follows:

| ● | 5,614,210 shares were sold to investors for $9,263,424

| ● | 292,500 shares valued at $482,624 were issued to employees and directors as compensation

| ● | 400,000 shares were granted to an executive that have not yet vested

74

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
At March 31, 2018, December 31, 2017 and 2016, outstanding and exercisable stock purchase warrants consisted of the following:

| 2016 |
| Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Life Remaining (Years) |
Outstanding at October 13, 2016 |  |  | - |  |  |  | - |  |  |  | - |
Granted |  |  | 720,000 |  |  | $ | 2.50 |  |  |  | 1.95 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at December 31, 2016 |  |  | 720,000 |  |  | $ | 2.50 |  |  |  | 1.95 |
Exercisable at December 31, 2016 |  |  | 720,000 |  |  | $ | 2.50 |  |  |  | 1.95 |

|  | 2017 |
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Life Remaining (Years) |
Outstanding at December 31, 2016 |  |  | 720,000 |  |  | $ | 2.50 |  |  |  | 1.95 |
Granted |  |  | 4,542,338 |  |  |  | 2.42 |  |  |  | 1.90 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at December 31, 2017 |  |  | 5,262,338 |  |  | $ | 2.43 |  |  |  | 1.77 |
Exercisable at December 31, 2017 |  |  | 5,262,338 |  |  | $ | 2.43 |  |  |  | 1.77 |

|  | 2018 |
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Life Remaining (Years) |
Outstanding at December 31, 2017 |  |  | 5,262,338 |  |  | $ | 2.43 |  |  |  | 1.77 |
Granted |  |  | 3,609,822 |  |  |  | 1.95 |  |  |  | 5.13 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | - |  |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2018 |  |  | 8,872,160 |  |  | $ | 2.23 |  |  |  | 2.97 |
Exercisable at March 31, 2018 |  |  | 8,872,160 |  |  | $ | 2.23 |  |  |  | 2.97 |

75

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
In November of 2017, the Board of Directors approved the 2017 Equity Incentive Plan (“the Plan”). Under the Plan, 485,000 shares of the common stock were reserved and authorized to be issued. As of December 31, 2017, 200,000 shares of common stock were approved and issued under the Plan, and we recognized approximately $250,000 of related consulting expense. On January 10, 2018, 200,000 shares were awarded, and we recognized $330,000 of compensation expense. There are 85,000 shares remaining to be issued under the Plan.
In October of 2017. we entered into a placement agent agreement to secure equity capital from qualified investors to provide funds to expand our operations. The offering consisted of Units priced at $1.65, which included one share of common stock and one five-year warrant to purchase an additional half-share of common stock for an exercise price of $2.00 per share. Effectively, every two units purchased provided the investor with a five-year warrant at an exercise price of $2.00 per share. Units sold under this arrangement totaled 594,702 shares of common stock and 297,351 warrants for $981,250 during the year ended December 31, 2017, and 5,614,210 shares of common stock and 2,807,105 warrants for a total of $9,263,424 for the period ended March 31, 2018. The total number of Units covered by this offering was 6,060,060, and the amount was $10,000,000. In March 2018, we entered into a second placement agent agreement with the same terms for up to an additional $3,500,000.
For services provided under the placement agreements, the placement agent collected a 12% cash fee on the sale of every Unit and a fee payable in warrants equaling 12% of the total Units sold. These warrants have a term of seven years and an exercise price of $1.65 per share. The cash fee totaled $117,750 for the year ended December 31, 2017 and $1,137,211 for the period ended March 31, 2018, including reimbursed expenses. Under this agreement, we recognized 71,364 and 673,605 warrants as authorized, but unissued as of December 31, 2017 and March 31, 2018, respectively.
NOTE 9 – ACCRUED LIABILITIES
At March 31, 2018, December 31, 2017 and December 31, 2016, accrued liabilities were as follows:

|  | 2018 |  |  | 2017 |  |  | 2016 |
Accrued payroll |  | $ | 172,419 |  |  | $ | 145,779 |  |  | $ | - |
Accrued interest |  |  | - |  |  |  | 74,896 |  |  |  | - |
Accrued FAET |  |  | 133,104 |  |  |  | 26,075 |  |  |  | - |
Accrued professional fees |  |  | 99,255 |  |  |  |  |  |  |  |  |
Other accruals |  |  | 136,432 |  |  |  | 8,024 |  |  |  | - |
|  | $ | 541,210 |  |  | $ | 254,774 |  |  | $ | - |

NOTE 10 – RELATED PARTY TRANSACTIONS
On December 16, 2016, we purchased a promissory note in the amount of $1,035,000 from Mansfield L.L.C. ("Mansfield"), a company owned by our CEO, Fred Wagenhals. We paid $75,000 on the note in the year ended December 31, 2016 and $960,000 in the year ended December 31, 2017 and recorded imputed interest of $46,340
Our executive offices are located in Scottsdale, Arizona where we lease approximately 5,000 square feet under a month-to-month triple net lease for $3,800 per month. This space houses our principal executive, administration, and marketing functions. Our Chairman, President, and Chief Executive Officer owns the building in which our executive offices are leased.
During the period ended March 31, 2018, we paid approximately $69,800 in consulting fees, and $12,434 of rent to related parties. During the year ended December 31, 2017, we paid approximately $212,700 in consulting fees, $143,000 in rents and corporate overhead and reimbursed general corporate expenses of $121,500 to related parties.
76

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
NOTE 11 – OPERATING LEASES
We are obligated under a triple-net operating lease for our 20,000 square foot manufacturing facility located in Payson, Arizona. The terms of the lease require a payment of approximately $10,000 per month, which includes an estimate for utilities, taxes, and repairs. This lease expires in November of 2021.
We believe this facility will be adequate to meet our needs in the near future. However, we are making plans to expand our building footprint in 2018 to accommodate additional automation equipment. We intend to pay for these improvements using working capital and will amortize the costs over the remaining lease period.
The following table outlines our future contractual financial obligations associated with this lease by fiscal year in which payment is expected, as of March 31, 2018:

| 2019 |  | 2020 |  | 2021 |  | 2022 |  | Total |
Payson Lease |  | $ | 120,000 |  |  | $ | 120,000 |  |  | $ | 120,000 |  |  | $ | 80,000 |  |  | $ | 440,000 |

Our executive offices are located in Scottsdale, Arizona where we lease approximately 5,000 square feet under a month-to-month triple net lease for $3,800 per month. This space houses our principal executive, administration, and marketing functions. We may require additional space in the near future but believe that suitable additional or alternative space will be available on commercially reasonable terms to accommodate our needs. This office building is owned by a related party. See Note 10.
Total lease and rent expense for the three months ended March 31, 2018 and the year ended December 31, 2017 were $47,400 and $199,950, respectively. There were no lease obligations for the period October 13, 2016 (Inception) to December 31, 2016.
77

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
NOTE 12 – INCOME TAXES
As of March 31, 2018, we had net operating loss carryforwards of approximately $5,893,235, which will expire beginning at the end of 2036. A valuation allowance has been provided for the deferred tax asset as it is uncertain whether the Company will have future taxable income.
On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act reduces the corporate tax rate to 21% effective January 1, 2018. Consequently, we have recorded an adjustment to the deferred tax provision for the year ended December 31, 2017.
Reconciliation of the benefit (expense) for income taxes with amounts determined by applying the statutory federal income rate of 21% in 2018 and 34% in 2017 and 2016 to the respective losses before income taxes as follows:

|  | 2018 |  |  | 2017 |  |  | 2016 |
Net (Loss) |  | $ | (1,797,228 | ) |  | $ | (5,788,901 | ) |  | $ | (155,024 | )
Benefit (expense) for income taxes computed using the statutory rate of 21% and 34% |  |  | 377,418 |  |  |  | 1,968,226 |  |  |  | 52,708 |
Non-deductible expense |  |  | (161,864 | ) |  |  | (360,952 | ) |  |  | (5,274 | )
Re-measurement of deferred income taxes due to tax reform |  |  | - |  |  |  | (632,683 | ) |  |  | - |
Change in valuation allowance |  |  | (215,554 | ) |  |  | (974,591 | ) |  |  | (47,434 | )
Provision for income taxes |  | $ | - |  |  | $ | - |  |  | $ | - |

Significant components of the Company's deferred tax liabilities and assets at March 31, 2018 and 2017 are as follows: |  |  |  |  |  |  |  |  |
|  | 2018 |  | 2017 |  | 2016 |
Total deferred tax assets – net operating losses |  | $ | 1,237,579 |  |  | $ | 1,022,025 |  |  | $ | 47,434 |
Deferred tax liabilities |  |  | - |  |  |  | - |  |  |  | - |
Net deferred tax assets |  |  | 1,237,579 |  |  | $ | 1,022,025 |  |  |  | 47,434 |
Valuation allowance |  | $ | (1,237,579 | ) |  | $ | (1,022,025 | ) |  | $ | (47,434 | )
|  | $ | - |  |  | $ | - |  |  | $ | - |

At March 31, 2018, net operating loss ("NOL") carry forwards summary follows:

Expiring December 31, |  |  |
2036 |  | $ | 139,512 |
2037 |  |  | 4,727,276 |
|  |  | 4,866,788 |
2018 Non-Expiring NOL |  |  | 1,026,447 |
Total NOL Carryforward |  | $ | 5,893,235 |

Tax period of 2018, 2017, and 2016 remain subject to Internal Revenue Service audit.
78

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
NOTE 13 – INTANGIBLE ASSETS
Intangible assets consist of the following:

|  |  |  |  | March 31, 2018 |
|  | Life |  |  | Licenses |  |  | Patent |
Licensing Agreement – Jesse James |  |  | 5 |  |  | $ | 125,000 |  |  | $ | - |
Licensing Agreement – Jeff Rann |  |  | 5 |  |  |  | 125,000 |  |  |  | - |
Patent |  |  | 11.2 |  |  |  | - |  |  |  | 950,000 |
|  |  |  |  |  |  | 250,000 |  |  |  | 950,000 |
Accumulated amortization – Licensing Agreements |  |  |  | (58,333 | ) |  |  | - |
Accumulated amortization – Patents |  |  |  | - |  |  |  | (49,627 | )
|  |  |  |  |  | $ | 191,667 |  |  | $ | 900,373 |

|  |  |  |  | December 31, 2017 |
|  | Life |  |  | Licenses |  |  | Patent |
Licensing Agreement – Jesse James |  |  | 5 |  |  | $ | 125,000 |  |  | $ | - |
Licensing Agreement – Jeff Rann |  |  | 5 |  |  |  | 125,000 |  |  |  | - |
Patent |  |  | 11.2 |  |  |  | - |  |  |  | 950,000 |
|  |  |  |  |  |  | 250,000 |  |  |  | 950,000 |
Accumulated amortization – Licensing Agreements |  |  |  | (45,833 | ) |  |  |  |
Accumulated amortization – Patents |  |  |  | - |  |  |  | (25,166 | )
|  |  |  |  |  | $ | 204,167 |  |  | $ | 924,834 |

Amortization expense for the three-month period ended March 31, 2018 is $36,961 and $70,999 for the year ended December 31, 2017.
NOTE 14 - SUBSEQUENT EVENTS
Subsequent to March 31, 2018, we sold an additional 1,967,886 shares of common stock for $3,247,030 and issued 236,141 common stock purchase warrants exercisable at $1.65, 983,957 common stock purchase warrants exercisable at $2.00.
We evaluated subsequent events through May 24, 2018, the date the financial statements were issued, and determined that there are not any other items to disclose.
79

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
NOTE 15 – Comparative Consolidated Financials (Unaudited)
The consolidated statement of operations and cash flows for the three-months ended March 31, 2017 follows:
Statement of Operations

|  | March 31, 2017 (Unaudited)
Gross Sales |  | $ | 653,784 |
Customer incentives, discounts, returns, and allowances |  |  | - |
Net sales |  |  | 653,784 |
Cost of Goods Sold, includes depreciation and amortization of $19,421 and |  |  |  |
federal excise taxes of $64,055 for the three months ended March 31, 2017 |  |  | 474,890 |
Gross Margin |  |  | 178,894 |
Operating Expenses |  |  |  |
Selling and marketing |  |  | 116,833 |
Corporate general and administrative |  |  | 578,402 |
Employee salaries and related expenses |  |  | 167,987 |
Depreciation expense |  |  | 379 |
Total operating expenses |  |  | 863,601 |
Loss from Operations |  |  | (684,707 | )
Other Income (Expenses) |  |  |  |
Loss on vendor notes receivable collectability |  |  | (1,414,921 | )
Interest expense |  |  | (421,180 | )
Profit (Loss) before Income Taxes |  |  | (2,520,808 | )
Provision for Income Taxes |  |  | - |
Net Profit (Loss) |  | $ | (2,520,808 | )
Loss per share |  |  |  |
Basic and fully diluted: |  |  |  |
Weighted average number of shares outstanding |  |  | 17,118,431 |
Loss per share |  | $ | (0.15 | )

80

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016
Statement of Cash Flows

|  | March 31, 2017 (Unaudited)
Cash flows from operating activities: |  |
Net (Loss) |  | $ | (2,520,808 | )
Adjustments to reconcile Net (Loss) to Net Cash provided by operations: |  |  |  |
Debt discount amortization |  |  | 356,250 |
Depreciation and amortization |  |  | 11,343 |
Common stock issued for legal fees |  |  | 124,000 |
Uncollectible vendor notes receivable |  |  | 1,414,921 |
Changes in Current Assets and Liabilities |  |  |  |
Vendor advances receivable |  |  | 186,486 |
Accounts receivable |  |  | 4,546 |
Other receivables |  |  | (2,465 | )
Inventories |  |  | (765,320 | )
Prepaid expenses |  |  | 9,927 |
Accounts payable |  |  | 252,984 |
Accounts payable |  |  | 66,383 |
Accrued liabilities |  |  | 86,785 |
Net cash used in operating activities |  |  | (766,511 | )
Cash flows from investing activities |  |  |  |
Purchase of equipment |  |  | (36,017 | )
Net cash used in investing activities |  |  | (36,017 | )
Cash flow from financing activities |  |  |  |
Note payment - related party |  |  | (362,000 | )
Insurance premium note payments |  |  | (79,328 | )
Sale of common stock |  |  | 1,350,875 |
Organization and fundraising costs |  |  | (17,000 | )
Net cash provided by financing activities |  |  | 892,547 |
Net increase in cash |  |  | 90,019 |
Cash, beginning of period |  |  | 10,116 |
Cash, end of period |  | $ | 100,135 |
Supplemental cash flow disclosures |  |  |  |
Cash paid during the period for - |  |  |  |
Interest |  | $ | 1,297 |
Income taxes |  | $ | - |

81

AMMO, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2018 and December 31, 2017 and 2016

(Continued) |
|  | March 31, 2017 (Unaudited) |
Non-cash investing and financing activities: |  |  |
Vendor note receivable foreclosure - |  |  |
Vendor notes receivable |  | $ | 1,170,079 |
Vendor advances receivable |  |  | (96,552 | )
Accounts receivable |  |  | (20,965 | )
Inventories |  |  | (509,447 | )
Equipment |  |  | (543,115 | )
Other receivables |  |  | (20,811 | )
Accounts payable |  |  | 20,811 |
Insurance premium note payable |  |  | 180,761 |
Prepaid expenses |  |  | (180,761 | )
Common stock |  |  | 601 |
Additional paid-in-capital |  |  | (601 | )
|  | $ | - |

82

13,242,186 Shares
AMMO, INC.
Common Stock
PROSPECTUS
__________, 2018

PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
The following table sets forth the fees and expenses payable by us in connection with the offering described in the registration statement. All of the amounts shown are estimates, except for the SEC registration fee:

|  | Amount to be Paid |
SEC Registration Fee |  | $ | 9,957.86 |
Printing and Engraving Expenses |  |  | 5,000 |
Legal Fees and Expenses |  |  | 40,000 |
Accounting Fees and Expenses |  |  | 6,000 |
Transfer Agent Fees |  |  | 250 |
Miscellaneous Fees |  |  | 5,000 |
Total |  | $ | 66,207.86 |

Item 15. Indemnification of Directors and Officers.
Our certificate of incorporation and bylaws provide that we will indemnify and advance expenses, to the fullest extent permitted by the Delaware General Corporation Law, to each person who is or was a director or officer of our company, or who serves or served any other enterprise or organization at the request of our company (an “indemnitee”).
Under Delaware law, to the extent that an indemnitee is successful on the merits in defense of a suit or proceeding brought against him or her by reason of the fact that he or she is or was a director, officer, or agent of our company, or serves or served any other enterprise or organization at the request of our company, we shall indemnify him or her against expenses (including attorneys’ fees) actually and reasonably incurred in connection with such action.
If unsuccessful in defense of a third-party civil suit or a criminal suit, or if such a suit is settled, an indemnitee may be indemnified under Delaware law against both (1) expenses, including attorney’s fees, and (2) judgments, fines, and amounts paid in settlement if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of our company, and, with respect to any criminal action, had no reasonable cause to believe his or her conduct was unlawful.
If unsuccessful in defense of a suit brought by or in the right of our company, where the suit is settled, an indemnitee may be indemnified under Delaware law only against expenses (including attorneys’ fees) actually and reasonably incurred in the defense or settlement of the suit if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of our company except that if the indemnitee is adjudged to be liable for negligence or misconduct in the performance of his or her duty to our company, he or she cannot be made whole even for expenses unless a court determines that he or she is fully and reasonably entitled to indemnification for such expenses.
Also under Delaware law, expenses incurred by an officer or director in defending a civil or criminal action, suit, or proceeding may be paid by the registrant in advance of the final disposition of the suit, action, or proceeding upon receipt of an undertaking by or on behalf of the officer or director to repay such amount if it is ultimately determined that he or she is not entitled to be indemnified by our company. We may also advance expenses incurred by other employees and agents of our company upon such terms and conditions, if any, that the Board of Directors of the registrant deems appropriate.
The foregoing discussion of indemnification merely summarizes certain aspects of indemnification provisions and is limited by reference to the above discussed sections of the Nevada Private Corporations Code.
Our articles of incorporation and bylaws provide that we may indemnify to the full extent of our power to do so, all directors, officers, employees, and/or agents.
II-1

Item 16. Exhibits.

Exhibit Number | Description
2.1 | Agreement and Plan of Merger to Redomicile dated December 30, 2016 changing our status to Delaware (1)
2.2 | Articles of Merger dated December 30, 2016 filed with the California Secretary of State (1)
2.3 | Certificate of Merger dated December 21, 2016 filed with the California Secretary of State (1)
2.4 | Share Exchange Agreement dated March 17, 2017 among us, our then controlling stockholders and its stockholders (2)
3.1(a) | Articles of Incorporation filed with the Delaware Secretary of Stated on December 28, 2016 (3)
3.2 | Bylaws (1)
4.1 | Form of Warrant dated January 25, 2017 (3)
4.2 | Form of Warrant dated January 3, 2018 (3)
4.3 | Form of Purchase Warrant with Paulson Investment Company, LLC dated April 20, 2018 (3)
4.4 | Form of Certificate of Common Stock
5.1 | Opinion of Greenberg Traurig, LLP*
10.1 | License Agreement with Jesse James (3)
10.2 | License Agreement with Jeff Rann (3)
14.0 | Code of Business Conduct and Ethics for Financial Executives
14.1 | Code of Conduct
23.1 | Consent of Greenberg Traurig, LLP (included in Exhibit 5.1)
23.2 | Consent of KWCO, PC, independent registered public accounting firm
24.1 | Power of Attorney (included on the Signatures page of the registration statement)

_____________

* | To be filed by amendment to this registration statement or by a report filed under the Exchange Act and incorporated herein by reference.

(1) | Filed as an exhibit to Form 8-K filed with the Commission on February 9, 2017, and incorporated herein by reference.

(2) | Incorporation by reference to Form 8-K filed with SEC on March 23, 2017.

(3) | Filed as an exhibit to Form 10-K as filed with the Commission on May 24, 2018.

II-2

Item 17. Undertakings.
(a) The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i) To include any prospectus required by section 10(a)(3) of the Securities Act;
(ii) To reflect in the Prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; provided, however, that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference into the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(4) That, for the purpose of determining liability under the Securities Act to any purchaser:
(i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
(ii) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus related, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.
(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
II-3

SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Scottsdale, state of Arizona, on July 6, 2018.

| AMMO, INC. |
| By: | /s/ Fred W. Wagenhals |
|  | Fred W. Wagenhals President and Chief Executive Officer |

II-4

POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitute and appoint Fred W. Wagenhals and Ronald Shostack, and each one of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to sign any registration statement for the same offering covered by this registration statement that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act, and all post-effective amendments thereto, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature |  | Capacity | Date
/s/ Fred W. Wagenhals |  | Chief Executive Officer, Director | July 6, 2018
Fred W. Wagenhals |  | (Principal Executive and Accounting Officer) |
/s/ Ronald Shostack |  | Chief Financial Officer, | July 6, 2018
Ronald Shostack |  | (Principal Financial Officer) |
/s/ Kathleen Hanrahan |  | Director, | July 6, 2018
Kathleen Hanrahan |  | (Global Tactical Defense Division) |
/s/ Christopher Besing |  | Director | July 6, 2018
Christopher Besing |  |  |
/s/ Randy Luth |  | Director | July 6, 2018
Randy Luth |  |  |
/s/ Harry S. Markley |  | Director | July 6, 2018
Harry S. Markley |  |  |
/s/ Russell W. Wallace, Jr. |  | Director | July 6, 2018
Russell W. Wallace, Jr. |  |  |

II-5

EXHIBIT INDEX

Exhibit Number | Description
2.1 | Agreement and Plan of Merger to Redomicile dated December 30, 2016 changing our status to Delaware (1)
2.2 | Articles of Merger dated December 30, 2016 filed with the California Secretary of State (1)
2.3 | Certificate of Merger dated December 21, 2016 filed with the California Secretary of State (1)
2.4 | Share Exchange Agreement dated March 17, 2017 among us, our then controlling stockholders and its stockholders (2)
3.1(a) | Articles of Incorporation filed with the Delaware Secretary of Stated on December 28, 2016 (3)
3.2 | Bylaws (1)
4.1 | Form of Warrant dated January 25, 2017 (3)
4.2 | Form of Warrant dated January 3, 2018 (3)
4.3 | Form of Purchase Warrant with Paulson Investment Company, LLC dated April 20, 2018 (3)
4.4 | Form of Certificate of Common Stock
5.1 | Opinion of Greenberg Traurig, LLP*
10.1 | License Agreement with Jesse James (3)
10.2 | License Agreement with Jeff Rann (3)
14.0 | Code of Business Conduct and Ethics for Financial Executives
14.1 | Code of Conduct
23.1 | Consent of Greenberg Traurig, LLP (included in Exhibit 5.1)
23.2 | Consent of KWCO, PC, independent registered public accounting firm
24.1 | Power of Attorney (included on the Signatures page of the registration statement)

____________

* | To be filed by amendment to this registration statement or by a report filed under the Exchange Act and incorporated herein by reference.

(1) | Filed as an exhibit to Form 8-K filed with the Commission on February 9, 2017, and incorporated herein by reference.

(2) | Incorporation by reference to Form 8-K filed with SEC on March 23, 2017.

(3) | Filed as an exhibit to Form 10-K as filed with the Commission on May 24, 2018.

II-6